Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Glucose measurement

Subclass of:

600 - Surgery

600300000 - DIAGNOSTIC TESTING

600309000 - Measuring or detecting nonradioactive constituent of body liquid by means placed against or in body throughout test

Patent class list (only not empty are listed)

Deeper subclasses:

Entries
DocumentTitleDate
20130030273TECHNIQUES TO IMPROVE POLYURETHANE MEMBRANES FOR IMPLANTABLE GLUCOSE SENSORS - The invention provides an implantable membrane for regulating the transport of analytes therethrough that includes a matrix including a first polymer; and a second polymer dispersed throughout the matrix, wherein the second polymer forms a network of microdomains which when hydrated are not observable using photomicroscopy at 400× magnification or less. In one aspect, the homogeneous membrane of the present invention has hydrophilic domains dispersed substantially throughout a hydrophobic matrix to provide an optimum balance between oxygen and glucose transport to an electrochemical glucose sensor.01-31-2013
20120172694GLYCEMIC HEALTH METRIC DETERMINATION AND APPLICATION - Disclosed are methods, apparatuses, etc. for determination and application of a unidimensional metric for assessing a patient's glycemic health. In one particular implementation, a computed metric may be used to balance short-term and long-term risks associated with a particular therapy. In another implementation, a computed unidimensional metric may be used to balance risks of hyperglycemia and hypoglycemia.07-05-2012
20100022863Inserter for Transcutaneous Sensor - The invention relates to an inserter for a transcutaneous sensor comprising a sensor part e.g. for registration of the bloods content of glucose. The inserter comprises a needle unit comprising a needle hub and a carrier body, and a sensor housing. The sensor housing and the needle hub are releasably connected and when they are connected, the insertion needle is placed along the sensor e.g. surrounding the sensor wholly or partly. The carrier body guides the movement relative to the housing between a retracted and an advanced position. When released the needle unit and the sensor housing are forced by a spring unit to an advanced position where the needle and sensor are placed subcutaneously. The object of the invention is to provide a disposable inserter for a transcutaneous sensor which inserter is easy and safe for the user to handle during use and to dispose of after use.01-28-2010
20100160759Combination communication device and medical device for communicating wirelessly with a remote medical device - An electronic device may selectively disable a bolus advice process according to which the electronic device recommends delivery of a bolus amount of a drug to a body of a user based on a plurality of factors including glucose concentration of the user. The electronic device may include a glucose measuring facility configured to measure glucose concentration of a body fluid sample, and a processor including a memory having instructions stored therein that comprise the bolus advice process. The memory may further have instructions stored therein that are executable by the processor to request a glucose concentration measurement by the glucose measurement facility prior to executing, or as part of, the bolus advice process, and to disable execution of the bolus advice process if a glucose concentration value resulting from the requested glucose concentration measurement is less than a threshold value.06-24-2010
20100160761Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.06-24-2010
20100160758IN VIVO COMPONENT MEASUREMENT METHOD AND IN VIVO COMPONENT MEASUREMENT APPARATUS - An in vivo component measurement method comprises steps of: extracting a tissue fluid from a biological body into an extraction medium and accumulating an objective component and an inorganic ion in the extracted tissue fluid; acquiring ion information on a quantity of the accumulated inorganic ion; acquiring a component information on a quantity of the accumulated objective component; and acquiring an analysis value on the quantity of the objective component based on the ion information and the component information.06-24-2010
20090192380SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA - Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.07-30-2009
20110196218BLOOD GLUCOSE LEVEL MEASURING APPARATUS AND METHOD, AND MEASUREMENT DATA MANAGEMENT APPARATUS - A blood glucose level measuring apparatus and measurement data management apparatus are provided which can carry out measurement of the blood glucose level of a plurality of patients relatively rapidly and reliably, while also addressing emergency situations. The blood glucose level measuring apparatus includes a patient identifier, blood glucose level measuring device, a date/time counter, a display, and a controller. The controller controls in a normal measurement mode the cross-checking of patient identification information and a patient data table, and then, if patient identification information is not found, measurement of the blood glucose level is inhibited. The controller also controls in an emergency measurement mode in which carrying out of measurement of the blood glucose level is permitted without acquiring the patient identification information by the patient identifier.08-11-2011
20110196217BLOOD GLUCOSE LEVEL INFORMATION PROCESSING APPARATUS, BLOOD GLUCOSE LEVEL INFORMATION PROCESSING METHOD AND BLOOD GLUCOSE LEVEL INFORMATION PROCESSING PROGRAM - A blood glucose level information processing apparatus, method and program provide blood glucose values and blood glucose value information within a period or range desired by a user without imposing cumbersome operation on the user. The apparatus, method and program provide blood glucose values and blood glucose value information within a period or desired range by acquiring blood glucose levels measured by a blood glucose level measuring device and date/time of measurement at which the blood glucose levels are measured, displaying a line graph obtained by plotting the blood glucose values within a predetermined period. A slide bar can also be provided, for example on a graph display screen image, whereupon if the slide bar is moved, only the blood glucose values corresponding to a preceding period backdating in response to the amount of movement of the slide bar are plotted on a line graph along a time series.08-11-2011
20100249567MANUAL DEVICE FOR EXAMINING A BODY FLUID - The present invention provides a portable blood sugar measuring device comprising a tape unit for winding a test tape forward in sections, a detection unit for detecting measured values on the sections of tape to which body fluid has been applied, and a housing to hold the tape unit and detection unit. The tape unit and/or the detection unit can be deflected relative to the housing from an operating position against a flexible restoring element when subjected to a shock load. Also disclosed is a novel cover having open and closed positions. The cover is positioned at an opening of the housing through which the receiving site of the tape unit protrudes. The cover thus protects the receiving site from external effects when the cover is in the closed position. Similarly, the receiving site is accessible to apply body fluid thereto when the cover is in the open position.09-30-2010
20100076293Health Monitor - Methods and devices to detect analyte in body fluid are provided. Embodiments include enhanced analyte monitoring devices and systems.03-25-2010
20100076292Health Monitor - Methods and devices to detect analyte in body fluid are provided. Embodiments include enhanced analyte monitoring devices and systems.03-25-2010
20100076291Health Monitor - Methods and devices to detect analyte in body fluid are provided. Embodiments include enhanced analyte monitoring devices and systems.03-25-2010
20100076290Health Monitor - Methods and devices to detect analyte in body fluid are provided. Embodiments include enhanced analyte monitoring devices and systems.03-25-2010
20120245448SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA - Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.09-27-2012
20120245446AUTOMATIC USER-SPECIFIC SPOT BG MEASURING ROUTINE BASED ON USER CONTINUOUS BG MEASUREMENTS - A method and data processing device for automatically generating a user-specific measuring data recording routine for discontinuous blood glucose measurement with a blood glucose measuring device in a data processing device. The method comprises the steps of providing of process data indicating an expected continuous course of the blood glucose value of a user, in the calculation unit based on blood glucose measuring values from continuous blood glucose measurement, generating of user-specific measuring routine data, which indicate a measuring routine with user-specific measuring events for discontinuous blood glucose measurement with a blood glucose meter taking into account the process data by means of the calculation unit, and providing of the user-specific measuring routine data to the data output interface for data transmission.09-27-2012
20120245445Glucose Monitoring System - A body fluid sampling system for use on a tissue site includes a drive force generator and one or more microneedles operatively coupled to the drive force generator. Each of a microneedle has a height of 500 to 2000 μm and a variable tapering angle of 60 to 90°. A sample chamber is coupled to the one or more microneedles. A body fluid is created when the one or more microneedles pierces a tissue site flows to the sample chamber for glucose detection and analysis.09-27-2012
20130085358Methods for Analyte Monitoring Management and Analyte Measurement Data Management, and Articles of Manufacture Related Thereto - Generally, methods of analyte monitoring management, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data and analyzing the analyte measurement data for health related parameters. Recommendations are determined for creating or modifying a treatment program based on the analysis, and provided within a user-interface that enables a user to create or modify the treatment program. Further, generally, methods of for managing analyte measurement data, and articles of manufacturing related thereto, are provided. The methods include receiving analyte measurement data that represent data collected over a time period, and analyzing the analyte measurement data for analyte episodes within that time period. Threshold based episodes and/or rate-of-change based episodes may be determined.04-04-2013
20130079613METHOD, SYSTEM, AND COMPUTER PROGRAM PRODUCT FOR IMPROVING THE ACCURACY OF GLUCOSE SENSORS USING INSULIN DELIVERY OBSERVATION IN DIABETES - Method and System for providing a signal from an insulin pump, artificial pancreas, or another insulin delivery device as a source of information for improving the accuracy of a continuous glucose sensor (CGS). The effect of using insulin information to enhance sensor accuracy is most prominent at low blood glucose levels, i.e. in the hypoglycemic range, which is critical for any treatment. A system for providing a filtering/state estimation methodology that may be used to determine a glucose state estimate at time t-τ. The estimation may be extrapolated to some future time t and then the extrapolated value is used to extract the blood glucose component. The blood glucose component of the extrapolation and the output of the CGS are weighted and used to estimate the blood glucose level of a subject.03-28-2013
20130079612Methods for Creating Recommended Dietary Regime - The present invention relates to a method of eating a personalized dietary regime that includes receiving personal information relating to the individual; determining the individual's metabolic profile from at least one of a noninvasive or an invasive measurement; and classifying the subject into a nutrition category selected from the group consisting of a low fat diet; a low carbohydrate diet; a high protein diet; or a balanced diet, wherein the invasive measurement does not include genetic testing.03-28-2013
20100056894Self-Cleaning Membrane for Implantable Biosensors - The present disclosure relates, according to some embodiments, to compositions, devices, systems, and methods including and/or for preparing and/or using a thermoresponsive nanocomposite hydrogel. In some embodiments, the disclosure relates to methods of preparing a hydrogel including, for example, photochemically curing an aqueous solution of NIPAAm and copoly(dimethylsiloxane/methylvinylsiloxane) colloidal nanoparticles (˜219 nm). At temperatures above a volume phase transition temperature (VPTT) of ˜33-34° C., a hydrogel may deswell and become hydrophobic, while lowering the temperature below a VPTT may cause the hydrogel to swell and become hydrophilic.03-04-2010
20130035575SYSTEMS AND METHODS FOR DETECTING GLUCOSE LEVEL DATA PATTERNS - Systems and methods for detecting and reporting patterns in analyte concentration data are provided. According to some implementations, an implantable device for continuous measurement of an analyte concentration is disclosed. The implantable device includes a sensor configured to generate a signal indicative of a concentration of an analyte in a host, a memory configured to store data corresponding at least one of the generated signal and user information, a processor configured to receive data from at least one of the memory and the sensor, wherein the processor is configured to generate pattern data based on the received information, and an output module configured to output the generated pattern data. The pattern data can be based on detecting frequency and severity of analyte data in clinically risky ranges.02-07-2013
20090182217ANALYTE SENSOR - Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.07-16-2009
20100145175SYSTEMS AND METHODS FOR VERIFICATION OF SAMPLE INTEGRITY - Disclosed are methods and apparatus for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can include an additive system for adding an additive to a sample to reduce the adverse affects of bubbles and microbubbles in the sample. Some systems and methods disclosed herein include performing an auxiliary measurement cycle in the event of a failure of a scheduled measurement cycle. Some systems and methods disclosed herein include a measurement system configured for use with multiple patients.06-10-2010
20100145174System And Method For Providing A Personalized Tool For Estimating Glycated Hemoglobin - A system and method for providing a personalized tool for estimating glycated hemoglobin is provided. An electronically-stored history of empirically measured glucose levels for a patient is maintained over a set period of time in order of increasing age. A decay factor is applied to each of the measured glucose levels. The measured glucose levels are aggregated and scaled as decayed into an estimate of glycated hemoglobin for the time period. The glycated hemoglobin estimate is displayed to the patient.06-10-2010
20100145173SYSTEM AND METHOD FOR CREATING A PERSONALIZED TOOL PREDICTING A TIME COURSE OF BLOOD GLUCOSE AFFECT IN DIABETES MELLITUS - A system and method for establishing a tool of blood glucose change for diabetes mellitus management in an individual patient is provided. Factors specific to a diabetic patient are determined. An insulin sensitivity for an insulin preparation for treatment of diabetes mellitus is identified. A carbohydrate sensitivity for a known quantity of carbohydrate is identified, which is measured postprandial after a fixed time period. A management tool for the diabetic patient is generated. A time course for a dose of the insulin preparation with an amplitude of change proportioned to the insulin sensitivity is mapped. A time course for an amount of carbohydrate with an amplitude of change proportioned to the carbohydrate sensitivity is mapped. The management tool is calibrated by aggregating feedback from testing of blood glucose into at least one of the insulin and the carbohydrate sensitivities.06-10-2010
20130041242System and Method for Continuously Monitoring and Presenting Body Substances - A medical monitoring unit for continuously monitoring a glucose value and a lactate value is provided. The monitoring unit comprises: a display unit, a first unit adapted to: receive a glucose/lactate/pyruvate signal based on a measured glucose/lactate/pyruvate value, transform the glucose signal into a graphically displayable glucose/lactate/pyruvate signal, and transmit the graphically displayable glucose/lactate/pyruvate signal to the display unit of the monitoring unit, and a second unit adapted to: receive a glucose/lactate/pyruvate signal based on a measured glucose/lactate/pyruvate value, transform the glucose/lactate/pyruvate signal into a graphically displayable glucose/lactate/pyruvate signal, and transmit the graphically displayable glucose/lactate/pyruvate signal to the display unit of the monitoring unit. Furthermore, a system comprising the monitoring unit, and a sensor unit for sensing glucose and/or lactate and/or pyruvate values, is provided, as well as a method for performing the steps made possible through the provided unit and method.02-14-2013
20120265043Method and System for Providing Integrated Analyte Monitoring and Infusion System Therapy Management - Method and system for providing diabetes management and insulin therapy based on substantially real time glucose monitoring system is provided.10-18-2012
20100324402Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.12-23-2010
20100324399ANALYTE MONITORING DEVICE AND METHODS OF USE - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.12-23-2010
20090156924SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA - Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.06-18-2009
20090156923Meter Having Post-Meal Test-Time Alarm - A method for using a meter and a meter (06-18-2009
20100106001Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.04-29-2010
20090131776ANALYTE SENSOR - Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.05-21-2009
20100331652MODULAR DIABETES MANAGEMENT SYSTEMS - In one embodiment, a modular diabetes management system includes a portable, stand-alone blood glucose meter and a portable docking device that includes an internal receptacle sized and structured to receive and house the blood glucose meter. The docking device is generally operable to interface with the blood glucose meter and perform various diabetes management functions. For example, the docking device may be operable to analyze blood glucose measurement data stored on the blood glucose meter, configure the blood glucose meter, and/or interact with an insulin delivery device, just to name a few possibilities. Other embodiments include unique methods, systems, kits, assemblies, equipment, and/or apparatus which are related to the management of diabetes.12-30-2010
20100331650EPISODIC BLOOD GLUCOSE MONITORING SYSTEM WITH AN INTERACTIVE GRAPHICAL USER INTERFACE AND METHODS THEREOF - A blood glucose monitoring system with a graphical user interface (GUI) and methods of controlling the system and performing episodic blood glucose testing using the GUI are disclosed. The system can comprise the GUI, an output display for displaying the GUI, user interfaces, a memory and a processor. An episodic blood glucose testing protocol can be programmed into the processor using the user interfaces and automatically saved into memory. A user can be alerted to test blood glucose levels based on the inputted testing protocol by the display of an alert icon on the GUI. Blood glucose level results can be received, displayed on the GUI along with a range icon and automatically saved into memory. Statistics of the saved blood glucose results can be calculated by the processor and saved into memory. The statistics can be retrieved for display on the GUI when prompted by the user.12-30-2010
20120215085DEVICE AND METHOD FOR DETERMINING BLOOD GLUCOSE CHARACTERISTICS - A device is provided for determining blood glucose characteristics including a display configured for presenting a graphical representation of a plurality of measurements of blood glucose values, wherein the graphical representation comprises a trend indicator indicating an approximate value trend in the sensed blood glucose value over a recent series of measurements, based on graphical segments having different graphical styles assigned to different ranges of sensed blood glucose values in order to indicating a transition from a first range to a second range of sensed blood glucose values. An associated method for operating a device for determining blood glucose characteristics is also provided.08-23-2012
20090124879TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.05-14-2009
20090036764FLUID INJECTION AND SAFETY SYSTEM - Various medical systems and methods are described, including a medical monitoring system. The medical monitoring system can have a fluid system configured to receive bodily fluid and optically analyze said fluid to determine analyte concentration. The fluid system can have a removable portion. The removable portion can have an opening with a port. The system can also have a container configured to contain anticoagulant. The container can have a portion configured to mate with the port of the removable portion. The container can be further configured to not fit into a conventional luer fitting. An anti-coagulant insertion apparatus is also described. The apparatus can have a syringe, a dock with a port, and an adapter configured to connect the syringe to the port. The dock can also have a tab configured to move with the port.02-05-2009
20110004085PERFORMANCE REPORTS ASSOCIATED WITH CONTINUOUS SENSOR DATA FROM MULTIPLE ANALYSIS TIME PERIODS - A method of providing performance reports to persons associated with the monitoring of an analyte level, such as blood glucose concentrations in a host, is provided. The performance reports can indicate a measure of an analyte variability of the host over a first analysis time period compared to a measure of analyte variability of the host over one or more other analysis time periods. The analyte level of the host can be received in each of a plurality of sensor readings from a continuous analyte sensor, such as multiple sensor readings per hour, so that the analyte variability that is used in determining the performance report of the host can be based on not just a few metered readings taken by the host, but a plurality of intermittent readings that are taken by a continuous analyte sensor, for example. Various types of performance reports can be generated, such as reports that comprise charts, graphs, tables, and/or other visual indicia of a host's performance during one analysis period versus another analysis period.01-06-2011
20090105569Introducer Assembly and Methods of Use - Method and apparatus for inserting at least a portion of a sensor into a patient is provided.04-23-2009
20090306490Methods and Devices for Non-Invasive Analyte Measurement - Methods and compositions for the non-invasive determination of the concentration of an analyte are provided.12-10-2009
20130060113METHODS AND APPARATUS FOR EVALUATING GLUCOSE LEVELS AROUND A REPEATING EVENT - Methods for evaluating changes in glucose levels include selecting a repeating event, obtaining a pre-event measurement and a post-event measurement for a plurality of occurrences of the repeating event wherein a glucose change between the pre-event measurement and post-event measurement may be determined for each of the plurality of occurrences of the repeating event, and, recording unique details for each of the plurality of occurrences of the repeating event such that the unique details may be correlated with the glucose change for each of the plurality of occurrences of the repeating event.03-07-2013
20130060112SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION - Systems and methods for processing sensor analyte data are disclosed, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. The sensor can be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. Reference data resulting from benchtop testing an analyte sensor prior to its insertion can be used to provide initial calibration of the sensor data. Reference data from a short term continuous analyte sensor implanted in a user can be used to initially calibrate or update sensor data from a long term continuous analyte sensor.03-07-2013
20130060111DUAL PAD FOR HYGIENE AND DETECTING CONDITIONS - The present invention provides a hygienic pad enabled not only to collect human discharges when a man or a woman uses the pad, but also to detect reactants contained in the discharges. The detected reactants are indicators of medical conditions. Means to detect the reactants are incorporated into the hygienic pad.03-07-2013
20110015511SYSTEMS AND METHODS FOR OPTIMIZING INSULIN DOSAGE - Embodiments of a testing method suitable for diabetic persons to optimize their administered insulin dosage comprise collecting one or more sampling sets of biomarker data, wherein each sampling set comprises a sufficient plurality of non-adverse sampling instances and wherein each sampling instance comprises an acceptable biomarker reading at a single point in time recorded upon compliance with adherence criteria, determining a biomarker sampling parameter from each sampling set, comparing the biomarker sampling parameter to a target biomarker range, calculating an insulin adjustment parameter associated with the biomarker sampling parameter if the biomarker sampling parameter falls outside the target biomarker range, adjusting the insulin dosage by the insulin adjustment parameter if the biomarker sampling parameter falls outside the target biomarker range and if the insulin dosage does not exceed maximum dosage, and exiting the testing method if the adjusted insulin dosage is optimized. The insulin dosage is optimized when one or more biomarker sampling parameters fall within a target biomarker range.01-20-2011
20090299163Method and Apparatus for Providing Data Communication in Data Monitoring and Management Systems - Method and apparatus for communicating with a sealed electronic device via the electronic device's existing data ports for programming, testing configuration or diagnosis of the electronic device such as a transmitter unit for use in a data monitoring and management system such as analyte monitoring and management system is provided.12-03-2009
20090299162SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR - Systems and methods for dynamically and intelligently estimating analyte data from a continuous analyte sensor, including receiving a data stream, selecting one of a plurality of algorithms, and employing the selected algorithm to estimate analyte values. Additional data processing includes evaluating the selected estimative algorithms, analyzing a variation of the estimated analyte values based on statistical, clinical, or physiological parameters, comparing the estimated analyte values with corresponding measure analyte values, and providing output to a user. Estimation can be used to compensate for time lag, match sensor data with corresponding reference data, warn of upcoming clinical risk, replace erroneous sensor data signals, and provide more timely analyte information encourage proactive behavior and preempt clinical risk.12-03-2009
20090270706ANALYTE MONITORING - Methods for covering an opening in an analyte meter are provided. Also provided are methods of determining analyte concentration.10-29-2009
20090270705Automobile Physiological Monitoring System and Method for Using the Same - An automobile monitoring system to monitor user body characteristics includes at least one sensor to monitor at least one user body characteristic. The at least one sensor is operatively coupled to a body of a user to monitor the at least one user body characteristic while the user is operating an automobile. The at least one user body characteristic is at least a glucose level of the user's body. At least one transmitter is operatively coupled to the at least one sensor to communicate sensor data obtained from the at least one sensor while the user is operating the automobile. Automobile electronics are operatively coupled to the at least one transmitter to receive sensor data from the at least one sensor while the user is operating the automobile. The automobile electronics provide the sensor data to the user while the user is operating the automobile. A global positioning system (GPS) is operatively coupled to the automobile electronics to determine a current location of the user. The automobile electronics provide a nearest destination from the current location of the user for the user to travel to based on the sensor data received from the at least one sensor.10-29-2009
20120226122Inserter for in-vitro analyte sensor - A device and method for implanting an analyte sensor into a subcutaneous fat layer is presented. The device comprises a housing that is positioned above the subcutaneous fat layer, a blade shuttle, and a sensor shuttle. In one embodiment, a spring is compressed between the blade shuttle and the sensor shuttle. The blade shuttle and sensor shuttle move towards the subcutaneous fat layer. When a spring force is released by the spring, the blade shuttle moves towards and pierces into the subcutaneous fat layer creating a pathway into the subcutaneous fat layer. The analyte sensor is implanted by the sensor shuttle by following the blade shuttle into the pathway created by the blade shuttle. The blade shuttle is then retracted from the subcutaneous fat layer, leaving the analyte sensor in the fat layer.09-06-2012
20120116197Methods and Apparatuses for Detecting Medical Device Acceleration, Temperature, and Humidity Conditions - An ambulatory medical device for detecting acceleration, temperature, and/or humidity conditions in or around the medical device is provided. The medical device includes one or more acceleration, thermal, and/or humidity sensors which detect acceleration, temperature, and/or humidity conditions in or around the medical device. In response to detected conditions, the medical device may, among other things, alter the operation of the device, provide an alarm or warning to the user, or transmit data about the detected conditions to another device.05-10-2012
20100081911Analyte Monitoring Devices and Methods Therefor - Method and apparatus for performing a discrete glucose testing and bolus dosage determination including a glucose meter with bolus calculation function are provided.04-01-2010
20100081910ANALYTE SENSOR - Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.04-01-2010
20100081909Optimizing Analyte Sensor Calibration - Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.04-01-2010
20100069730System and Methods for Improved Diabetes Data Management and Use Employing Wireless Connectivity Between Patients and Healthcare Providers and Repository of Diabetes Management Information - Methods, devices and a system for disease management are provided that employ diagnostic testing devices (e.g., blood glucose meters) and medication delivery devices (e.g., insulin delivery devices) for providing data to a repository in real-time and automatically. Repository data can be analyzed to determine such information as actual test strip use, patient health parameters to outside prescribed ranges, testing and medication delivery compliance, patient profiles or stakeholders to receive promotional items or incentives, and so on. Connected meters and medication delivery devices and repository data analysis are also employed to associate a diagnostic test to a mealtime based on timing of a therapeutic intervention performed by an individual.03-18-2010
20120238854INSULIN PUMP WITH BLOOD GLUCOSE MODULES - An apparatus comprising a pump, an input configured to receive information related to a user, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a timing module configured to initiate delivery of a drug in time and to adjust delivery according to the received information. Other devices, systems, and methods are disclosed.09-20-2012
20120238853INTEGRATED GLUCOSE MONITOR AND INSULIN INJECTION PEN WITH AUTOMATIC EMERGENCY NOTIFICATION - An insulin injection pen and blood glucose monitoring device is integrated into a single unit that fits in a user's clothing pocket or handbag. The device includes a blood glucose monitoring system for detecting the user's blood glucose level, an insulin injection mechanism, and a microprocessor that calculates an insulin dosage appropriate to the detected blood glucose level of a particular user and sets the insulin injection mechanism to administer the calculated insulin dosage. The device automatically informs a remote emergency service provider if the microprocessor determines that the detected blood glucose level presents a potential danger to the user. The microprocessor also calculates treatment regimens based on the detected blood glucose level and displays the treatment regimens on an LCD display. The device can include a GPS receiver that detects the location of the device, which is transmitted by the device to the remote emergency service.09-20-2012
20120238852INTEGRATED DELIVERY DEVICE FOR CONTINUOUS GLUCOSE SENSOR - Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.09-20-2012
20120238851Devices, Methods and Systems for Wireless Control of Medical Devices - A medical device system is disclosed. The medical device system includes a first medical device and a second medical device. A remote interface including a touch screen is also included. The remote interface is in wireless communication with the first medical device and the second medical device. The remote interface is configured to provide a user interface to the first medical device and the second medical device. The remote interface is configured to receive user input through a touch screen. Also, a charging device is included. The charging device is configured to receive at least the first medical device and the remote interface and the charging device is configured to recharge a first medical device battery and the charging device is configured to recharge an interface battery in the remote interface. The charging device is connected to a personal computer wherein the personal computer provides information to the remote interface.09-20-2012
20080294028DISEASE SIMULATION SYSTEM AND METHOD - A system and method for predicting the effect of patient self-care actions on a disease control parameter. A future disease control parameter value X(t11-27-2008
20100331657SYSTEMS AND METHODS FOR PROCESSING, TRANSMITTING AND DISPLAYING SENSOR DATA - Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.12-30-2010
20090312621METHOD AND DEVICE FOR MONITORING A PHYSIOLOGICAL PARAMETER - The present invention is related to a method and device for monitoring a physiological parameter, like the blood glucose level, using prediction of future evolution of the physiological parameter based on continuous traces. The present method and device can be employed as a decision support system for diabetic patients.12-17-2009
20110282173PORTABLE MEDICAL APPARATUS - A portable medical apparatus including at least a sampling assembly for providing at least one sample of a fluid in an object, a detector for determining at least one parameter of the fluid, an injector for performing at least one injection of an injection medium, and which are operable independent of each other for improved self-treatment of diseases such as diabetes. The portable medical apparatus has a single common housing for these components and a switch for changing between the sampling mode, the determining mode, and the injection mode. The apparatus also includes an actuator means for individually actuating the other components. The apparatus is an all-in-one device that facilitates the medical treatment process for patients, medical professionals or others.11-17-2011
20110282174ANALYSIS DEVICE WITH USER-FRIENDLY MENU CONTROLS - An analysis device is proposed for detecting an analyte in a liquid sample, in particular for detecting glucose in a bodily fluid. The analysis device comprises at least one control element, which is configured to provide a function menu with at least two menu items. The analysis device further comprises at least one adjustable selector element, in particular a mechanically adjustable selector element, which can be adjusted by a user to at least two different selection positions. The selector element is configured to remain in the adjusted selection position after being adjusted. The control element is configured to select a menu item corresponding to the adjusted selection position. The analysis device further comprises at least one operating element. At least one parameter in the selected menu item can be influenced by the user via the operating element.11-17-2011
20090247857Analyte Sensor Calibration Management - Methods and devices to detect analyte in body fluid are provided. Embodiments include positioning an analyte sensor in fluid contact with an analyte, detecting an attenuation in a signal from an analyte sensor after positioning during a predetermined time period, categorizing the detected attenuation in the analyte sensor signal based, at least in part, on one or more characteristics of the signal, performing signal processing to generate a reportable data associated with the detected analyte sensor signal during the predetermined time period, managing if and when to request additional reference signal measurements, and managing if and when to temporarily not display results.10-01-2009
20100268052BLOOD SUGAR MEASURED LEVEL MANAGEMENT SYSTEM AND BLOOD SUGAR LEVEL MEASUREMENT APPARATUS - The present invention is made to prevent accident of mistaking blood glucose meter among a plurality of blood glucose meters used in a hospital ward.10-21-2010
20120289803SYSTEMS AND METHODS FOR HANDLING UNACCEPTABLE VALUES IN STRUCTURED COLLECTION PROTOCOLS - Embodiments of methods of querying a diabetic patient regarding compliance with adherence criteria comprises instructing the diabetic patient to collect at least one sample in a sampling set of biomarker data, wherein each sampling set comprises a sufficient plurality of samples recorded over a collection period, comparing the collected samples to an acceptable range, wherein the acceptable range encompasses biomarker values that would be expected upon compliance with the adherence criteria, and informing the diabetic patient if at least one sample is an unacceptable value which falls outside of the acceptable range, and performing at least one additional task after detecting the unacceptable value.11-15-2012
20100198036CALIBRATION TECHNIQUES FOR A CONTINUOUS ANALYTE SENSOR - Disclosed herein are systems and methods for calibrating a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes one or more electrodes to measure an additional analyte. Such measurements may provide a baseline or sensitivity measurement for use in calibrating the sensor. Furthermore, baseline and/or sensitivity measurements may be used to trigger events such as digital filtering of data or suspending display of data.08-05-2010
20080269585System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor - An apparatus and method are provided for determining a patient's carbohydrate to insulin ratio (CIR) and insulin sensitivity factor (ISF), and using these values, along with values for current blood glucose level and deviation from target blood glucose level, for determining insulin dose in view of carbohydrate intake during a particular time period. The apparatus and method employ algorithms that can be implemented in any of a personal computer, personal data assistant, hand held computing device, blood glucose monitor, infusion pump, medication delivery pen, meter, calculator, among other therapeutic, diagnostic or informational devices used for managing a patient's blood glucose levels.10-30-2008
20120289806Analyte Monitoring Devices and Methods Therefor - Method and apparatus for performing a discrete glucose testing and bolus dosage determination including a glucose meter with bolus calculation function are provided.11-15-2012
20120289802USER-DEFINED STRUCTURED TESTING FOR USE IN DIABETES CARE - A method is provided for constructing a structured test having user-defined adherence criteria. The method includes: presenting a patient with a plurality of contextual criterion for a structured test; receiving selection of one or more contextual criterion from the plurality of contextual criterion; and constructing a structured test that includes the contextual criterion selected by the patient. During administration of the structured test, each of the contextual criteria selected by the patient is evaluated. Sample data acquired during the structured test is reported as compliant when each of the context criterion selected by the patient was met during the administration of the structured test or tagged as non-compliant when at least one contextual criterion was not met during the administration of the structured test11-15-2012
20120289804BACK CALIBRATION OF SENSOR DATA - Methods, apparatuses and systems for back calibration of data from a continuous sensor are provided. The continuous sensor may be calibrated periodically by comparing raw sensor values from the sensor to sensor values obtained from a second sensor, such as a blood glucose meter (BGM). Each calibration may produce a calibration factor. In an aspect, the calibration factor may be applied to sensor values acquired prior to the calibration (i.e., back calibration). In a further aspect, a first calibration and a second calibration may be applied to raw sensor values acquired at a time point between the first calibration and the second calibration. The first and second calibrations may be applied to the raw sensor values by weighted averaging according to the proximity of the first and second calibrations to the acquisition time of the raw sensor value.11-15-2012
20110301446Device and Method for Food Management - A medical device is disclosed. The medical device includes an RFID reader for receiving information from at least one RFID transponder. The medical device also includes a memory for storing a database and at least one processor for processing information. Also, a remote controller for a medical device is disclosed. The remote controller includes an information receiver for receiving information related to food. The infusion device also includes a memory for storing a database and at least one processor for processing information. A method for use in a medical device is also disclosed. The method includes receiving information from an RFID transponder related to food. Also, the processing the information by comparing the information to a database is included in the method. The method also includes determining the acceptability of the food and providing information related to acceptability to the user.12-08-2011
20110288390Protector apparatus - An apparatus and a method for use with a device for delivery of a therapeutic fluid into a body of a patient and/or for sensing of a bodily analyte are disclosed. The apparatus is adapted for accommodating at least one subcutaneously insertable element and at least one penetrating member for penetrating the skin of the patient. The apparatus includes a protective member having an elongate body from which the subcutaneously insertable element and the penetrating member can be protracted to penetrate the skin of the patient and into which the penetrating member can be retracted subsequent to the penetrating, thereby retaining the subcutaneously insertable element in the body of the patient.11-24-2011
20100106000Methods and Systems for Evaluating Glycemic Control - A method of evaluating glycemic control of a patient includes providing a pentagon having five axes radiating from a center of the pentagon. A first pentagon area formed by a first point, a second point, a third point, a fourth point, and a fifth point plotted on the five axes, respectively, is determined. A second pentagon area formed by a sixth point, a seventh point, an eighth point, a ninth point, and a tenth point plotted on the five axes, respectively, is determined. A glycemic control parameter is determined based on the first pentagon area and the second pentagon area.04-29-2010
20090292190BLOOD GLUCOSE MEASURING DEVICE AND METHOD OF MEASURING AVERAGE POSTPRANDIAL BLOOD GLUCOSE - A practical measuring device and a measuring method that allow simply measuring average postprandial blood glucose from urinary glucose. The blood glucose measuring device includes a measuring unit that measures postprandial urinary glucose from subject's urine at a predetermined time after meal, a processing unit that calculates average postprandial blood glucose through a period up to the predetermined time after meal, based on the postprandial urinary glucose, a storage unit that stores calibration data including the postprandial urinary glucose and the average postprandial blood glucose in association, and an output unit that outputs data indicating the calculated average postprandial blood glucose. The processing unit calculates the average postprandial blood glucose, based on the postprandial urinary glucose from the urine of the subject who has intaken a desired amount of water or perspired in the period up to the predetermined time after meal, and the calibration data.11-26-2009
20110295095Meter with bi-stable display - A medical handheld device having a bi-stable display, which can be supplemented by a further display, is presented. The display of the medical handheld device can have a display surface. The display surface can have a keypad in the form of a matrix of sensors. The matrix of sensors can be coupled to image segments on the display surface and can detect touches on the display surface. By coupling the matrix of sensors to the image segments of the display surface, a change of the representation of touched areas of the display surface can occur.12-01-2011
20100249566Interactive device for monitoring and reporting glucose levels with integrated atomic clock module - An apparatus for determining the amount of glucose in a patient comprising a CPU for receipt and analysis of data; a glucose testing means for testing the amount of glucose in the patient's blood, providing patient data to the CPU, and determining the amount; a storage means for storing data linked to the patient; a display means for displaying the glucose amount and/or glucose data and interfacing with the patient; a voice processing means for processing the glucose amount and/or glucose data and synthesizing an auditory output and optionally includes further instructions as determined by a treating physician and the CPU after analysis of the glucose amount and/or glucose data; a data acquisition means for acquiring data; a digital storage means for storing data; and an atomic clock means for generating real time clock signals from time code signals transmitted by a time standard and received by an antenna.09-30-2010
20100249565Analyte Sensor Introducer and Methods of Use - Method and apparatus for providing an introducer for transcutaneous placement of at least a portion of an analyte sensor through the skin of a patient is provided.09-30-2010
20100249564PREDICTION METHOD OF CONCENTRATION FLUCTUATION OF MEASUREMENT TARGET COMPONENTS IN BLOOD USING AREA UNDER BLOOD CONCENTRATION TIME CURVE, AND DEVICE THEREFOR - The invention provides A method for predicting a concentration fluctuation of a measurement target component in the blood, comprising steps of: obtaining an initial value of the amount relating to the measurement target component in a subject; obtaining, as a first measurement value, a value of an area under the blood concentration time curve of the measurement target component during a first extraction period; obtaining, as a second measurement value, a value of an area under the blood concentration time curve of the measurement target component during a second extraction period; and predicting the concentration fluctuation of the measurement target component in the blood from the initial value, the first measurement value and the second measurement value, as well as a device for predicting a concentration fluctuation of a measurement target component in the blood.09-30-2010
20100249563PUNCTURE DEVICE AND IN VIVO COMPONENT MEASUREMENT SYSTEM - A puncture device which punctures a skin of a subject for extracting a tissue fluid from a puncture site of the subject. The puncture device included a timer; a notifying section which notifies a user that specific time measured by the time has passed; a puncture mechanism which punctuates the skin; and an interlock mechanism which caused the timer to start time measurement in conjunction with a punctuate action by the puncture mechanism.09-30-2010
20100249562ULTRASONIC IMAGING DEVICE - Various embodiments of the present invention include systems and methods for multimodal functional imaging based upon photoacoustic and laser optical scanning microscopy. In particular, at least one embodiment of the present invention utilizes a contact lens in combination with an ultrasound transducer for purposes of acquiring photoacoustic microscopy data. Traditionally divergent imaging modalities such as confocal scanning laser opthalmoscopy and photoacoustic microscopy are combined within a single laser system. Functional imaging of biological samples can be utilized for various medical and biological purposes.09-30-2010
20100249561LQG Artificial Pancreas Control System and Related Method - The invention relates to a methods and systems for determining an insulin dosing recommendation. The invention employs Linear Quadratic methodology to determine the insulin dosing recommendation based on a patient's present physiological state, which is estimated by an adaptive filter methodology employing a dynamic model, which utilizes real-time measurements of blood glucose concentration.09-30-2010
20090118605Surface-enhanced raman nanobiosensor - The present invention relates to biosensors, in particular to surface-enhanced Raman biosensors for detection of in vivo and ex vivo analytes. In particular, the present invention provides compositions and methods for the in vivo detection of analytes such as glucose.05-07-2009
20100137698Method and Apparatus for Providing Power Management in Data Communication Systems - A blood glucose meter having a compact housing, a display unit disposed on the housing, the display unit including a display light source to illuminate the display unit, an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter, and a power source provided within the housing for providing power to the blood glucose meter, where the housing includes a port integrated on said housing configured to receive a blood glucose test strip, and corresponding methods of measuring blood glucose meter is provided.06-03-2010
20100191085Method and Device for Providing Offset Model Based Calibration for Analyte Sensor - Methods and devices to detect analyte in body fluid are provided. Embodiments include processing sampled data from analyte sensor, determining a single, fixed, normal sensitivity value associated with the analyte sensor, estimating a windowed offset value associated with the analyte sensor for each available sampled data cluster, computing a time varying offset based on the estimated windowed offset value, and applying the time varying offset and the determined normal sensitivity value to the processed sampled data to estimate an analyte level for the sensor.07-29-2010
20090240129Apparatus and method for monitoring blood glucose levels including convenient diplay of blood glucose value average and constituent values - A method of presenting glucose data to a person with diabetes from a blood glucose meter is provided in which an effective meal average (EMA) value is presented, followed by two or more of the individual values that make up the EMA, to provide improved feedback data for clinical decisions by patients who need to alter their dose of insulin. The EMA can also comprise a measure of the variability of its constituent values. The EMA encompasses those values that occur at specified times such as 1 hour before and 1 hour after a specified meal time. The EMA is calculated over a limited number of days previous to the calculation (e.g., 3 days) and has a minimum number of values that must be obtained within the time and date ranges. An algorithm allows for exclusion of any given reading from the average (e.g., post-prandial or control solution readings). Patients can use 1 to 8 EMA on any given date range (e.g., preferably 4, that is, breakfast, lunch, supper and bedtime snack).09-24-2009
20090099437Lancing Depth Adjustment Via Moving Cap - A lancing device includes a housing for containing a lancet. A lancet driver couples with and moves the lancet within the housing. A skin interface cap has an opening defined therein to expose at least part of the lancet when moved by the driver. A sliding frame is coupled to the housing and to the skin interface cap. The frame being adjustable relative to the housing for accordingly adjusting said cap relative to the housing, whereby an extent to which the lancet is exposed through the opening is adjustable by adjusting the sliding frame.04-16-2009
20110263958SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR - Systems and methods for dynamically and intelligently estimating analyte data from a continuous analyte sensor, including receiving a data stream, selecting one of a plurality of algorithms, and employing the selected algorithm to estimate analyte values. Additional data processing includes evaluating the selected estimative algorithms, analyzing a variation of the estimated analyte values based on statistical, clinical, or physiological parameters, comparing the estimated analyte values with corresponding measure analyte values, and providing output to a user. Estimation can be used to compensate for time lag, match sensor data with corresponding reference data, warn of upcoming clinical risk, replace erroneous sensor data signals, and provide more timely analyte information encourage proactive behavior and preempt clinical risk.10-27-2011
20100036223SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.02-11-2010
20100036222SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.02-11-2010
20100121170FLUID COMPONENT ANALYSIS SYSTEM AND METHOD FOR GLUCOSE MONITORING AND CONTROL - Disclosed are methods and apparatuses for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment dose (e.g. insulin, dextrose, etc.) and provide glycemic control. The dose of the treatment drug may be based on the patient's calculated sensitivity to treatment dosing, for example. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte. Delivery of the treatment drug can be cut off if the determined analyte concentration indicates that continued delivery would be harmful to the patient.05-13-2010
20100268053Method and Device for Detecting USB Cable Connection - Methods, devices, and system including detecting the presence of an electrical connection in a data port of a medical device, the presence of the electrical connection associated with a variation in a signal level resulting from the electrical connection in the data port, and generating a control signal in response to the detected presence of the electrical connection in the data port, where generating the control signals includes one or more of outputting a notification associated with the presence of the electrical connection in the data port or modifying one or more operational parameters associated with the medical device are provided.10-21-2010
20100268051SYSTEM AND METHOD FOR WELLNESS MONITORING IN A VEHICLE - A vehicle-based system interfaces with at least one wellness device to track and monitor various aspects of user wellness. The aspects include, but are not limited to, heart rate, glucose levels, distance traveled, pace, body temperature, etc. The vehicle-based system may be capable of reporting results to a remote server and to the user directly. The vehicle-based system may further be capable of recommending courses of action based on analysis of the results.10-21-2010
20090149729METHOD OF INPUTTING DATA INTO ANALYTE TESTING DEVICE - A meter is provided that includes an improved user interface that enables the user to take a specific action, leading them directly to data input options. Such a user interface could be used to input first selected information, such as whether a test was premeal or postmeal, immediately after receiving a result. Optionally, the user interface may include the ability to add an additional comment after inputting the first selected information. Provision of such a user interface would facilitate simpler capture of the first selected information each time the user performs a test, leading to an enhanced understanding of a patient's level of glycemic control. Designing a user interface to enable first selected information to be entered by a user directly after receiving a result is more likely to engage a patient by making it easy and simple to enter important information. This may enable capture of the information thought to be most pertinent e.g. premeal and postmeal information, enhancing the understanding by patients and their carers of the patient's control.06-11-2009
20100056895Indicia-coded medical diagnostic apparatus - An apparatus for quantitative measurement of glucose or other biological substance. analysis. The apparatus accepts a sample of blood or biological substance onto or into a diagnostic reagent test device which has a reagent carrier and mode of relaying to the instrument the identifying reagent characteristics. The instrument includes a housing structure having an indicia-coded display and multi-function keypad, a programmable microcontroller which enables the apparatus to emanate or emit said indicia display or a plurality of indicia displays corresponding to an arrangement of quantitative blood glucose or biological substance values wherein said values are programmed into said apparatus and are determinate upon known quantitative analysis ranges of glucose or other analyzed components in sampled blood or biological substances.03-04-2010
20120035448Analyte Monitoring and Management Device and Method to Analyze the Frequency of User Interaction with the Device - Methods and Devices to monitor the level of at least one analyte are provided.02-09-2012
20120108936FLUID ACCESS INTERFACE - The present invention relates generally to systems, apparatuses, and methods for obtaining a fluid sample from a patient. In particular, the present invention relates to a various types of fluid access interfaces for enabling contact between a patient blood sample and blood parameter sensors for the measurement of physiological parameters and blood constituents.05-03-2012
20120108932GLUCOSE SENSOR SIGNAL PURITY ANALYSIS - Disclosed are methods, apparatuses, etc. for glucose sensor signal purity analysis. In certain example embodiments, a series of samples of at least one sensor signal that is responsive to a blood glucose level of a patient may be obtained. Based at least partly on the series of samples, at least one metric may be determined to characterize one or more non-physiological anomalies of a representation of the blood glucose level of the patient by the at least one sensor signal. A reliability of the at least one sensor signal to represent the blood glucose level of the patient may be assessed based at least partly on the at least one metric. Other example embodiments are disclosed herein.05-03-2012
20100087724MEMBRANE FOR USE WITH IMPLANTABLE DEVICES - The present invention provides a biointerface membrane for use with an implantable device that interferes with the formation of a barrier cell layer including; a first domain distal to the implantable device wherein the first domain supports tissue attachment and interferes with barrier cell layer formation and a second domain proximal to the implantable device wherein the second domain is resistant to cellular attachment and is impermeable to cells. In addition, the present invention provides sensors including the biointerface membrane, implantable devices including these sensors or biointerface membranes, and methods of monitoring glucose levels in a host utilizing the analyte detection implantable device of the invention. Other implantable devices which include the biointerface membrane of the present invention, such as devices for cell transplantation, drug delivery devices, and electrical signal delivery or measuring devices are also provided.04-08-2010
20090292191MATERIAL FOR IMPLANTATION - The present invention includes a method for implanting a cardiac pacemaker. The cardiac pacemaker has leads with a plurality of spaced apart patches disposed on the leads, each patch having a distance of separation from its nearest adjacent patch of about 10 nm to about 10 μm. The invention also includes a method for sensing glucose in a mammal, which includes implanting an a sensor having a permeable membrane and a plurality of spaced apart patches of titanium dioxide disposed on the permeable membrane and sensing glucose in the mammal.11-26-2009
20110201911RECEIVERS FOR ANALYZING AND DISPLAYING SENSOR DATA - This disclosure provides systems, methods and apparatus for processing, transmitting and displaying data received from an analyte sensor, such as a glucose sensor. The system may include a display device with at least one input device. In response to movement of or along the input device, the display device may change a glucose data output parameter and update an output of the display device using the changed output parameter.08-18-2011
20100099973Glucose Measuring Device Integrated Into a Holster for a Personal Area Network Device - A glucose meter module integrated into a holster device that can securely accommodate another device such as a portable server device or an insulin pump is described. The glucose measuring module and the health device communicate with each other by a short range wireless modality. In the case in which the accommodated device is a server, such as personal digital assistant or cell phone, the device stores data in a memory, displays data on a visual display, and can wirelessly transmit such data to other devices within a personal area network. In the case where the accommodated device is a cell phone, the phone can further transmit data to remote sites. In the case where the accommodated device is an insulin pump, wirelessly received data are stored in a memory, are available for visual display on the insulin pump, and can be incorporated into the electronic processes that regulate the performance of the pump.04-22-2010
20080319295HEALTH MANAGEMENT DEVICES AND METHODS - Methods and devices and systems including a data collection module for receiving and storing analyte data over a predetermined time period from a subject, a user interface unit coupled to the data collection module for providing one or more indication related to the analyte data, a control unit coupled to the data collection module and the user interface unit to control, at least in part the operation of the data collection module and the user interface unit, a communication module coupled to the control unit for communicating one or more signals associated with the analyte data to a remote location, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of the analyte level received by the data collection module, and a retrospective analysis mode including limited output of information to the subject during the predetermined time period, and further where the communication module is configured to communicate with the remote location after the analyte data is received and stored in the data collection module over the predetermined time period, are provided.12-25-2008
20080306368SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.12-11-2008
20090275816DEVICE CASING - The invention relates to portable electronic devices, particularly health-monitoring devices, and their casings. Such a device comprises a first case part and a second case part, which are arranged in the first position to lie tightly against each other, in order to protect the internal parts of the device, so that a compression joint is formed between them. The case parts are also arranged to slide in one direction relative to each other to a second position, in order to reveal at least one user-interface element. According to the invention, the direction of the said joint differs over its entire length essentially from the said sliding direction. The invention permits the manufacture of health-monitoring devices that are more tightly sealed and user-friendly than previously.11-05-2009
20090043183INTEGRATED STENT AND BLOOD ANALYTE MONITORING SYSTEM - An integrated stent and blood analyte monitoring system includes a stent configured for implantation into a cardiovascular system of a user's body and a blood analyte monitoring system. The blood analyte monitoring system includes a continuous blood analyte determination module attached to the stent and a reader module configured for disposition external to the user's body and proximal to a portion of the user's skin layer. The continuous blood analyte determination module has a sensor for determining the concentration of a blood analyte (e.g., blood glucose concentration) and a reflection antenna with a switch. The reader module is configured to emit an RF carrier signal toward the stent. The reflection antenna is configured to receive the RF carrier signal and reflect a modulated signal that has been modulated by the switch to encode an analyte concentration determined by the sensor. Furthermore, the reader module is configured to receive the modulated signal and decode the analyte concentration therefrom.02-12-2009
20090281406Analyte Monitoring System and Method - Devices and methods for monitoring an analyte are provided. Embodiments include continuous analyte sensors having a high degree of accuracy.11-12-2009
20090281407Method and System for Providing Analyte Monitoring - Methods and apparatuses for determining an analyte value are disclosed.11-12-2009
20090287073SILICONE BASED MEMBRANES FOR USE IN IMPLANTABLE GLUCOSE SENSORS - Membrane systems incorporating silicone polymers are described for use in implantable analyte sensors. Some layers of the membrane system may comprise a blend of a silicone polymer with a hydrophilic polymer, for example, a triblock poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) polymer. Such polymeric blends provide for both high oxygen solubility and aqueous analyte solubility.11-19-2009
20110270063METHOD OF INPUTTING DATA INTO AN ANALYTE TESTING DEVICE - A meter is provided that includes an improved user interface that enables the user to take a specific action, leading them directly to data input options. Such a user interface could be used to input first selected information, such as whether a test was premeal or postmeal, immediately after receiving a result. Optionally, the user interface may include the ability to add an additional comment after inputting the first selected information. Provision of such a user interface would facilitate simpler capture of the first selected information each time the user performs a test, leading to an enhanced understanding of a patient's level of glycemic control. Designing a user interface to enable first selected information to be entered by a user directly after receiving a result is more likely to engage a patient by making it easy and simple to enter important information. This may enable capture of the information thought to be most pertinent e.g. premeal and postmeal information, enhancing the understanding by patients and their carers of the patient's control.11-03-2011
20110208027Methods And Systems For Providing Therapeutic Guidelines To A Person Having Diabetes - A method is disclosed for providing therapeutic guidelines to a person having diabetes. The method comprises measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person; recording the measured bG levels in a computing device; determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; an automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.08-25-2011
20080249386Systems, Methods, and Computer Program Product for Improved Management of Medical Procedures for Patients on Medical Protocols - Techniques are described for improved monitoring and control of a patient's physiologic status, such as blood glucose control according to a protocol for use in a patient care unit, such as an intensive care unit. Instructions to medical staff are adapted to factor in variations in responses to protocol recommendations. For example, a patient's physiological data as a result of a blood analysis is submitted as input to a program. An instruction for a medical procedure for the patient in response to the physiological data is automatically provided by the program. A confirmation response that the medical procedure has been accomplished and results of following the medical procedure are requested by the program. The time when the medical procedure was accomplished and the results of following the medical procedure are evaluated by the program to determine whether to adapt a subsequent instruction.10-09-2008
20100137697MEASUREMENT DEVICE - A measurement device A includes a display section 06-03-2010
20080287765INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR - A system is provided for monitoring glucose in a host, including a continuous glucose sensor that produces a data stream indicative of a host's glucose concentration and an integrated receiver that receives the data stream from the continuous glucose sensor and calibrates the data stream using a single point glucose monitor that is integral with the integrated receiver. The integrated receiver obtains a glucose value from the single point glucose monitor, calibrates the sensor data stream received from the continuous glucose sensor, and displays one or both of the single point glucose measurement values and the calibrated continuous glucose sensor values on the user interface.11-20-2008
20080287766INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR - A system is provided for monitoring glucose in a host, including a continuous glucose sensor that produces a data stream indicative of a host's glucose concentration and an integrated receiver that receives the data stream from the continuous glucose sensor and calibrates the data stream using a single point glucose monitor that is integral with the integrated receiver. The integrated receiver obtains a glucose value from the single point glucose monitor, calibrates the sensor data stream received from the continuous glucose sensor, and displays one or both of the single point glucose measurement values and the calibrated continuous glucose sensor values on the user interface.11-20-2008
20080287764INTEGRATED RECEIVER FOR CONTINUOUS ANALYTE SENSOR - A system is provided for monitoring glucose in a host, including a continuous glucose sensor that produces a data stream indicative of a host's glucose concentration and an integrated receiver that receives the data stream from the continuous glucose sensor and calibrates the data stream using a single point glucose monitor that is integral with the integrated receiver. The integrated receiver obtains a glucose value from the single point glucose monitor, calibrates the sensor data stream received from the continuous glucose sensor, and displays one or both of the single point glucose measurement values and the calibrated continuous glucose sensor values on the user interface.11-20-2008
20080287761Method and apparatus for providing data processing and control in a medical communication system - Methods and apparatus for providing data processing and control for use in a medical communication system are provided.11-20-2008
20100010330WIRELESS MONITOR FOR A PERSONAL MEDICAL DEVICE SYSTEM - A monitor device for a fluid infusion system and its operating, display, and data processing characteristics are described herein. One embodiment of the monitor device is used in an insulin infusion system having an insulin infusion pump and a continuous glucose sensor transmitter. The monitor device is configured as a wireless bedside monitor that wirelessly receives status data from a device in the fluid infusion system, such as the infusion pump or the sensor transmitter. The monitor device supports a number of user interface features, alarm/alert features, and graphical display features, where such features enhance the overall operation and user-friendliness of the monitor device. For example, the monitor device can generate status icons that graphically indicate the time remaining for an exhaustible operating quantity of a device in the infusion system (e.g., a battery charge, a fluid reservoir volume, or a calibration or replacement period). The monitor device can also estimate future measurements of a physiological characteristic of a monitored patient, based upon empirical measurement data received by the monitor device.01-14-2010
20130217990IN VEHICLE GLUCOSE APPARATUS AND VEHICULAR OPERATION INHIBITOR - When diabetics undergo a hyperglycemic or hypoglycemic event, their cognitive-motor function can be severely impaired. This has contributed to a positive correlation between diabetes and traffic incidences. Thus, there are ongoing efforts to improve blood glucose monitoring to improve safety of diabetic drivers.08-22-2013
20100099972Glucose Measuring Device Integrated Into a Holster for a Personal Area Network Device - A glucose meter module integrated into a holster device that can securely accommodate another device such as a portable server device or an insulin pump is described. The glucose measuring module and the health device communicate with each other by a short range wireless modality. In the case in which the accommodated device is a server, such as personal digital assistant or cell phone, the device stores data in a memory, displays data on a visual display, and can wirelessly transmit such data to other devices within a personal area network. In the case where the accommodated device is a cell phone, the phone can further transmit data to remote sites. In the case where the accommodated device is an insulin pump, wirelessly received data are stored in a memory, are available for visual display on the insulin pump, and can be incorporated into the electronic processes that regulate the performance of the pump.04-22-2010
20120296189Methods of Collecting and Analyzing Samples - Provided are methods of measuring analyte concentrations in interstitial fluid samples, methods of determining accuracy of subcutaneously implantable analyte sensors, methods of manufacturing and determining calibration factors for subcutaneously implantable analyte sensors, as well as subcutaneously implantable analyte sensors manufactured according to the described methods and having a high level of accuracy. Methods of determining the concentration of an analyte in a bodily sample, and methods of extracting interstitial fluid are also provided.11-22-2012
20090264726ANALYTE METER PROTECTORS AND METHODS - Analyte meter protectors, meters that include the same, and methods.10-22-2009
20090264725ANALYTE METER PROTECTORS AND METHODS - Analyte meter protectors, meters that include the same, and methods.10-22-2009
20080275324Fluid Access Interface - The present invention relates generally to systems, apparatuses, and methods for obtaining a fluid sample from a patient. In particular, the present invention relates to a various types of fluid access interfaces for enabling contact between a patient blood sample and blood parameter sensors for the measurement of physiological parameters and blood constituents.11-06-2008
20080269584Devices for Continuous Measurement of Glucose in Body Fluid - A device for monitoring a constituent of body fluid continuously or repeatedly over a time period includes a body fluid sampling system and an optical sensor arrangement. The sampling system has a pumping arrangement which pumps body fluid from a cannula to a fluid sink. The optical sensor determines a concentration of at least one constituent of the body fluid. The pumping arrangement preferably ejects drops of body fluid from a fine nozzle. According to certain embodiments, optical sensor arrangements ensure that the optical paths do not pass through surfaces wetted by the fluid to be examined.10-30-2008
20120035449Apparatus method and for intelligent electronic medical devices - An enhanced electronic medical device is provided that combines some of the enhanced electronic features found in other electronic medical devices with software for executing a stochastic process control and evaluating the digital respiratory and other physiological data collected by the electronic medical device. The programmed stochastic process control is capable of selecting and calculating any one of a number of pulmonary function and other physiological parameters including at least one statistical process control variable to determine a pulmonary or other physiological threshold. Information systems linking doctor's offices and patient's electronic medical devices are further provided to transmit warning data in cases where the pulmonary or other physiological threshold is exceeded.02-09-2012
20090124878SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.05-14-2009
20090124877SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.05-14-2009
20090143661ANALYTE MONITORING AND MANAGEMENT DEVICE AND METHOD TO ANALYZE THE FREQUENCY OF USER INTERACTION WITH THE DEVICE - Methods and Devices to monitor the level of at least one analyte are provided.06-04-2009
20090137890DEVICES TO MONITOR GLUCOSE LEVELS AND ISCHEMIA - The disclosure relates to systems, methods, and devices for monitoring a patient's blood and cardiac condition. Patients with diabetes oftentimes wear diabetes management equipment (e.g., a glucose monitor, an external insulin pump, or a device having dual functionality). Such patients risk silent myocardial infarction. Herein described is regular cardiac ischemia/infarction monitoring—which if not monitored can lead to (silent) myocardial infarction. Moreover herein described are combined blood monitoring functionality and cardiac condition monitoring functionality via a single device, meaning that the patient is not required to wear additional equipment. Adding this functionality to already-existing equipment is significantly less invasive than requiring a patient to wear one piece of equipment to monitor his/her blood and a second piece of equipment to monitor his/her cardiac condition. This reduction in invasiveness can lead to significantly greater patient participation and compliance, which can improve health and save the lives of many patients.05-28-2009
20090005665Method and apparatus for providing data processing and control in a medical communication system - Methods and apparatus for providing data processing and control for use in a medical communication system are provided.01-01-2009
20090143662System for Providing Blood Glucose Measurements to an Infusion Device - An infusion system includes a characteristic determining device and an infusion device. The characteristic determining device includes a receptacle for receiving and testing an analyte from the user to determine a concentration of the analyte in the user. The characteristic determining device also includes a communication system for transmitting a communication including data indicative of the determined concentration of the analyte in the user, and the infusion device includes a communication system for receiving the communication from the characteristic determining device. The infusion device further includes a bolus estimator for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user, and an indicator to indicate when the estimated amount of fluid to be infused has been calculated.06-04-2009
20090005666REAL TIME SELF-ADJUSTING CALIBRATION ALGORITHM - A method of calibrating glucose monitor data includes collecting the glucose monitor data over a period of time at predetermined intervals. It also includes obtaining at least two reference glucose values from a reference source that temporally correspond with the glucose monitor data obtained at the predetermined intervals. Also included is calculating the calibration characteristics using the reference glucose values and corresponding glucose monitor data to regress the obtained glucose monitor data. And, calibrating the obtained glucose monitor data using the calibration characteristics is included. In preferred embodiments, the reference source is a blood glucose meter, and the at least two reference glucose values are obtained from blood tests. In additional embodiments, calculation of the calibration characteristics includes linear regression and, in particular embodiments, least squares linear regression. Alternatively, calculation of the calibration characteristics includes non-linear regression. Data integrity may be verified and the data may be filtered.01-01-2009
20080319296HEALTH MONITOR - Methods and devices to detect analyte in body fluid are provided. Embodiments include enhanced analyte monitoring devices and systems.12-25-2008
20110224524MATERIALS FOR IMPLANTATION - The present invention includes a method for sensing glucose in a mammal, which includes implanting an a sensor having a permeable membrane and a plurality of spaced apart patches of titanium dioxide disposed on the permeable membrane and sensing glucose in the mammal.09-15-2011
20110224523Systems, Devices and Methods for Managing Glucose Levels - Systems, devices and methods for the management of glucose levels in the body of patient featuring user interface input mechanisms configured to provide haptic feedback to the user are provided.09-15-2011
20090198119PACKAGE FOR AN OBJECT HAVING A HYDROPHILIC SURFACE COATING - A package for an object having a hydrophilic surface includes at least one of a loose cover for the hydrophilic surface and an adsorbing surface, the affinity of which for apolar gases is equal to or greater than that of the hydrophilic surface.08-06-2009
20090054754CLINICIAN-CONTROLLED SEMI-AUTOMATED MEDICATION MANAGEMENT - The present invention is directed to methods and apparatuses of medication management based upon active authorization of medication infusion by a clinician that can provide for effective management of an analyte in a patient's blood, reducing the opportunities for human error common with current manual systems while still placing final control of the medication management with the human clinician. For example, a semi-automated glucose management system can measure the glucose level in a patient's blood, recommend infusion parameters to a clinician who can authorize an infusion of glucose or insulin, and infuse the glucose or insulin into the patient.02-26-2009
20090062635SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR - Systems and methods for dynamically and intelligently estimating analyte data from a continuous analyte sensor, including receiving a data stream, selecting one of a plurality of algorithms, and employing the selected algorithm to estimate analyte values. Additional data processing includes evaluating the selected estimative algorithms, analyzing a variation of the estimated analyte values based on statistical, clinical, or physiological parameters, comparing the estimated analyte values with corresponding measure analyte values, and providing output to a user. Estimation can be used to compensate for time lag, match sensor data with corresponding reference data, warn of upcoming clinical risk, replace erroneous sensor data signals, and provide more timely analyte information encourage proactive behavior and preempt clinical risk.03-05-2009
20090099438SYSTEM FOR MANAGING GLUCOSE LEVELS IN PATIENTS WITH DIABETES OR HYPERGLYCEMIA - A blood glucose maintenance system for use by hyperglycemic individuals measures their blood glucose level and calculates an appropriate glucose or insulin dosage based on the measurement. Recheck intervals responsive to dosage history are determined. Warning or alert messages or signals are produced if certain measurements or calculations fall outside established normal ranges. It is particularly useful for patients in a hospital or in-patient environment.04-16-2009
20090082654Glucose Measuring Module And Insulin Pump Combination - A combination glucose measuring and insulin pumping device is described. The two major components, a glucose measuring module and an insulin pump, are held together by a quick attach and release mechanism. Communication between the glucose measuring module and the insulin pump is by a wireless modality. The glucose measuring module determines the glucose level in a sample, and wirelessly transmits the data to the insulin pump, where the data are stored in a memory, and are available for visual display on the insulin pump, and for incorporation into selection of appropriate protocols for the rate of insulin infusion by the pump into the patient.03-26-2009
20110230744SYSTEM AND APPARATUS FOR THE NON-INVASIVE MEASUREMENT OF GLUCOSE LEVELS IN BLOOD - A system for estimating the glucose levels in blood is developed in the present invention. Said system establishes a physiological model of the pulse wave and its energy, which are also correlated with the glucose metabolic function, for generating a fixed length vector containing the values of the previous model combined with other variables related to the user such as, for example, age, sex, height, weight, etc. . . . This fixed length vector is used as an excitation of a function estimation system based on “random forests” for the calculation of the interest variable. The main advantage of this parameter estimation system lays in the fact that it does not apply any restriction a priori on the function to be estimated, and that it is robust in front of heterogeneous data, such as in the case of the present invention.09-22-2011
20090171179Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.07-02-2009
20080262333Analytical Method and Investigation System - Metabolism diseases are evaluated by using a sensor to measure concentration of a medically significant analyte in a human or animal body fluid. The measurement data are correlated with the concentration of a medically significant analyte in body fluid over a time period of at least eight hours. An analytical facility analyzes time intervals within the time period to determine a stability parameter that characterizes the analyte concentration dynamics of change. The analytical facility further analyzes the stability parameters to determine disease-related particularities of metabolism.10-23-2008
20080262334METHOD AND DEVICE FOR PREDICTING PHYSIOLOGICAL VALUES - The invention relates generally to methods, systems, and devices for measuring the concentration of target analytes present in a biological system using a series of measurements obtained from a monitoring system and a Mixtures of Experts (MOE) algorithm. In one embodiment, the present invention describes a method for measuring blood glucose in a subject.10-23-2008
20120078075DETERMINATION OF A MEASURE OF A GLYCATION END-PRODUCT OR DISEASE STATE USING TISSUE FLUORESCENCE IN COMBINATION WITH ONE OR MORE OTHER TESTS - The present invention provides a method of determining disease state in an individual. A portion of the tissue of the individual is illuminated with excitation light, then light emitted by the tissue due to fluorescence of a chemical in the tissue responsive to the excitation light is detected. The HbA1c or FPG measurement of the individual (or other secondary indication of disease state) can also be determined. A model combining the tissue fluorescence and one or more of the secondary indications can be used to determine the disease state of the individual. In some embodiments, the tissue fluorescence can be used as an initial screen, and the combination with secondary indications only made for those individuals for whom the fluorescence screen indicates an increased likelihood of disease.03-29-2012
20080319294HEALTH MANAGEMENT DEVICES AND METHODS - Methods, devices and systems to detect analyte level in a patient with gestational diabetes and/or provide related therapy management are provided.12-25-2008
20110230743Self Contained In-Vitro Diagnostic Device - A portable apparatus for measuring a glucose level of a user having: a card-like member; a processor within the card-like member; at least one glucose sensor comprising a reagent, the glucose sensor generating a signal indicative of a measured glucose level upon application of a blood sample to the glucose sensor, wherein the glucose sensor is fixed to the card-like member and operably coupled to the processor; and at least one cover alterable between a first position in which the glucose sensor is covered and a second position in which the glucose sensor is exposed for use.09-22-2011
20090203982Glucose Measuring Device For Use In Personal Area Network - A glucose measuring system includes a glucose meter that incorporates wireless communication capabilities. The meter can advantageously be a low cost meter by eliminating expensive components, such as the display. The user nevertheless is able to retrieve and view his or her glucose values by referring to displays within the glucose measuring local area network. Feedback via these displays can advantageously be used by the diabetic to create a higher level of confidence and safety.08-13-2009
20090203980SENSORS EMPLOYING COMBINATORIAL ARTIFICIAL RECEPTORS - The present invention relates to sensors including artificial receptors and methods of using them. In an embodiment, the present invention includes an artificial receptor as a component of a receptor system including a ligand permeable interface that isolates the artificial receptor from certain components of the surrounding environment. In an embodiment, the present invention includes an artificial receptor and a competitor against a ligand of interest.08-13-2009
20090221892Dual Transdermal Analyte Sensor Assembly and Methods of Using the Same - A transdermal test sensor assembly adapted to assist in determining at least one analyte concentration of a fluid sample is provided. The test sensor assembly comprises a sensor support, a first test sensor, a second test sensor, a first hydrogel composition, and a second hydrogel composition. The first test sensor couples to the sensor support. The second test sensor couples to the sensor support. The first hydrogel composition is positioned on the first test sensor. The second hydrogel composition is positioned on the second test sensor.09-03-2009
20090240127METHODS OF DETERMINING PRE OR POST MEAL TIME SLOTS OR INTERVALS IN DIABETES MANAGEMENT - A diabetes management system or process is provided herein that may be used to analyze and recognize patterns for a large number of blood glucose concentration measurements and other physiological parameters related to the glycemia of a patient. In particular, a method of monitoring glycemia in a patient may include storing a patient's data on a suitable device, such as, for example, a blood glucose meter. The patient's data may include blood glucose concentration measurements. The diabetes management system or process may be installed on, but is not limited to, a personal computer, an insulin pen, an insulin pump, or a glucose meter. The diabetes management system or process may identify a plurality of pattern types from the data including a testing/dosing pattern, a hypoglycemic pattern, a hyperglycemic pattern, a blood glucose variability pattern, and a comparative pattern. After identifying a particular pattern with the data management system or process, a warning message may be displayed on a screen of a personal computer or a glucose meter. Other messages can also be provided to ensure compliance of any prescribed diabetes regiments or to guide the patient in managing the patient's diabetes.09-24-2009
20090221893Unitized Painfree Blood Glucose Measuring Device - A blood glucose measuring device is equipped with a drill device, attachment assembly, and disposable sensing and measurement assembly. The attachment assembly contains an attachment ring that connects to the drill device and is used to hold the disposable sensing and measurement assembly. A detach actuating cam and output shaft are attached to the drill device. Spring tongs are attached to the output shaft by a compression ring further clamp to an end cap. A skin penetrator is attached to the end cap. The disposable sensing and measurement assembly is enclosed in a disposable case. An outer telescoping anti-bend tube is attached to the end cap. An inner anti-bend capillary sensor tube contains analyte sensors and is attached to the disposable case. The electrical conductors for the analyte sensor electrodes are attached to the capillary sensor tube and thus to the disposable case. An impedance sensing electrode on the bottom of the case provides electrical contacts to the skin. The electrical conductor to the impedance sensing electrode is attached to the bottom of the disposable case.09-03-2009
20090221891Optical sensor for in vivo detection of analyte - A sensor for the in vivo detection of glucose comprises: 09-03-2009
20090240128SYSTEMS AND METHODS FOR BLOOD GLUCOSE MONITORING AND ALERT DELIVERY - Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.09-24-2009
20090253973APPARATUS FOR OPTIMIZING A PATIENT'S INSULIN DOSAGE REGIMEN - An apparatus for optimizing a patient's insulin dosage regimen over time, comprising: at least a first computer-readable memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen and the patient's blood-glucose-level measurements determined at a plurality of times; a processor operatively connected to the at least first computer-readable memory, the processor programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components of the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range; and a display operative to display information corresponding to at least the patient's present insulin dosage regimen.10-08-2009
20120035447MEDICAL DEVICE WITH A COLLECTION CHANNEL FOR A BODILY FLUID - A medical device for carrying out at least one medical function. The medical device comprises at least one control part, which can be applied to a body surface of a user, and at least one functional element, which can be inserted into a body tissue of the user at at least one insertion site. The functional element can be connected to the control part. The functional element is designed to carry out at least one medical function. The control part has at least one base part with at least one supporting surface, which faces the body surface. The base part has at least one collection channel for collecting bodily fluid emerging from the insertion site.02-09-2012
20090318791Perfusion Device with Compensation of Medical Infusion During Wear-Time - A medical action device is adapted to cooperate with an object to be inserted into a body and to cooperate with a timing device, able to start timing from the moment the object is inserted. This information is fed to a control unit whereby the control unit gets an input which can be used to compensate one or more parameters of the medical action as a function of the increased blood flow in the area around the inserted object over time due to the inflammation reaction.12-24-2009
20100160760DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS - Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices include unique architectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.06-24-2010
20100160757DEVICE AND METHOD FOR ASSESSING BLOOD GLUCOSE CONTROL - A blood glucose and lifestyle tracking apparatus is disclosed. The blood glucose and lifestyle tracking apparatus provides a method for recording both blood glucose values for fasting, postprandial, and preprandial time periods and lifestyle factors.06-24-2010
20100168545SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION - Systems and methods for processing sensor analyte data are disclosed, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. The sensor can be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. Reference data resulting from benchtop testing an analyte sensor prior to its insertion can be used to provide initial calibration of the sensor data. Reference data from a short term continuous analyte sensor implanted in a user can be used to initially calibrate or update sensor data from a long term continuous analyte sensor.07-01-2010
20100185072SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-22-2010
20100185075TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.07-22-2010
20100185073SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-22-2010
20100261988DEVICES AND METHODS FOR REDUCED-PAIN BLOOD SAMPLING - Systems, methods and devices are provided for invasive reduced-pain blood sampling and testing, the devices including, a horizontally-disposed finger support element configured to support the finger thereupon, a finger holding element adapted, in a closed position, to radially grip the finger on said support element near to a tip thereof and configured to force blood into said tip, a lancet housing element disposed vertically underneath the finger support element for piercing the finger tip with a lancet while said finger tip is gripped by said finger holding element and supported by said finger support element; and a test strip conveying element adapted to be received by the finger support element after retraction of the lancet housing element thereby bringing a test strip into direct contact with a predetermined volume of blood from said finger support element thereby effecting a blood test.10-14-2010
20100191086SENSING SYSTEM WITH AUXILIARY DISPLAY - A system is provided for sensing blood glucose data of a patient. The system includes a sensor, user interface, and an optional auxiliary device. If the connection between the sensor and user interface is by a wire, the sensor remains powered when the wire is disconnected. The communication between the sensor and the user interface may be wireless. The auxiliary device can be a patient monitor or other display or signal device, which displays information about the blood glucose data collected by the sensor. The sensor is connected to sensor electronics, which include a sensor power supply, a voltage regulator, and optionally a memory and processor.07-29-2010
20100185074SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-22-2010
20080208026SYSTEMS AND METHODS FOR DETECTING HYPOGLYCEMIC EVENTS HAVING A REDUCED INCIDENCE OF FALSE ALARMS - The present invention is directed to a method of reducing false readings in a hypoglycemic detector that includes establishing a predetermined hypoglycemic threshold, a predetermined critical threshold, a predetermined rate of change in glucose concentration where the predetermined critical threshold is below the predetermined hypoglycemic threshold. A first sampling rate is then calculated based upon said predetermined hypoglycemic threshold, said predetermined critical threshold, and said predetermined rate of change in glucose concentration.08-28-2008
20100217105Insertion device and method for inserting a subcutaneously insertable element into body - An insertion device (08-26-2010
20100217106SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.08-26-2010
20100234711DEVICE AND METHOD FOR ACCURATELY MEASURING CONCENTRATION OF BLOOD COMPONENT - In a measurement computation device arranged in a measurement device, an elapse of a predetermined time is detected after acceleration of perspiration, and a concentration of a first component in the perspiration obtained thereafter is converted to concentration of the first component in blood.09-16-2010
20100240978GAME DISPLAY OF A DIAGNOSTIC DEVICE AND METHOD OF PLAYING - A game display for use with a diagnostic device, such as a blood glucose measuring device, that includes a grid which defines a plurality of spaces. In use, a sample of body fluid, such as blood, is obtained and the device determines a diagnostic concentration in the sample. Once the diagnostic concentration is determined, one of the spaces displays an indicia associated with the result of the diagnostic test and a character associated with the successful completion of the diagnostic test. The display also includes a score area which displays another indicia relating to the level of success of a patient's diagnostic testing regimen.09-23-2010
20100240979Device and System for Monitoring Blood Glucose Levels - A device and method for transmitting blood glucose level information from user provided glucometers, said glucometers originating from different manufacturers, to a receiver constructed and arranged to monitor, and sort said information and to selectively output said information.09-23-2010
20100240977METHOD FOR MEASURING THE RESPONSE OF A TISSUE TO AN ELECTROMAGNETIC FIELD - The present invention relates to a method for measuring the response of the tissue of a human or animal body to an electromagnetic field, comprising the steps of i) treatment of a skin area of said body with a topical composition comprising one or more reversible mnAChR-antagonists, ii) applying to the treated skin area a measuring device and iii) measuring by means of said measuring device at least one parameter depending on a response to said electromagnetic field; to a method for measuring in vivo the glucose content in blood and to topical compositions useful in said methods09-23-2010
20090076361TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.03-19-2009
20090076360TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.03-19-2009
20090076358Method and System for Providing Data Management in Data Monitoring System - Method and system for providing a fault tolerant data receiver unit configured with a partitioned or separate processing units, each configured to perform a predetermined and/or specific processing associated with the one or more substantially non-overlapping functions of the data monitoring and management system is provided03-19-2009
20100137699Fluctuating Blood Glucose Notification Threshold Profiles and Methods of Use - Embodiments of the present invention provide a new system and methods for monitoring blood glucose concentration. A user of a continuous glucose monitor may program upper and lower blood glucose notification thresholds to fluctuate over time in order to facilitate management of the short-term effects of food consumption, insulin delivery aberrations, physical activity, emotions, and unforeseen circumstances.06-03-2010
20120035446METHOD AND APPARATUS FOR MONITORING DIABETIC PATIENTS - Diabetic patients are provided with blood sugar testers that are used to check the sugar level of the patients at home. The blood sugar data from the testers is automatically transmitted to a data bank that collects the data for each day from a plurality of patients and presents the data to the physician as required. Patients may also be provided with A1c testers that measure and transmit to the data bank A1c data collected monthly. This A1c data is also presented to the physicians so that the physicians can make an appropriate drug dosage level for each patient.02-09-2012
20100222660Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.09-02-2010
20100168543SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-01-2010
20100168542SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-01-2010
20110028818Methods and Apparatuses for Detecting Medical Device Acceleration, Temperature, and Humidity Conditions - An ambulatory medical device for detecting acceleration, temperature, and/or humidity conditions in or around the medical device is provided. The medical device includes one or more acceleration, thermal, and/or humidity sensors which detect acceleration, temperature, and/or humidity conditions in or around the medical device. In response to detected conditions, the medical device may, among other things, alter the operation of the device, provide an alarm or warning to the user, or transmit data about the detected conditions to another device.02-03-2011
20100036221Noninvasive Method to Estimate Variation of Blood Glucose Levels Using Metabolic Measurements - A method to estimate the variation of blood glucose concentration in a patient without blood sampling. The method can be implemented by measuring metabolic parameters including heat dissipation by conduction, percentage oxygen content of expired air and volume per minute of expired air. These parameters are used to calculate estimated blood glucose variation.02-11-2010
20090275817Method of Calibrating an Analyte-Measurement Device, and Associated Methods, Devices and Systems - The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.11-05-2009
20120245447Devices, Systems, and Methods Associated with Analyte Monitoring Devices and Devices Incorporating the Same - Analyte monitoring systems, devices, and methods associated with analyte monitoring devices, and devices incorporating the same are provided. Various graphical user interfaces (GUI) and navigation flows are provided for performing various features, activities, functions, etc., associated with the analyte monitoring device or system. Intuitive navigation is provided to enhance the interpretation of analyte measurements.09-27-2012
20090203981SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR - Systems and methods for dynamically and intelligently estimating analyte data from a continuous analyte sensor, including receiving a data stream, selecting one of a plurality of algorithms, and employing the selected algorithm to estimate analyte values. Additional data processing includes evaluating the selected estimative algorithms, analyzing a variation of the estimated analyte values based on statistical, clinical, or physiological parameters, comparing the estimated analyte values with corresponding measure analyte values, and providing output to a user. Estimation can be used to compensate for time lag, match sensor data with corresponding reference data, warn of upcoming clinical risk, replace erroneous sensor data signals, and provide more timely analyte information encourage proactive behavior and preempt clinical risk.08-13-2009
20090318792Analyte Monitoring System and Methods - Methods and systems for providing data communication in medical systems are disclosed.12-24-2009
20090112076System for Providing Blood Glucose Measurements to an Infusion Device - An infusion system includes a characteristic determining device and an infusion device. The characteristic determining device includes a receptacle for receiving and testing an analyte from the user to determine a concentration of the analyte in the user. The characteristic determining device also includes a communication system for transmitting a communication including data indicative of the determined concentration of the analyte in the user, and the infusion device includes a communication system for receiving the communication from the characteristic determining device. The infusion device further includes a bolus estimator for calculating an estimated amount of fluid to be infused into the body of the user based upon the received data indicative of the determined concentration of the analyte in the user and a target concentration of the analyte in the user, and an indicator to indicate when the estimated amount of fluid to be infused has been calculated.04-30-2009
20090105571Method and System for Providing Data Communication in Data Management Systems - Method and apparatus for providing efficient power management in a data transmitter unit of a data monitoring and management system including a current to frequency conversion unit is provided.04-23-2009
20090105573MEDICAL DEVICE FOR PREDICTING A USER'S FUTURE GLYCEMIC STATE - A medical device for predicting a user's future glycemic state includes a memory module, a processor module and a user alert module. The memory module is configured to receive and store a plurality of glucose concentrations as a function of time that were generated by a user's use of a continuous glucose monitor. The processor module is configured to derive first and second glucose prediction equations that are fits to the plurality of glucose concentrations stored in the memory module with the fits being based on first and second mathematical models, respectively. The processor module is also configured to calculate first and second predicted glucose concentrations at a future time using the first and second glucose prediction equations, respectively, and to also calculate an average predicted glucose concentration and a merit index based on the first and second predicted glucose calculations. The processor module is further configured to input the plurality of glucose concentrations as a function of time, the average predicted glucose concentration and the merit index into a trained model (e.g., a Hidden Markov Model) that outputs a set of glucose concentration probabilities for the future time and to then predict the user's future glycemic state based on the set of glucose concentration probabilities. The user alert module is configured to alert the user in a manner dependent on the predicted user's future glycemic state.04-23-2009
20090105572METHOD FOR PREDICTING A USER'S FUTURE GLYCEMIC STATE - A method for predicting a user's future glycemic state includes measuring a user's glucose concentration at intervals over a time duration, thereby generating a plurality of glucose concentrations as a function of time. First and second glucose prediction equations that are fits to the plurality of glucose concentrations based on first and second non-identical mathematical models, respectively, are then derived. The method also includes calculating first and second predicted glucose concentrations at a future time using the first and second glucose prediction equations, respectively. Thereafter, an average predicted glucose concentration and a merit index are calculated based on the first and second predicted glucose calculations. The plurality of glucose concentrations as a function of time, the merit index and average predicted glucose concentration are input into a trained model (for example, a Hidden Markov Model) that outputs a set of glucose concentration probabilities. The user's future glycemic state is then predicted based on the set of glucose concentration probabilities.04-23-2009
20090105570Analyte monitoring devices and methods therefor - Method and apparatus for performing a discrete glucose testing and bolus dosage determination including a glucose meter with bolus calculation function are provided.04-23-2009
20090054753Variable Sampling Interval for Blood Analyte Determinations - The present invention provides methods and apparatuses that can provide measurement of glucose with variable intervals between measurements, allowing more efficient measurement with greater patient safety. A method according to the present invention can comprise measuring the value of an analyte such as glucose at a first time; determining a second time from a patient condition, an environmental condition, or a combination thereof; then measuring the value of the analyte at the second time (where the second time can be expressed as an interval after the first time, an absolute time, or a time indicated when certain patient or environmental conditions, or both, are reached or detected). The second time can be determined, as an example, from a comparison of the analyte value at the first time with a threshold. The interval between the first time and the second time can be related to the difference between the analyte value at the first time and the threshold; e.g., the closer to the threshold, the closer the two measurement times. The invention can be used with automated measurement systems, allowing the system to determine measurement times and automatically make measurements at the determined times, reducing operator interaction and operator error.02-26-2009
20100312085Method and Apparatus for Providing Power Management in Data Communication Systems - A blood glucose meter having a compact housing, a display unit disposed on the housing, the display unit including a display light source to illuminate the display unit, an input unit disposed on the housing, the input unit configured to provide input functions for the blood glucose meter, and a power source provided within the housing for providing power to the blood glucose meter, where the housing includes a port integrated on said housing configured to receive a blood glucose test strip, and corresponding methods of measuring blood glucose meter is provided.12-09-2010
20100168546SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION - Systems and methods for processing sensor analyte data are disclosed, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. The sensor can be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. Reference data resulting from benchtop testing an analyte sensor prior to its insertion can be used to provide initial calibration of the sensor data. Reference data from a short term continuous analyte sensor implanted in a user can be used to initially calibrate or update sensor data from a long term continuous analyte sensor.07-01-2010
20130137952METHOD AND SYSTEM TO DISPLAY ANALYTE SENSOR DATA - Described and illustrated herein are an exemplary methods and system to display analyte sensor data. Such method may be achieved by the medical device receiving data from the analyte sensor for a period of time and displaying a target zone and a graphical representation of the data in which one or more portions of the graphical representation comprises a specific indicia of clinical risk.05-30-2013
20130137953ANALYTE MONITORING SYSTEM AND METHODS OF USE - The present disclosure provides methods of processing data provided by a transcutaneous or subcutaneous analyte sensor utilizing different algorithms to strike a balance between signal responsiveness accompanied by signal noise and the introduction of error associated with that noise. The methods utilize the strengths of a lag correction algorithm and a smoothing algorithm to optimize the quality and value of the resulting data (glucose concentrations and the rates of change in glucose concentrations) to a continuous glucose monitoring system. Also provided are systems and kits.05-30-2013
20100312084Systems and methods for lumbar cerebrospinal fluid access and treatment - A system and method for accessing and treating the cerebrospinal fluid with a multilumen catheter configured for placement along a cerebrospinal fluid pathway and a subcutaneous, dual reservoir/pump. The subcutaneous dual reservoir/pump allows simultaneous, bidirectional cerebrospinal fluid access and cerebrospinal fluid exchange. The two chambers prevent mixing of newly treated and discardable cerebrospinal fluid. The subcutaneous dual reservoir/pump can be used inline with other cerebrospinal fluid devices. The catheter may be coupled with a medical probe that sends a wire to a computational device, which can then send wireless data and receive wireless instructions. A method of assessing cerebrospinal fluid infections is provided, whereby monitoring of the cerebrospinal glucose concentrations with a cerebrospinal glucose sensor and analysis of the data by a computational device can notify a patient or medical provider of an impending infection. This assembly can help better diagnose and treat injury and disease.12-09-2010
20100312083System for Monitoring Glucose and Measuring Wattage - A computerized system for monitoring information related to the power being generated by a user and blood glucose levels of the user, the system comprising: a shoe worn by the user, an electronic force sensor associated with the shoe, and a computer electronically coupled to the force sensor.12-09-2010
20090076359Analyte monitoring and management system and methods therefor - Method and apparatus for providing multiple data receiver units in a data monitoring and management system such as analyte monitoring system where a first data receiver includes all of the functionalities for the data monitoring and management system receiver unit, and a second data receiver unit is configured with a limited functions to provide application specific convenience to the user or patient is disclosed.03-19-2009
20130144144DEVICE SYSTEM AND METHOD FOR MONITORING AND CONTROLLING BLOOD ANALYTE LEVELS - Systems, devices, and methods for monitoring an analyte in a subject. The systems, devices, and methods may include a sensor element being designed and configured for detecting said analyte in blood flowing through a bone of the subject, and a fixation element that is capable of fixating said sensor element within the bone tissue06-06-2013
20100331653Analyte Meter with a Moveable Head and Methods of Using the Same - The present disclosure provides in vitro analyte meters that include a meter portion that is moveable relative to at least one other meter portion. Embodiments include moveable meters that are integrated with in vivo analyte systems. Also provided are methods, systems and kits.12-30-2010
20100331655CALIBRATION TECHNIQUES FOR A CONTINUOUS ANALYTE SENSOR - Disclosed herein are systems and methods for calibrating a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes one or more electrodes to measure an additional analyte. Such measurements may provide a baseline or sensitivity measurement for use in calibrating the sensor. Furthermore, baseline and/or sensitivity measurements may be used to trigger events such as digital filtering of data or suspending display of data.12-30-2010
20100331651BLOOD GLUCOSE MANAGEMENT AND INTERFACE SYSTEMS AND METHODS - A blood glucose management device is operable to seamlessly provide a sequence of at least two displays of data relating to one or more blood glucose measurements to a user, upon minimal user interaction, with the blood glucose management device.12-30-2010
20110009726TAPE CASSETTE FOR A MEDICAL HANDHELD DEVICE AND BLOOD SUGAR MEASURING SYSTEM - A tape cassette for a medical handheld device. The inventive tape cassette includes a carrier tape with a plurality of functional elements which may take the form of test fields for analyzing a sample of a human or animal body fluid and/or a plurality of lancets. During use, the carrier tape slides past friction points. To reduce friction between the carrier tape and at least one of the friction points, the at least one friction point includes a surface made of a fluoropolymer. The tape cassette may have a housing that includes a sealed compartment with a tape exit opening wherein the friction point is disposed proximate the tape exit opening. A cover element may also be positioned to cover the tape exit opening. The cover element may also include a fluoropolymer material engageable with the carrier tape. A method of manufacturing such tape cassettes is also disclosed.01-13-2011
20110009724PROVIDING CONTEXTUALLY RELEVANT ADVERTISEMENTS AND E-COMMERCE FEATURES IN A PERSONAL MEDICAL DEVICE SYSTEM - A medical device system includes a portable (patient-worn or patient-carried) medical device that can automatically initiate certain e-commerce and/or advertisement presentation features in response to the detection of one or more triggering events. A triggering even may, for example, be associated with the monitoring of the operation or status of the medical device, the operation or status of the medical device system, a medical condition of the patient, treatment of the patient, and/or the preferences of the patient or user. In one application, the medical device is an insulin infusion pump and the user is automatically prompted to purchase, order, or otherwise obtain replaceable or replenishable items associated with the operation of the insulin infusion pump, such as a continuous glucose sensor, an infusion set, or an insulin reservoir.01-13-2011
20110009727SYSTEMS AND METHODS FOR PROCESSING, TRANSMITTING AND DISPLAYING SENSOR DATA - Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.01-13-2011
20110034792Noninvasive Body Chemistry Monitor and Method - There is disclosed a noninvasive body chemistry monitor and method. A sensor may be disposed in close gaseous communication with the subject's skin. The sensor may be configured to provide a sensor output signal indicative of a level of at least one gaseous material released through the subject's skin. An event detector may detect a body chemistry event based on the sensor output signal.02-10-2011
20110028817Continuous Glucose Monitoring System and Methods of Use - A continuous glucose monitoring system including a sensor configured to detect one or more glucose levels, a transmitter operatively coupled to the sensor, the transmitter configured to receive the detected one or more glucose levels, the transmitter further configured to transmit signals corresponding to the detected one or more glucose levels, and a receiver operatively coupled to the transmitter configured to receive transmitted signals corresponding to the detected one or more glucose levels, and methods thereof, are disclosed. In one aspect, the transmitter may be configured to transmit a current data point and at least one previous data point, the current data point and the at least one previous data point corresponding to the detected one or more glucose levels.02-03-2011
20110034793Method and Device for Utilizing Analyte Levels to Assist in the Treatment of Diabetes - A health-monitoring device assesses the health of a user based on levels of two analytes in a biological fluid. A first analyte that is utilized to assess a user's health is a fat metabolism analyte, such as ketones, free fatty acids and glycerol, which is indicative of fat metabolism. A second analyte that is utilized is a glucose metabolism analyte, such as glucose. The levels of the two analytes may be used to assess insulin sensitivity, to detect both recent hypoglycemia and the cause of high glucose levels, and/or to guide therapeutic intervention. The dual analyte model may calculate a discrepancy between an actual insulin activity level and a theoretical insulin activity level. The dual analyte model of the present invention may be used to identify individuals at risk for metabolic syndrome, insulin resistance and non-insulin dependent diabetes, and allows monitoring of the progression of those disease states, as well as progress made by therapeutic interventions.02-10-2011
20110040165INTEGRATED CARTRIDGE AND TUB ASSEMBLY - An assembly for storing and dispensing a plurality of integrated lancet and test strips for use in a testing meter is provided. The assembly comprises a cartridge portion for housing a plurality of integrated lancet and test strips, and a tub portion coupled to the cartridge portion and providing a surface for advancing a single integrated lancet and test strip for use in the testing meter. A system is also provided which includes the assembly and a meter for determining an analyte concentration.02-17-2011
20110040166EXTRACTING KIT, EXTRACTING DEVICE, AND EXTRACTING METHOD - An extracting kits for extracting analyte through the skin of a living body are disclosed that comprises an inserting device comprising needles for forming a plurality of extraction holes in the skin through the stratum corneum but not reaching the subcutaneous tissue and an extracting device for extracting the analyte into a liquid supplied into the extraction holes by supplying the liquid into the plurality of extraction holes. An extracting device and extracting method are also described.02-17-2011
20110118580SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.05-19-2011
20110124997SYSTEM AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.05-26-2011
20100168541SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-01-2010
20100168540SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-01-2010
20100168539METHOD AND/OR SYSTEM FOR ESTIMATING GLYCATION OF HEMOGLOBIN - Disclosed are systems, methods and techniques to estimate an extent of glycation of hemoglobin in a patient. In one particular implementation, although claimed subject matter is not limited in this respect, an estimate of glycation of hemoglobin in a patient may be measured based, at least in part, on blood-glucose measurements obtained from the patient.07-01-2010
20100168538METHOD AND/OR SYSTEM FOR SENSOR ARTIFACT FILTERING - Disclosed are a method and/or system for filtering sensor measurements. In one particular implementation, a sensor signal may be processed concurrently in a plurality of signal-filter paths. A particular signal-filter path may be selected to provide an output signal for obtaining a measurement based, at least in part, on a measurement of noise associated with the sensor signal.07-01-2010
20110124996DIABETES HEALTH MANAGEMENT SYSTEMS AND METHODS - Diabetes health management systems for use in portable devices having and methods thereof having a user interface, a processor, a memory, and a communication circuit are disclosed. In one embodiment, a diabetes health management system has program code further including a communications module, a data module, a therapy module, and an analysis module. The communications module wirelessly couples the portable device to a plurality of user devices. The data module receives and stores into the memory blood glucose measurement values, insulin dosage data, and health data entries. The therapy module determines a therapy advice message based at least in part on the received blood glucose measurement values, the received insulin dosage data, and displays the therapy advice message on the user interface. The analysis module displays on the user interface a graphical representation of selected blood glucose measurement values, selected insulin dosage data, selected health data entries, or combinations thereof.05-26-2011
20110130639Method and System for Providing Continuous Calibration of Implantable Analyte Sensors - Method and system for providing continuous calibration of analyte sensors includes calibrating a first sensor, receiving data associated with detected analyte levels from the first sensor, and calibrating a second sensor based on a predetermined scaling factor and data associated with detected analyte levels from the first sensor, is disclosed.06-02-2011
20100191087SENSING SYSTEM WITH AUXILIARY DISPLAY - A system is provided for sensing blood glucose data of a patient. The system includes a sensor, user interface, and an optional auxiliary device. If the connection between the sensor and user interface is by a wire, the sensor remains powered when the wire is disconnected. The communication between the sensor and the user interface may be wireless. The auxiliary device can be a patient monitor or other display or signal device, which displays information about the blood glucose data collected by the sensor. The sensor is connected to sensor electronics, which include a sensor power supply, a voltage regulator, and optionally a memory and processor.07-29-2010
20100261987METHODS AND SYSTEMS FOR PROMOTING GLUCOSE MANAGEMENT - Methods and systems for encouraging interactions with a glucose monitoring system include incrementing a score and/or providing a reward based on a variety of different interactions with the glucose monitoring system. The interactions which improve the score may include initiating or changing displays, downloading data, setting operational parameters and other interactions that are independent of a user's glucose measurements. Encouraging these interactions can enhance success in maintaining healthy glucose concentrations.10-14-2010
20100036225SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.02-11-2010
20100036224SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.02-11-2010
20090048503GLYCEMIC CONTROL MONITORING USING IMPLANTABLE MEDICAL DEVICE - An apparatus for monitoring a patient's blood glucose level. The apparatus includes an implantable medical device having a controller and an implantable heart sounds sensor configured to transmit signals to the controller of the implantable medical device. The controller is configured to determine if a patient is hypoglycemic or hyperglycemic based on the signals from the heart sounds sensor. A method is also disclosed that includes sensing the patient's heart sounds, determining the amplitude of the S2 heart sound, determining the length of the interval from the S1 heart sound to the S202-19-2009
20090312620Diabetes monitor - A diabetes monitor can provide diabetes information is invented in this invention. It comprises an input module, a storage module, and a knowledge base system module. This invention breaks through the design idea of traditional diabetes monitors. It not only can monitor the blood glucose values but also can generate the diabetes state of the patient. So it makes patients recognizing their own diabetes state in time, and can take effective control and treatment accordingly.12-17-2009
20100010331SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR - Systems and methods for dynamically and intelligently estimating analyte data from a continuous analyte sensor, including receiving a data stream, selecting one of a plurality of algorithms, and employing the selected algorithm to estimate analyte values. Additional data processing includes evaluating the selected estimative algorithms, analyzing a variation of the estimated analyte values based on statistical, clinical, or physiological parameters, comparing the estimated analyte values with corresponding measure analyte values, and providing output to a user. Estimation can be used to compensate for time lag, match sensor data with corresponding reference data, warn of upcoming clinical risk, replace erroneous sensor data signals, and provide more timely analyte information encourage proactive behavior and preempt clinical risk.01-14-2010
20100063374Analyte meter including an RFID reader - A glucose monitoring system, includes a glucose sensor strip or package of strips. The strip includes a substrate and a glucose monitoring circuit that has electrodes and a bodily fluid application portion of selected chemical composition. An antenna is integrated with the glucose sensor strip. A RFID sensor chip is coupled with the glucose sensor strip and the antenna. The chip has a memory containing digitally-encoded data representing calibration and/or expiration date information for the strip.03-11-2010
20110178382BLOOD GLUCOSE IGNITION INTERLOCK - The present invention relates to an ignition interlock that requires a blood glucose level measurement prior to permitting ignition of a vehicle. The interlock prevents operation of equipment in which it is installed if a blood glucose level measurement is not taken or if the resultant measurement is outside of a desired range. In another embodiment, a method for ignition interlock is provided. The method includes activating an identification system and activating an ignition interlock system based on information from the identification system. The method further comprises testing a blood glucose level of the user to generate a determined blood glucose level and comparing the determined blood glucose level to preset blood glucose levels, wherein the preset blood glucose levels include an acceptable minimum blood glucose level. Ignition is enabled or prevented based on the comparison. More particularly, ignition is enabled if the determined blood glucose level is above the acceptable minimum blood glucose level and ignition is prevented if the determined blood glucose level is below the acceptable minimum glucose level.07-21-2011
20120172693Pump Arrangement in Continuous Analyte Monitoring - A method of monitoring an analyte (such as, e.g., glucose) including the following steps: diffusing the analyte from a sampling location into a sensing fluid within a sensing chamber; detecting a concentration of the analyte in the sensing fluid; moving flushing fluid into the sensing chamber and simultaneously removing sensing fluid from the sensing chamber; permitting the flushing fluid to remain in the sensing chamber without flowing for a dwell time; removing the flushing fluid from the sensing chamber after the dwell time expires; and, after removing the flushing fluid from the sensing chamber, moving sensing fluid into the sensing chamber. The invention also includes an analyte monitoring device performing this method.07-05-2012
20090216105BLOOD GLUCOSE TRACKING APPARATUS AND METHODS - A measurement module for glucose testing includes a glucose testing measurement module housing, a test strip receptacle formed in the housing, and a connector portion formed in the housing and shaped to permit mechanical removable attachment of the housing to a hand-held computer. Electronics determine the amount of glucose present in a sample of body fluid, when the test strip is positioned in the receptacle and the body fluid is placed on a test strip, and communicate the glucose amount to the hand-held computer via the connector portion.08-27-2009
20090216104USE OF ACID DERIVATIVES OF FLUOROPOLYMERS FOR FOULING-RESISTANT SURFACES - The presently disclosed subject matter describes acid-derivatized perfluoropolyether (PFPE) materials and their use as coatings, sealants, and flexible fillers for devices, apparatuses, and structural parts for a variety of medical applications, and as coatings, sealants, flexible fillers, and structural parts for vessels, structures, and machinery exposed to a marine environment.08-27-2009
20100056893MEDICAL AID - The invention relates to a medical aid which comprises a lancet (03-04-2010
20100069732Medical Devices and Methods of Using the Same - Medical devices having restrictive access, and methods thereof are provided.03-18-2010
20100069731Non-Invasive Weight and Performance Management - Systems and methods for weight and performance management are described. More particularly, an embodiment relates to a system and method of employing a non-invasive, real-time, continuous blood glucose monitoring device to measure glucose levels in a subject. The determined levels are subsequently used to manage the subject's caloric intake and utilization multiple times during the course of a day.03-18-2010
20110251472SYSTEM FOR COLLECTING PATIENT INFORMATION FOR DIABETES MANAGEMENT - A system is provided for collecting patient information from which diabetes therapy may be determined. The system may comprise a patient interface device, a patient notification device, an input device for entering patient information, and an information collecting unit. The information collecting unit may include a processor electrically coupled to a memory having stored therein at least one algorithm executable by the processor to activate the patient notification device followed by presenting instructions to the patient via the patient interface device for collecting specified information from the patient via the input device.10-13-2011
20110098548METHODS FOR MODELING INSULIN THERAPY REQUIREMENTS - Various methods for improving the use of model based prediction of future blood glucose control in a patient having diabetes are described. A system for processing diabetes related information, including glucose information, for accurately predicting future glucose levels as a function of glucose data, carbohydrate intake, insulin delivery history and exercise history and then providing recommendations related to the predicted future glucose levels, is also described.04-28-2011
20110077494Method and Apparatus for Providing Notification Function in Analyte Monitoring Systems - Method and apparatus for determining and outputting projected alarms or notifications associated with anticipated hyperglycemic or hypoglycemic conditions are provided. Systems and kits employing the devices described herein executing the one or more routines described are also provided.03-31-2011
20110077492Systems for Bidirectional Communication With A Patient Via A Medical Measurement Device - The present disclosure describes a system for providing bidirectional communication between a patient operating a medical measurement device and a third party, using the device to facilitate such communication. Some examples of the device collect data concerning the physiological condition of the patient. The device transmits the data to a DME server for subsequent transmission to the third party, and also receives treatment-related information from the DME server that is originated by the same or a different third party. The DME server transmits the data received from the device to the third party, if said third party is authorized to receive such data.03-31-2011
20110152655SYSTEMS AND APPARATUSES FOR TESTING BLOOD GLUCOSE MEASUREMENT ENGINES - A system for testing a blood glucose measurement engine includes a host device emulator having a measurement engine port communicatively coupled to a communications port and electrically coupled to a power supply. A diagnostic computer may be communicatively coupled to the communications port of the host device emulator. The diagnostic computer may include a processor and a memory having computer readable and executable instructions. When the blood glucose measurement engine is communicatively coupled to the measurement engine port, the host device emulator simulates connection to a host device by facilitating the communication of signals between the diagnostic computer and the blood glucose measurement engine. The processor executes the computer readable and executable instructions to: transmit control signals and diagnostic signals to the measurement engine, receive and analyze data signals transmitted from the measurement engine, and monitor a glucose measurement process performed by the measurement engine.06-23-2011
20110077493ANALYTE TESTING METHOD AND DEVICE FOR DIABETES MANGEMENT - Various embodiments are described and illustrated to calculate an insulin bolus, recommend such bolus, and provide reminder messages for performing an additional glucose test.03-31-2011
20080234563Device for and Method of Delivery and Removal of Substances in and From a Tissue or Vessel - The invention relates to a device (09-25-2008
20110213230On-Line Measuring System of Body Substances - A measuring system (09-01-2011
20100004523Active, radiating low frequency implantable sensor and radio tag system - A low frequency implantable sensor and radio tag system, includes a sensor device which in turn includes: storage storing information including information identifying the device; an apparatus, coupled to the transceiver, for measuring a body condition for transmission to a reader; a transceiver, coupled to the storage, the transceiver operating at a frequency sufficiently low to operate near or within water; and an antenna, coupled to the transceiver, communicating with an external reader.01-07-2010
20120302855SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA - Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.11-29-2012
20110152657Apparatus and methods for taking blood glucose measurements and recommending insulin doses - The present disclosure related to an apparatus that may be used for taking blood glucose measurements and providing individualized insulin dose recommendations wherein the apparatus is easy to use and facilitates improved diabetes control in patients. Also disclosed are related methods.06-23-2011
20110152656Collection Device With Selective Display of Test Results, Method And Computer Program Product Thereof - A collection device with a selective display of test results and method thereof are disclosed. A structured collection procedure defining data collection times and the associated context of the collection also defines what information regarding the results of the collection may be viewable by a user performing the structured collection procedure on the device. In this manner, the patient can be monitored according to the structured collection procedure while preventing the patient from modifying his or her behavior based on collection results.06-23-2011
20120302854SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA - Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.11-29-2012
20120302853SYSTEM AND METHOD FOR MEASURING PHYSIOLOGICAL PARAMETERS - A measuring method for measuring a physiological parameter via a measuring system comprising a test strip, an auxiliary measuring device and an electronic device having an application program and an analog-to digital converting unit is provided. The measuring method includes steps of coupling the auxiliary measuring device between the test strip and the electronic device to form a loop; the electronic device executing the application program to provide a first analog signal, and transferring the first analog signal to the auxiliary measuring device via the loop; the auxiliary measuring device applying a voltage to the test strip according to the first analog signal, and causing the test strip to generate a second analog signal; the analog-to-digital converting unit converting the second analog signal into a digital signal via the application program; and the application program calculating the digital signal to estimate the physiological parameter.11-29-2012
20120302852IMPLANTABLE MEDICAL DEVICE REMOVAL/INSERTION TOOL - When replacing an implanted medical device, the physician may have difficulty locating the new unit in exactly the same space or cavity within the body that held the old unit. Various embodiments and combinations of embodiments of a medical removal/insertion tool are proposed which can be inserted temporarily, as “place holders,” in the space of the implanted medical device to be removed, and used to guide the insertion of the replacement unit and to ensure that the replacement unit is properly situated within the body. In its simplest form, the removal/insertion tool has a “first part” which is configured to facilitate the positioning of the new unit in approximately the same space as the old unit, and a “second part” which serves as a handle for gripping, during use, to insert, position and subsequently remove the first part within the body cavity when replacement is complete.11-29-2012
20090112075SELECTIVELY PERMEABLE COATED MEMBRANE - There is provided a selectively permeable biointerface membrane, permitting selective diffusion of analyte therethrough, for use in an analyte sensor comprising a nanoporous substrate and a coating, on the nanoporous substrate, comprising a plurality of polymer chains whereby each polymer chain is attached at one chain end thereof to a surface of the nanoporous substrate. There are also provided methods for the preparation of the selectively permeable membrane and an analyte sensor comprising the membrane.04-30-2009
20120302851PHYSIOLOGICAL SIGNAL MEASURING APPARATUS AND METHOD WITH IDENTIFICATION FUNCTION - A physiological signal measuring apparatus and method with identification function are provided. The physiological signal measuring apparatus with identification function includes a measuring module, an identifying module, and a transmitting module. The measuring module obtains a physiological signal and produces a physiological datum according to the physiological signal. The identifying module obtains an identification datum. The transmitting module is electrically connected to the measuring module and the identifying module for transmitting the physiological datum and the identification datum to a computer.11-29-2012
20120302850METHOD AND APPARATUS FOR MEASURING A HUMAN PHYSIOLOGICAL SIGNAL - A method for measuring a human physiological signal includes: receiving a reminder canceling time range; measuring a human physiological signal by a human physiological signal measuring apparatus; and determining if a measurement-related time for measuring the physiological signal falls within the reminder canceling time range, followed by releasing a reminding device in response to an affirmative determination.11-29-2012
20120302849MEDICAL DEVICE INCLUDING A SLIDER ASSEMBLY - A medical system includes an input assembly for receiving one or more user inputs. The input assembly includes at least one slider assembly for providing an input signal. Processing logic receives the input signal from the input assembly and provides a first output signal and a second output signal. A display assembly is configured to receive, at least in part, the first output signal from the processing logic and render information viewable by the user. The second output signal is provided to one or more medical system components. The information rendered on the display assembly may be manipulatable by the user and at least a portion of the information rendered may be magnified.11-29-2012
20120302848Inter Dialytic Monitoring Device - An inter dialytic monitoring device is disclosed which monitors in vivo preselected parameters of blood content during an inter dialytic period to monitor patient health. The monitoring device is configured to extend through and releasably engage a catheter which has been placed within a patient to monitor a patient's blood. A sensor is provided to detect the presence of selected analytes and to identify when preselected parameters have been reached.11-29-2012
20080287762Method and apparatus for providing data processing and control in a medical communication system - Methods and apparatus for providing data processing and control for use in a medical communication system are provided.11-20-2008
20080214919SYSTEM AND METHOD FOR IMPLEMENTATION OF GLYCEMIC CONTROL PROTOCOLS - A system for implementing a wide-range of glycemic control protocols (e.g., Tight Glycemic Control protocols) in an automated, semi-closed or closed loop manner thereby eliminating common sources of system error is provided herein. More specifically, the system can include a blood glucose measuring device in communication with a wide-range of databases and/or interfaces thereby allowing for typically independent steps such as patient testing, result determination, protocol adjustment (suggestions as well as actual calculations of new dosages), meal information, scheduling of future testing in light of test results, and administration of medicine to be performed automatically in a semi-closed or closed loop manner. Furthermore, the system provides for ultimate flexibility by allowing a protocol administrator to continuously add, subtract, and/or modify various steps of the protocol while maintaining the integrity and safety of the system. Additionally, methods of implementing such glucose control protocols are also provided herein.09-04-2008
20080255438SYSTEM FOR MONITORING PHYSIOLOGICAL CHARACTERISTICS - Apparatuses and methods for medical monitoring physiological characteristic values such as blood glucose levels for the treatment of diabetes, are presented. The apparatuses and methods provide for preventing any negative consequence in the operation of a monitor and/or infusion device as a result of disorientation that may occur from waking from slumber with a low blood glucose level. In addition, a graphical display is disclosed incorporating a variety of enhancements which readily conveys to the user historical as well as real time information regarding the measured characteristic value.10-16-2008
20110009725PROVIDING CONTEXTUALLY RELEVANT ADVERTISEMENTS AND E-COMMERCE FEATURES IN A PERSONAL MEDICAL DEVICE SYSTEM - A medical device system includes a portable (patient-worn or patient-carried) medical device that can automatically initiate certain e-commerce and/or advertisement presentation features in response to the detection of one or more triggering events. A triggering even may, for example, be associated with the monitoring of the operation or status of the medical device, the operation or status of the medical device system, a medical condition of the patient, treatment of the patient, and/or the preferences of the patient or user. In one application, the medical device is an insulin infusion pump and the user is automatically prompted to purchase, order, or otherwise obtain replaceable or replenishable items associated with the operation of the insulin infusion pump, such as a continuous glucose sensor, an infusion set, or an insulin reservoir.01-13-2011
20110263957TEST SYSTEM - The invention concerns a test system for carrying out blood sugar tests with a diagnostic tape cassette which comprises a windable analytical test tape for detecting an analyte and a cassette housing accommodating the test tape, and a test device which has a device housing for inserting and removing the tape cassette and a measuring unit for detecting the analyte on the test tape. According to the invention it is proposed that the tape cassette can be detachably fastened by positioning elements on a platform mounted in the device housing and that the measuring unit is rigidly attached on the platform or can be engaged therewith.10-27-2011
20110054285Flexible and Conformal Patch Pump - Provided is a flexible and conformal wearable, self-contained medical device. The medical device comprises an integral housing formed by a flexible upper portion and a flexible lower portion joined along their perimeters. The medical device is also provided in a plurality of shapes and configurations for increasing the flexibility and conformability of the housing. The components contained within the housing, such as a drug reservoir, printed circuit board, and power supply are preferably constructed from flexible materials and are formed, connected and positioned according to the configuration of the housing in a manner for enhancing flexibility of the housing. A thermal bubble micropump is provided for controlling flow of a drug from the flexible reservoir, that utilizes a thermal resistor provided locally to a thermal expansion fluid that causes a surrounding membrane to expand and displace a volume of drug to be provided to the user.03-03-2011
20110054284Anti-Coagulant Calibrant Infusion Fluid Source - Methods and systems for preventing or eliminating thrombus during use of a sensor are disclosed. The method comprises providing a calibrant infusion fluid source comprising a predetermined amount of a calibrant and adding a predetermined amount of a non-heparin anti-thrombotic agent into the calibrant infusion fluid source. A system and method is disclosed that includes an infusion calibrant source comprising a predetermined amount of a calibrant and a predetermined amount of a non-heparin anti-thrombotic agent with a glucose sensor.03-03-2011
20110021898REAL TIME MANAGEMENT OF DATA RELATING TO PHYSIOLOGICAL CONTROL OF GLUCOSE LEVELS - Continuous glucose monitoring (CGM) data and insulin delivery data are used to generate more reliable projected alarms related to a projected glucose levels. A memory stores endogenous data related to measurements of glucose level in a patient, and also stores exogenous data, such as insulin on board, both of which are used by a processor to create projected alarms. Profiles of CGM data are created for use in tuning patient-specific insulin data, such at basal rate, carb ratio, and insulin sensitivity. A processor searches for patterns in the data profiles and if found, recommended changes to patient-specific insulin data are provided to permit more accurate control over a patient's glucose levels.01-27-2011
20110257498BLOOD TEST APPARATUS AND BLOOD TEST METHOD - A blood test apparatus has a housing with an opening, and a plunger that moves back and forth inside the housing, the plunger having a projecting member. A fixing member fixes the plunger, which is provided in the housing. A blood sampling cartridge, in which a blood sensor, a puncturer, and a holder that holds the blood sensor and the puncturer, are integrated. The blood sampling cartridge is removably attached to the opening. The puncturer includes a lancet, one end of which is held by the plunger, and a blood collection needle attached to an other end of the lancet. A measuring circuit measures a signal obtained from the blood sensor to analyze components in the blood.10-20-2011
20110257497Flux Enhancement in Continuous Glucose Monitoring - One aspect of the invention is a method of in vivo monitoring of an individual's interstitial fluid glucose concentration comprising inserting a plurality of tissue piercing elements through a stratum corneum layer of an area of the individual's skin. The tissue piercing elements each comprise a distal end in fluid communication with interstitial fluid of the individual, and a proximal end in fluid communication with a sensing zone located outside of the patient's body. An interior space extends between the distal and proximal ends of the tissue piercing elements. A sensing fluid fills substantially the entire interior space and the sensing fluid concentration comprises a concentration of citrate in a buffer solution. The concentration of citrate may range from 100 mM to 200 mM, preferably 135-165 mM.10-20-2011
20100292557METHOD AND DEVICE FOR SUBSTANCE MEASUREMENT - Embodiments of the present disclosure present systems, devices and methods for ISF glucose monitoring that more accurately reflects the blood glucose levels by introducing a treatment element allowing stable and accurate prediction of blood glucose levels based measured glucose levels from interstitial fluid.11-18-2010
20110118579SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.05-19-2011
20100305422Electrochemical Analyte Sensor - An electrochemical analyte sensor formed using conductive traces on a substrate can be used for determining and/or monitoring a level of analyte in in vitro or in vivo analyte-containing fluids. For example, an implantable sensor may be used for the continuous or automatic monitoring of a level of an analyte, such as glucose, lactate, or oxygen, in a patient. The electrochemical analyte sensor includes a substrate and conductive material disposed on the substrate, the conductive material forming a working electrode. In some sensors, the conductive material is disposed in recessed channels formed in a surface of the sensor. An electron transfer agent and/or catalyst may be provided to facilitate the electrolysis of the analyte or of a second compound whose level depends on the level of the analyte. A potential is formed between the working electrode and a reference electrode or counter/reference electrode and the resulting current is a function of the concentration of the analyte in the body fluid.12-02-2010
20100324401DIABETES MANAGEMENT METHODS AND SYSTEMS - The present invention relates to methods and systems for monitoring the effectiveness of diabetes treatment. Methods and systems in accordance with the present invention provide information relating to variability of glucose levels and hypoglycemia and hyperglycemia. Such information is based on time-stamped blood glucose data obtained from a meter or the like and actual measurements of HbA1c levels are not required.12-23-2010
20100324403TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.12-23-2010
20100324398NON-INVASIVE CHARACTERIZATION OF A PHYSIOLOGICAL PARAMETER - The present invention provides a method and device for characterizing a physiological parameter. The method, in one application, uses one or more non-invasive sensors to collect patient data, and may also collect data on environmental conditions. At least some of the patient data has a direct relationship with the physiological parameter, that is, a change in the physiological parameter is reflected in the data set, although the magnitude of the physiological parameter may masked by noise, interference, or other environmental or patient influences. The direct patient data preferably has a generally linear relationship with the physiological parameter, and if not, the patient data is linearized according to an algorithm, table, or other adjustment process. These linearizing processes may be predefined, and may adaptively learn or adjust. A blind signal source process is applied to the linearized data to generate separated signals, and the signal associated with the physiological parameter is identified. The identified signal is scaled or further processed, and the characterization result is presented. Although the method and device are described for use with a human, they may be advantageously used on animals.12-23-2010
20100324400ANALYTE MONITORING DEVICE AND METHODS OF USE - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.12-23-2010
20100331656SYSTEMS AND METHODS FOR PROCESSING, TRANSMITTING AND DISPLAYING SENSOR DATA - Systems and methods for continuous measurement of an analyte in a host are provided. The system generally includes a continuous analyte sensor configured to continuously measure a concentration of analyte in a host and a sensor electronics module physically connected to the continuous analyte sensor during sensor use, wherein the sensor electronics module is further configured to directly wirelessly communicate displayable sensor information to a plurality of different types of display devices.12-30-2010
20100331654SYSTEMS FOR DIABETES MANAGEMENT AND METHODS - Described herein are systems and methods to utilize factual information based on stored blood glucose data to allow greater insight into the management of diabetes of a user.12-30-2010
20100168544SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-01-2010
20090171178Method and System for Powering an Electronic Device - Methods and apparatuses for providing power supply to a device are provided.07-02-2009
20090177068Method and apparatus for providing derived glucose information utilizing physiological and/or contextual parameters - Various methods and apparatuses for measuring a state parameter of an individual using signals based on one or more sensors are disclosed. In one embodiment, a first set of signals is used in a first function to determine how a second set of signals is used in one or more second functions to predict the state parameter. In another embodiment, first and second functions are used where the state parameter or an indicator of the state parameter may be obtained from a relationship between the first function and the second function. The state parameter may, for example, include blood glucose levels, calories consumed or calories burned by the individual. Various methods for making such apparatuses are also disclosed.07-09-2009
20100030053SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.02-04-2010
20100030052ANALYTE SENSORS COMPRISING PLASTICIZERS - A method and analyte-measurement device adapted to determine the concentration of an analyte in a fluid from a measurement site within a body, including an animal body, a mammalian body, or a human body. The invention further relates to the use of partially or fully implantable glucose-monitoring devices, including transcutaneous or subcutaneous glucose-monitoring devices. Devices, systems and kits making use of the aforementioned method are provided as well.02-04-2010
20100016700ANALYTE MEASUREMENT AND MANAGEMENT DEVICE AND ASSOCIATED METHODS - Various embodiments of a diabetes management system are provided. One exemplary system may include an analyte measurement device and a therapeutic agent delivery device. The measurement device includes a measurement unit, display, and first wireless module. The therapeutic agent delivery device has a delivery device housing, delivery mechanism disposed in the housing that delivers a dosage of the agent to the user upon actuation by the user or health care provider, and a second wireless module. The second module, automatically, without prompting from a user or any active input or action by the user, transmits a signal to the first wireless module indicative of: (a) type of therapeutic agent delivered; and (b) amount of therapeutic agent delivered to the user; or (c) type of therapeutic agent device from which the therapeutic agent was administered. Also described are diabetes management devices and methods.01-21-2010
20110046469Glucose Measuring Device for Use In Personal Area Network - A glucose measuring system includes a glucose meter that incorporates wireless communication capabilities. The meter can advantageously be a low cost meter by eliminating expensive components, such as the display. The user nevertheless is able to retrieve and view his or her glucose values by referring to displays within the glucose measuring local area network. Feedback via these displays can advantageously be used by the diabetic to create a higher level of confidence and safety.02-24-2011
20100087723SURFACE-ENHANCED RAMAN NANOBIOSENSOR - The present invention relates to biosensors, in particular to surface-enhanced Raman biosensors for detection of in vivo and ex vivo analytes. In particular, the present invention provides compositions and methods for the in vivo detection of analytes such as glucose.04-08-2010
20110118578HYPOGLYCEMIC TREATMENT METHODS AND SYSTEMS - A system for treating hypoglycemia includes a continuous blood glucose monitor that monitors blood glucose levels of a patient on a continuous basis over a period of time. An alarm and injector apparatus is configured to be worn by the patient and includes a glucagon delivery mechanism for automatically delivering glucagon to the patient if a hypoglycemic condition is detected using the continuous blood glucose monitor.05-19-2011
20090069659Blood sugar measurement automatic correction system - A blood sugar measurement automatic correction system includes a blood sugar measuring unit which has a reaction zone to allow blood and a test agent to generate a chemical reaction to produce electrons, and a test device to measure the produced electrons and output a blood sugar measurement signal to a reading unit, and an error correction unit to receive the blood sugar measurement signal and tune the blood sugar measurement signal according to a correction value set in an error correction zone and output to the reading unit.03-12-2009
20080208027Method for Visualizing a Chronological Sequence of Measurements - The invention comprises a method for visualising a chronological sequence of measurements, in particular obtained from a continuous glucose monitoring (CGM) process, comprising the step of presenting measured data in polar coordinate graphing system. A device 08-28-2008
20110152658IDENTIFICATION OF ABERRANT MEASUREMENTS OF IN VIVO GLUCOSE CONCENTRATION USING TEMPERATURE - Disclosed herein are methods and systems for generating an estimate of an in vivo analyte concentration and identifying whether the estimate is aberrant. In some embodiments, the system includes a sensor comprising an analyte sensor and a temperature sensing element, and a control unit programmed to identify changes in temperature that may indicate a non-physiologic condition (and result in an aberrant glucose measurement). In some embodiments, the methods include generating an estimate of analyte concentration at a particular time using the analyte sensor, and generating first and second signals indicative of temperature using the temperature sensing element. In some embodiments the methods include identifying the estimate of analyte concentration as aberrant if the magnitude of the difference between the first and second signals indicative of temperature exceeds a threshold value.06-23-2011
20110306859MULTIPURPOSE, MODULAR PLATFORM FOR MOBILE MEDICAL INSTRUMENTATION - A system provides for mobile medical instrumentation for use with a body. The system includes a primary wireless communication device, such as a cell phone or tablet computer, and one or more cradles. The cradles provide an interface to the body which provides for input of signals from the body, and optionally, therapeutic outputs to the body. The cradle and the primary wireless communication device may be releasably joined together so as to form a unitary structure when contacting the body. Alternately, the cradle may interface with the body, and communicate wirelessly to the primary wireless communication device. A cradle adapted to provide for a portable electrocardiogram includes a plurality of electrodes adapted for contact or non-contact sensing of the body. In the preferred embodiment, three electrodes are arranged in a triangular arrangement, most preferably a Einthoven triangular arrangement, with the distance between electrodes being 4 centimeters or less.12-15-2011
20110034794BLOOD GLUCOSE METER WITH INDEPENDENT VOICE IC SUPPORTING POST-PRODUCTION ADJUSTMENT OF VOICE FUNCTION - A blood glucose meter with an independent voice IC supporting post-production adjustment of voice function is provided. The blood glucose meter is allowed to work with a replaceable voice carrier so as to provide voice services in different languages that help users to correctly and easily operate the blood glucose meter. The blood glucose meter features that the voice carrier is not built in the blood glucose meter during production of the blood glucose meter. Instead, a driving module is edited in an IC chip of the blood glucose meter. When an actual ordered amount is confirmed, the different voice carriers can be assembled to a voice-IC expansion port of the blood glucose meter, thereby reducing manufacturing and inventory costs for the blood glucose meter.02-10-2011
20120041291Temporal control of a lumen traveling device in a body tube tree - Methods of controlling the operation of a device traveling in a body tube tree, including determining a time based on a signal from a timing device and performing an action based on the determined time, implemented with a control system located partially or fully on the lumen traveling device. Various actions can be performed by the device for, e.g., medical or therapeutic purposes. Machine-readable media including instructions for performing the methods are also described.02-16-2012
20120116196Medical Device and Method for Glycemic Control - A medical device and method for determining a dose of insulin to be administered for glycemic control is provided, wherein the dose is stepwise adapted, comprising determining a blood glucose value, receiving glycemic event information in respect to a predetermined glycemic event, wherein the predetermined glycemic event occurred within a predetermined time interval, receiving a previously adapted dose value stored in a storage unit, and setting an alert based on at least the blood glucose value, the glycemic event information and the previously adapted dose, wherein the alert indicates that the blood glucose value and the predetermined glycemic event are not in a specified relation to the previously adapted dose value.05-10-2012
20090131778DEVICES, SYSTEMS, METHODS AND TOOLS FOR CONTINUOUS GLUCOSE MONITORING - One aspect of the invention provides a glucose monitor having a plurality of tissue piercing elements, each tissue piercing element having a distal opening, a proximal opening and interior space extending between the distal and proximal openings; a sensing volume in fluid communication with the proximal openings of the tissue piercing elements; sensing fluid extending into the sensing volume; and a glucose sensor adapted to detect a concentration of glucose in the sensing fluid within the sensing volume. Another aspect of the invention provides A method of in vivo monitoring of an individual's interstitial fluid glucose concentration comprising: inserting distal ends of a plurality of tissue piercing elements through a stratum corneum area of the individual's skin, the tissue piercing elements each comprising a distal opening, a proximal opening, and an interior space extending between the distal and proximal opening; allowing interstitial fluid to flow into the interior space of the tissue piercing elements to substantially fill the interior space; filling substantially the entire interior space of the sensing area; and sensing a glucose concentration of the sensing fluid.05-21-2009
20120004525MULTI-USER REMOTE HEALTH MONITORING SYSTEM WITH BIOMETRICS SUPPORT - The invention presents a networked system for identifying an individual, communicating information to the individual, and remotely monitoring the individual. The system includes a remotely programmable apparatus that occasionally connects to a server via a communication network such as the Internet. The remotely programmable apparatus interacts with the individual in accordance with a script program received from the server Among other capabilities, the script program may instruct the remotely programmable apparatus to identify the individual, to communicate information to the individual, to communicate queries to the individual, to receive responses to the queries, and to transmit information identifying the individual and the responses from the remotely programmable apparatus to the server. Information identifying the individual may be obtained via a biometrics sensor, a data card, a remote monitoring device, or the interception of data from a separate information system. The information identifying the individual may be used by either or both the server system and remotely programmable apparatus for security, customization and other purposes. As the present invention has multi-user capabilities, it can be used in a public place, such as a pharmacy or health care clinic. The multi-user capabilities also allow collection and tracking of user data for the healthcare industry.01-05-2012
20120209099APPARATUS AND METHOD FOR GENERATING A CONDITION INDICATION - An apparatus for generating a condition indication using a time sequence of data values, each data value representing a physiological measure of a condition of a subject at a time, includes: a transformer for transforming the time sequence of data values into a transformed sequence of data values using a transform rule, wherein the transform rule is such that a certain characteristic in a time course of the physiological measure is represented by the transformed sequence of data values is more linear than the time course before the transform; a rate of change calculator for calculating an estimated rate of change for the transformed sequence of data values; and a processor for processing the estimated rate of change to output the condition indication.08-16-2012
20120010489TEST METHOD AND TEST DEVICE FOR ANALYSING A BODY FLUID - There is provided a test method for analysing a body fluid in which a test tape is used in a test device in order to successively provide analytical test fields stored on the test tape, wherein body fluid is applied by a user to the test field provided at a time and the said test field is photometrically scanned using a measuring unit of the device to record measurement signals. In order to increase the measurement reliability, it is proposed that a control value is determined from a time-dependent and/or wavelength-dependent change in the measurement signals and that the measurement signals are processed as valid or discarded as erroneous depending on the control value.01-12-2012
20120010488Method and apparatus for improving personnel safety and performance using logged and real-time vital sign monitoring - Group (including, without limitation, occupational work forces) safety and wellness monitoring utilizes baseline physiology testing and vital sign monitoring and sampling technologies. Aerobic capacity of individual members of a group is determined through initial baseline testing which results in an individual health risk assessment. Thereafter non-invasively observed and monitored during incremental work and exercise is commenced. Subsequent data collected is used for advance identification of personnel at risk of injury, such as during unexpected vital sign elevations that can signal early onset of fatigue and heat stress/dehydration prior to injury.01-12-2012
20120010487SYSTEMS AND METHODS FOR MONITORING HEALTH AND DELIVERING DRUGS TRANSDERMALLY - The present invention pertains to a system and method for transdermal sampling, comprising: at least one sampler for retrieving and transferring at least one analyte obtained transdermally from the skin of a subject; at least one detector system for identifying and quantifying said at least one analyte; and at least one logic module for (i) receiving and storing input data from said at least one detector, (ii) relating the input data to other data obtained from the subject, (iii) displaying output information, (iv) transmitting the output information to another system, and (v) controlling the operation of said at least one sampler and at least one detector.01-12-2012
20120065487SYSTEMS, METHODS, AND DEVICES FOR REDUCING THE PAIN OF GLUCOSE MONITORING AND INSULIN ADMINSTRATION IN DIABETIC PATIENTS - The various embodiments disclosed herein are devices that deliver electrical stimulation and/or vibration stimulation to the surface of skin in proximity to insulin injections and/or glucose testing in order to decrease or eliminate the pain of these procedures.03-15-2012
20120022354MEDICAL DEVICE FOR MEASURING AN ANALYTE CONCENTRATION - There is provided a medical device for measuring an analyte concentration in the subcutaneous tissue of a patient, the medical device comprising a body access unit and a processing unit. The body access unit and the processing unit are functionally connected when an analyte concentration is measured. The body access unit comprises a transcutaneous dialysis member for accessing the body of a patient. A fluid reservoir is contained at least partially in the transcutaneous dialysis member, and the fluid reservoir is at least partially bounded by a porous membrane. The fluid reservoir contains an analyte sensitive liquid. The processing unit comprises an excitation means adapted to act on a displacement member of the body access unit to generate a flow of the analyte sensitive liquid in the fluid reservoir. The processing unit further comprises a displacement sensor adapted to measure a displacement behavior of the displacement means, a damping of the displacement behavior caused by at least the viscosity of the analyte sensitive liquid contained in the fluid reservoir.01-26-2012
20120022353System for Optimizing a Patient's Insulin Dosage Regimen - A system for optimizing a patient's insulin dosage regimen over time, comprising at least a first memory for storing data inputs corresponding at least to one or more components in a patient's present insulin dosage regimen, and data inputs corresponding at least to the patient's blood-glucose-level measurements determined at a plurality of times, and a processor operatively connected to the at least first memory. The processor is programmed at least to determine from the data inputs corresponding to the patient's blood-glucose-level measurements determined at a plurality of times whether and by how much to vary at least one of the one or more components in the patient's present insulin dosage regimen in order to maintain the patient's future blood-glucose-level measurements within a predefined range.01-26-2012
20090326357Method, system, and computer program product for calculating daily weighted averages of glucose measurements (or derived quantities) with time-based weights - A method and system for calculating daily weighted averages of glucose measurements (or derived quantities) with time-based weights are disclosed. The present invention computes an average daily glucose value using the time based weights based on only consecutive glucose measurements in the plurality of glucose measurements with acceptable time intervals that do not exceed a predefined maximum time interval. The invention further relates to a computer program for implementing the method for calculating daily weighted averages of spot monitoring glucose measurements (or derived quantities) with the time-based weights.12-31-2009
20120059237SYSTEM AND METHOD FOR MONITORING BLOOD GLUCOSE LEVELS NON-INVASIVELY - A system and method is described for non-invasive monitoring of blood glucose levels. The system includes a pulse-sensor unit configured to detect a pulse wave travelling through a blood vessel and a processor unit configured to determine pulse wave velocity, to calculate the blood density and so to determine blood glucose level. Various embodiments include pulse-sensor arrays and wearable units configured to communicate with insulin pumps worn about the person of the subject.03-08-2012
20120059236IMPLANTABLE DEVICE FOR REAL-TIME MONITORING OF GLYCEMIA AND DOSAGE - An implantable device for constant collection and dosage of glycemia with real-time monitoring, with no need of external collection by punctioning which is constituted by a metal compartment, hermetically sealed with the cap, containing at least a micro-computerized mini-center fed by the battery or similar, which is externally rechargeable. The device contains a sensor which collects a portion of the circulating blood and reads glycemia levels in real time, sending reading information through the transmission component. The device is connected to an inlet catheter with its collecting edge duly implanted by means of punctioning at the subclavian vein, to deviate a small flow of blood to pass through within said dosage and monitoring device, thus allowing the sensor to verify the glycemic dosage and following its natural course by exiting the exit catheter through the outlet edge, thus returning to the blood current within said subclavian vein.03-08-2012
20120108934CONTINUOUS ANALYTE MONITOR DATA RECORDING DEVICE OPERABLE IN A BLINDED MODE - A system is provided including a continuous analyte sensor that produces a data stream indicative of a host's analyte concentration and a device that receives and records data from the data stream from the continuous analyte sensor. The data received from the continuous analyte sensor may be used to provide alarms to the user when the analyte concentration and/or the rate of change of analyte concentration, as measured by the continuous analyte sensor, is above or below a predetermined range. Data received from the continuous analyte sensor may also be used to prompt the diabetic or caregiver to take certain actions, such as to perform another single point blood glucose measurement. The device may provide for toggling between modes that allow or prevent the display of glucose concentration values associated with the continuous glucose sensor.05-03-2012
20110092788Systems And Methods For Providing Guidance In Administration Of A Medicine - A method of providing guidance using a portable hand-held electronic device in administration of a medicine by a patient is provided. The method includes acquiring image data of a first container of a first medicine prescribed to the patient and acquiring image data of a second container of a second medicine prescribed to the patient. The second container is different visually from the first container. The image data of the first container and the second container is stored in memory of the electronic device. On the portable hand-held electronic device, an instruction is processed to administer at least one of the first medicine and the second medicine to the patient. The stored image data is retrieved from memory corresponding to the at least one of the first medicine and the second medicine to be administered in the instruction. The retrieved image data is displayed on a display of the electronic device.04-21-2011
20120157806REPRESENTATION OF LARGE, VARIABLE SIZE DATA SETS ON SMALL DISPLAYS - A method of enhancing readability of a graph showing glucose values received from a continuous glucose monitoring device (CGM) on the display of a handheld device includes receiving a plurality of CGM glucose values separated by a first fixed time interval. A second fixed time interval at which to display at least a portion of the plurality of CGM glucose values is received. The second fixed time interval is greater than the first fixed time interval. A computer processor of the handheld device determines a characteristic CGM glucose value at a preselected fixed time for each of a sequence of second fixed time intervals within a patient-specified time period. Each characteristic CGM glucose value is derived from two or more received CGM values centered about the preselected fixed time in the corresponding second fixed time interval. The characteristic CGM glucose values for a patient-selected period of time on the display.06-21-2012
20120108935GLUCOSE SENSOR SIGNAL RELIABILITY ANALYSIS - Disclosed are methods, apparatuses, etc. for glucose sensor signal reliability analysis.05-03-2012
20120108933SYSTEM AND/OR METHOD FOR GLUCOSE SENSOR CALIBRATION - The subject matter disclosed herein relates to systems, methods and/or devices for calibrating sensor data to be used in estimating a blood glucose concentration. A relationship between sensor signal values and reference readings may be used to estimate a relationship between sensor signal values and measurements of blood glucose concentration.05-03-2012
20100168537BLOOD GLUCOSE MEASUREMENT SYSTEM - A blood glucose measurement system in which a blood glucose level measured with an invasive blood glucose measurement apparatus 101 is used to calibrate a blood glucose level measured with a non-invasive blood glucose measurement apparatus 07-01-2010
20110105873Method and Apparatus for Detecting False Hypoglycemic Conditions - Embodiments of the present disclosure include detecting a concurrent occurrence of a decrease in monitored analyte level and a corresponding decrease in monitored on-skin temperature, confirming a presence of an impending hypoglycemic condition, and asserting a notification corresponding to the confirmed impending hypoglycemic condition. Devices, methods, systems and kits incorporating the same are also provided.05-05-2011
20110105872SYSTEMS AND METHODS FOR APPLICATION TO SKIN AND CONTROL OF ACTUATION, DELIVERY, AND/OR PERCEPTION THEREOF - The present invention generally relates, in certain aspects, to systems and methods for application to the skin, and control of actuation, delivery, and/or perception thereof. For example, certain aspects of the invention are generally directed to devices for delivering to and/or withdrawing fluid or from subjects, e.g., to or from the skin and/or beneath the skin. In one aspect, the delivery and/or withdrawal of fluid is at least partially obscured. For example, the obscuration may be by time, and/or by sensory obscuration (e.g., by providing tactile, olfactory, auditory, and/or visual sensations). Certain aspects of the invention are generally directed to devices able to automatically deliver to and/or withdraw fluid from the skin and/or beneath the skin after activation, e.g., where the fluid is delivered and/or withdrawn without the need for any additional intervention. The devices may be activated by any suitable technique. In other aspects, a device may be contained in a package, and when removed from the package, the device may be constructed and arranged to be able to deliver and/or withdraw fluid when the device is applied to the skin, and in some cases, automatically and/or without any further intervention by the subject or another person.05-05-2011
20100094114USE OF MULTIPLE CALIBRATION SOLUTIONS WITH AN ANALYTE SENSOR WITH USE IN AN AUTOMATED BLOOD ACCESS SYSTEM - The invention relates to an automated calibration procedure for analyte sensors such as glucose sensors. The system can provide a calibration point at zero analyte concentration as well as a second calibration point at a known analyte concentration or other pre-determined points. Although not restricted to two point calibration procedure, the system as described enables the system to create one or more calibration points. The use of multiple calibration points can allow the system to correct for both slope and bias drifts. The system also provides the opportunity to provide one or more validation samples. The present invention enables a multitude of options in both calibration and validation to ensure effective operation of the system.04-15-2010
20120123235IMPLANTABLE THERANOSTIC ARTICLE - A theranostic article has one or more specific molecular recognition markers for cells on the surface thereof, wherein the recognition markers are selected from the group consisting of peptides, proteins, antibodies, antigens, aptamers, molecular imprinted polymers and polynucleotides. When the article is implanted in a body, cellular ingrowth is controlled, with desired cell types anchoring and proliferating on the implant's surface to generate a thin layer, and thereafter ceasing accumulation. The cellular layer thereby presents a biomimetic surface acceptable to the body, and also presents a low barrier to diffusion of analytes with at least substantially constant diffusion characteristics, allowing use of an analyte sensor within the article.05-17-2012
20120123234METHOD AND SYSTEM FOR AUTOMATIC MONITORING OF DIABETES RELATED TREATMENTS - The present invention discloses a monitoring system and method for use in monitoring diabetes treatment of a patient. The system comprises a control unit comprising a first processor module for processing measured data indicative of blood glucose level and generating first processed data indicative thereof, a second processor module comprising at least one fuzzy logic module; the second processor module receives input parameters corresponding to the measured data, the first processed data and a reference data including individualized patient's profile related data, to individualized patient's treatment history related data and processes the received data to produce at least one qualitative output parameter indicative of patient's treatment parameters, such that the second processor module determines whether any of the treatment parameters is to be modified.05-17-2012
20090131777ANALYTE SENSOR - Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.05-21-2009
20110124999Method and System for Providing Data Management in Data Monitoring System - Method and system for providing a fault tolerant data receiver unit configured with a partitioned or separate processing units, each configured to perform a predetermined and/or specific processing associated with the one or more substantially non-overlapping functions of the data monitoring and management system is provided05-26-2011
20110124998IN VIVO COMPONENT MEASUREMENT METHOD, DATA PROCESSING METHOD FOR IN VIVO COMPONENT MEASUREMENT, IN VIVO COMPONENT MEASUREMENT APPARATUS AND COLLECTION MEMBER - An in vivo component measurement method allowing how long a high concentration state of a measurement target component continues in an organism to be grasped is provided. In this in vivo component measurement method, a value relating to an amount of a measurement target component in tissue fluid extracted for 60 minutes or more from an organism on which a treatment for enhancing extraction of tissue fluid has been made is acquired.05-26-2011
20120232368Continuous Glucose Monitoring System and Methods of Use - A continuous glucose monitoring system including a sensor configured to detect one or more glucose levels, a transmitter operatively coupled to the sensor, the transmitter configured to receive the detected one or more glucose levels, the transmitter further configured to transmit signals corresponding to the detected one or more glucose levels, and a receiver operatively coupled to the transmitter configured to receive transmitted signals corresponding to the detected one or more glucose levels, and methods thereof, are disclosed. In one aspect, the transmitter may be configured to transmit a current data point and at least one previous data point, the current data point and the at least one previous data point corresponding to the detected one or more glucose levels.09-13-2012
20120165641CONTINUOUS BLOOD GLUCOSE MONITOR - A device may be implanted subcutaneously with an attached catheter inserted within, e.g., the peritoneal cavity of a subject. The catheter and/or device may also be inserted into another space, e.g., subcutaneous, vascular, peritoneal, cerebrospinal, pleural spaces, etc. The peritoneal fluid which normally collects and/or flows through the peritoneal cavity may be detected by the catheter and analyzed via the device to detect the concentration of glucose within the fluid.06-28-2012
20120165640STRUCTURED BLOOD GLUCOSE TESTING PERFORMED ON HANDHELD DIABETES MANAGEMENT DEVICES - A handheld diabetes management device includes a bG measurement engine, a data store, a display, and a testing module. The bG measurement engine selectively measures bG levels in blood samples. The data store includes data for executing a plurality of structured tests, each of the structured tests calling for execution of one or more of: a first procedure including prompting the patient to input a first blood sample at a first predetermined time; a second procedure including prompting the patient to input second and third blood samples at second and third predetermined times, respectively; a third procedure including prompting the patient to input M blood samples at predetermined intervals beginning after a predetermined offset period; and a fourth procedure including prompting the patient to input N number of blood samples at N predetermined times of a day, respectively. The testing module selectively executes one or more of the structured tests.06-28-2012
20120165639STORAGE OF CALIBRATION DATA AT A CONTINUOUS GLUCOSE MONITOR - A method for storing data at a continuous glucose monitor is presented. The method includes measuring the blood glucose level of the patient. The method also includes receiving a plurality of physical attributes related to the glucose level of the patient. The method further includes determining calibration data based on the measured blood glucose level and at least one of the plurality of physical attribute samples, the calibration data configured to allow the handheld diabetes managing device to determine the estimated glucose level of the patient based on the plurality of physical attribute samples. Finally, the method includes transmitting the calibration data from the handheld diabetes managing device to the continuous glucose monitor for storage at the continuous glucose monitor. The calibration data and plurality of physical attribute samples can be retrieved by a separate device to determine an estimated glucose level of the patient.06-28-2012
20120165638Patient Monitoring System With Efficient Pattern Matching Algorithm - A patient monitoring system with an efficient pattern matching algorithm, a method, and a computer product thereof are disclosed. The system may include a physiological data input device or sensor which receives a plurality of physiological measurements within a time window thereby generating at least one time window data set, a memory which stores a program, and a processor. The program when executed by the processor, causes the processor to compress the at least one time window data set to a reduced-rank basis, and perform a pattern match between a reference pattern and the compressed at least one time window data set using a distance metric.06-28-2012
20120220847ALARM SYSTEMS USING MONITORED PHYSIOLOGICAL DATA AND TREND DIFFERENCE METHODS - A method and system are described for detecting a hypoglycaemic state in a patient. The patient's heart rate is monitored to provide a heart-rate signal. A time-lagged signal is determined as the difference between the heart-rate signal and a time-lagged version of the heart rate-signal. The heart-rate signal is filtered with a low-pass filter to provide a heart-rate trend. An absolute difference between the heart-rate signal and the heart-rate trend is determined to provide an absolute-difference signal. A second time-lagged signal is determined as a difference between the absolute-difference signal and a time-lagged version of the absolute-difference signal. The occurrence of a hypoglycaemic condition is inferred dependent on the time-lagged signal and the second time-lagged signal.08-30-2012
20120316414SYSTEMS, METHODS AND APPARATUS FOR POWERING DEVICES USING RF ENERGY FROM A MOBILE TRANSMITTER - In some embodiments, a personal area network (PAN) includes a mobile transmitter (e.g., a mobile or cellular phone) and one or more devices (e.g., sensors) that require power to operate (e.g., collect data). The mobile transmitter can be configured to transmit a sufficient amount of power (e.g., RF energy) to the one or more devices to power the one or more local devices. In addition to transmitting power, the mobile transmitter can be configured to communicate over a wireless network (e.g., a cellular network) as its primary function.12-13-2012
20100204559DEVICE AND METHOD FOR DETERMINING ANALYTE LEVELS - Devices and methods for determining analyte levels are described. The devices and methods allow for the implantation of analyte-monitoring devices, such as glucose monitoring devices, that result in the delivery of a dependable flow of blood to deliver sample to the implanted device. The devices comprise a unique microarchitectural arrangement in the sensor region that allows accurate data to be obtained over long periods of time.08-12-2010
20120215087METHOD TO RECALIBRATE CONTINUOUS GLUCOSE MONITORING DATA ON-LINE - In a method of recalibrating continuous glucose monitoring data from a user, operable on a digital processor, an indication from the user that the user has taken a meal is received (08-23-2012
20120215086SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as interfering species, ischemia, pH changes, temperatures changes, known or unknown sources of mechanical, electrical and/or biochemical noise, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system processes some or the entire data stream continually or intermittently based at least in part on whether the signal artifact event has occurred.08-23-2012
20100204558Blood Glucose Monitoring Kit - A blood glucose monitoring kit includes a case constructed in the form of a bi-fold wallet which comprises an upper flap and a lower flap that are connected together through a fold. The case includes an outer layer constructed out of a water resistant and soft fabric and an inner layer constructed out of a water resistant material, the outer and inner layers being sewn together about their peripheries. A layer of cushioned material is preferably disposed between the inner and outer layers to provide the case with a soft feel. Blood glucose monitoring electronics are preferably integrated directly into the upper flap of the case, the electronics including a printed circuit board (PCB), a test port mounted on the PCB and a display mounted on the PCB. Preferably, the upper flap is provided with an opening through which the test port is externally accessible. Additionally, the upper flap is provided with a window through which the display is externally visible. A pouch is secured onto the inner surface of the lower flap and is sized and shaped to retain a plurality of disposable test components.08-12-2010
20100198035CALIBRATION TECHNIQUES FOR A CONTINUOUS ANALYTE SENSOR - Disclosed herein are systems and methods for calibrating a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes one or more electrodes to measure an additional analyte. Such measurements may provide a baseline or sensitivity measurement for use in calibrating the sensor. Furthermore, baseline and/or sensitivity measurements may be used to trigger events such as digital filtering of data or suspending display of data.08-05-2010
20100198034Compact On-Body Physiological Monitoring Devices and Methods Thereof - Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned analyte sensor automatically or on demand upon request from a user.08-05-2010
20100198033FLEXIBLE INDWELLING BIOSENSOR, FLEXIBLE INDWELLING BIOSENSOR INSERTION DEVICE, AND RELATED METHODS - A flexible indwelling biosensor includes an elongated framework formed from a flexible material (e.g., a Nitinol strip) with a body portion, a sharp head, a distal end, and a proximal end. The flexible indwelling sensor also includes a biosensor (such as an interstitial fluid glucose sensor) integrated with the elongated framework with the biosensor having a sensing element disposed over (for example, on or suspended over) at least one of the body portion or sharp head of the elongated framework. Moreover, the sharp head is disposed at the distal end of the elongated framework and the sharp head and at least the sensing element of the biosensor are configured for insertion into a target site (for example, a subcutaneous target site).08-05-2010
20110184267Methods And Systems For Processing Glucose Data Measured From A Person Having Diabetes - Methods and systems are disclosed for estimating a glucose level of a person having diabetes comprises. One method may comprise: receiving into a computing device a plurality of measured glucose results from a glucose sensor coupled to the person; using the computing device to analyze the plurality of measured glucose results with a probability analysis tool configured to determine a probability of glucose sensor accuracy based on the plurality of measured glucose results; and using the computing device to estimate a glucose level of the person with a recursive filter configured to estimate the glucose level based on the plurality of measured glucose results weighted with the probability of glucose sensor accuracy.07-28-2011
20110184268Method, Device and System for Providing Analyte Sensor Calibration - Methods and devices for providing calibration in analyte monitoring systems are provided.07-28-2011
20110184266Blood glucose monitoring system - A method and apparatus for blood glucose monitoring is provided which allows blood sampling and insulin infusion through the same catheter lumen of a multi-lumen, central venous catheter. It is designed to be used with a nearby continuous glucose sensor. The catheter lumen with the most proximal aperture leads to a connecting tube which is split into two parts, with both parts having a low internal volume. The described catheter allows for rapid switching between insulin delivery and blood sampling and minimizes the amount of purge fluid needed to clear the line.07-28-2011
20100174167SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-08-2010
20120083679Automatic Biological Analyte Testing Meter with Integrated Lancing Device and Methods of Use - The invention is directed to an integrated device for sampling and testing an analyte. The device generally comprises a housing, a lancing device for sampling an analyte, a test strip for substantially capturing at least a portion of the analyte, and a display unit for displaying a result corresponding to the captured portion of the analyte. The invention is further directed to methods for sampling and testing. For example, one method comprises performing a single operation to sample an analyte, to capture the sampled analyte, to perform testing on the sampled analyte, and to display a result corresponding to the performed test. A method such as this can be carried out using an integrated sampling and testing device of the invention, for example, by placing the device the device on a test site of a subject, such as a patient, and performing the single operation to obtain a test result. The invention has particular application in the sampling and testing of analytes in blood, such as the blood of a diabetic patient.04-05-2012
20120172692Sensing Fluid Concentration for Continuous Glucose Monitoring - An analyte monitor having a plurality of fluid paths, each fluid path having a distal opening adapted to be disposed on one side of a stratum corneum layer of a user's skin, a proximal opening adapted to be disposed on another side of the stratum corneum layer and an interior space extending between the distal and proximal openings; a sensing zone in fluid communication with the proximal openings of the fluid paths; sensing fluid extending from the sensing zone into substantially the entire interior space of the fluid paths; and an analyte sensor adapted to detect a concentration of analyte in the sensing fluid within the sensing zone, wherein at least one of the sensing fluid and the analyte sensor comprises a catalyst for mutarotation of glucose. The invention also includes a method of using the monitor.07-05-2012
20100049024COMPOSITE MATERIAL FOR IMPLANTABLE DEVICE - Devices suitable for implantation in a body of a host and systems and methods for their manufacture are provided. The implantable devices include a composite material formed at least from a matrix material and hollow gas-filled beads. In preferred embodiments, the composite material includes a polymeric matrix mixed with hollow air-filled glass beads, which are mixed and cured to form at least a portion of the body of the implantable device. Implantable devices including this composite material have decreased weight and/or overall density as compared to implantable devices without the beads incorporated therein, which is believed to improve the acceptance and function of the implantable device in vivo. Additionally, implantable devices concerned with transmitting and receiving via RF are believed to achieve improved RF performance due to a reduced dielectric constant provided by the incorporation of beads within the composite material.02-25-2010
20090287074ANALYTE SENSOR - Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.11-19-2009
20100049025On-Body Medical Device Securement - Devices and methods for maintaining a medical device on-body are provided. Embodiments include medical device securement systems having first and second on-body securement elements. Also provided are systems and kits for use maintaining a medical device on-body.02-25-2010
20100280348METHOD AND IMPLANTABLE SYSTEM FOR BLOOD-GLUCOSE CONCENTRATION MONITORING USING PARALLEL METHODOLOGIES - In an implantable medical device for monitoring glucose concentration in the blood, a blood-glucose concentration analysis is performed using correlations of blood-glucose concentration with measures of metabolic oxygen consumption including oxymetric, and/or temperature. Analysis of electrocardiographic data is used in a parallel method to detect and/or confirm the onset and/or existence and/or extent of hypoglycemia and/or hyperglycemia. Blood-glucose concentration calculation is enhanced by using the combination of the oxygen metabolism analysis and electrocardiographic analysis.11-04-2010
20100298686Method and System for Providing Data Management in Data Monitoring System - Method and system for providing a fault tolerant data receiver unit configured with a partitioned or separate processing units, each configured to perform a predetermined and/or specific processing associated with the one or more substantially non-overlapping functions of the data monitoring and management system is provided11-25-2010
20100298685ADAPTIVE INSULIN DELIVERY SYSTEM - A proactive system and method in which levels of glucose are monitored after a meal signal and compared to a safe range. If a monitored glucose level is outside the safe range, a post-prandial vertex of the glucose level is identified and an action is provided to more rapidly return the glucose level to a target level within the safe range than if no action was provided. In another aspect a control parameter in an IDM system is adjusted by determining a performance metric of the system as a function of the levels of glucose and a medication administration signal over a first window of time; and, if the performance metric is outside an expected range, adjusting the control parameter to adjust an amount of medication and to bring the performance metric inside the expected range.11-25-2010
20100298684ANALYTE SENSOR - Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.11-25-2010
20120179017BLOOD GLUCOSE METER AND BLOOD GLUCOSE LEVEL MEASUREMENT METHOD - An internal temperature sensor for measuring internal temperature of a case of the blood glucose meter is arranged inside the case of the blood glucose meter, and an external temperature sensor configured by components with low heat capacity and adapted for measuring external temperature is arranged at a position separated from the central portion of the case of the blood glucose meter. Further, a microcomputer of the blood glucose meter includes the following processing: judging whether or not the temperature fluctuation falls within the acceptable range based on the difference between the respective temperatures and, if the temperature fluctuation exceeds the acceptable range, temporarily stopping the processing until the temperature fluctuation falls within the acceptable range when in the case where the blood glucose measurement has not yet been performed, or stopping the blood glucose measurement processing when in the case where the blood glucose measurement is being performed.07-12-2012
20120179015TELEMETERED CHARACTERISTIC MONITOR SYSTEM AND METHOD OF USING THE SAME - A telemetered characteristic monitor system includes a remotely located data receiving device, a sensor for producing signal indicative of a characteristic of a user, and a transmitter device. The transmitter device includes a housing, a sensor connector, a processor, and a transmitter. The transmitter receives the signals from the sensor and wirelessly transmits the processed signals to the remotely located data receiving device. The processor coupled to the sensor processes the signals from the sensor for transmission to the remotely located data receiving device. The data receiving device may be a characteristic monitor, a data receiver that provides data to another device, an RF programmer for a medical device, a medication delivery device (such as an infusion pump), or the like.07-12-2012
20120179016INJECTION DEVICE WITH PUNCTURE FUNCTION, METHOD FOR CONTROLLING INJECTION DEVICE WITH PUNCTURE FUNCTION, CHEMICAL SOLUTION ADMINISTRATION DEVICE, AND METHOD FOR CONTROLLING CHEMICAL SOLUTION ADMINISTRATION DEVICE - An injection device with a puncture function includes, in a single casing, a cylindrical cartridge in which insulin is enclosed, a cartridge holder to which the cartridge is inserted, a needle inserted at a front end of the cartridge, a reciprocation unit for reciprocating the cartridge toward the needle, and an extrusion member for extruding the insulin from a rear end of the cartridge toward the needle, and the motion speed and the motion amount of the reciprocation unit are made variable.07-12-2012
20100010332SIGNAL PROCESSING FOR CONTINUOUS ANALYTE SENSOR - Systems and methods for dynamically and intelligently estimating analyte data from a continuous analyte sensor, including receiving a data stream, selecting one of a plurality of algorithms, and employing the selected algorithm to estimate analyte values. Additional data processing includes evaluating the selected estimative algorithms, analyzing a variation of the estimated analyte values based on statistical, clinical, or physiological parameters, comparing the estimated analyte values with corresponding measure analyte values, and providing output to a user. Estimation can be used to compensate for time lag, match sensor data with corresponding reference data, warn of upcoming clinical risk, replace erroneous sensor data signals, and provide more timely analyte information encourage proactive behavior and preempt clinical risk.01-14-2010
20100010329Closed Loop Control System Interface and Methods - Method and apparatus including calling, retrieving and/or initiating a programmed function in conjunction with execution of one or more commands related to a closed loop control algorithm, receiving one or more data in response to the one or more commands over a data interface, and executing the one or more commands related to the closed loop control algorithm based on the received one or more data are provided.01-14-2010
20110105871MONITORING METHOD AND/OR APPARATUS - A method and apparatus for substance monitoring. One application is an easy to handle continuous glucose monitor using a group of hollow out-of-plane silicon microneedles to sample substances in interstitial fluid from the epidermal skin layer. The glucose of the interstitial fluid permeates a dialysis membrane and reaches a sensor. Using MEMS technology, for example, allows well-established batch fabrication at low cost.05-05-2011
20120226124INSULIN PUMP BASED EXPERT SYSTEM - An apparatus comprising a pump configured to deliver insulin, an input configured to receive blood glucose data, a user interface, and a controller communicatively coupled to the pump, the input, and the user interface. The controller includes a blood glucose data module to compare the blood glucose data to a target blood glucose level for an insulin pump user. The controller is configured to present a question related to the blood glucose level via the user interface when the blood glucose level is different than the target blood glucose level, receive a response to the question via the user interface, and present a recommended user action based at least in part on the response. Other devices, systems, and methods are disclosed.09-06-2012
20120226123LANCING DEVICE HAVING SADDLE-SHAPED TIP09-06-2012
20120190953INTEGRATED DELIVERY DEVICE FOR CONTINUOUS GLUCOSE SENSOR - Systems and methods for integrating a continuous glucose sensor, including a receiver, a medicament delivery device, and optionally a single point glucose monitor are provided. Manual integrations provide for a physical association between the devices wherein a user (for example, patient or doctor) manually selects the amount, type, and/or time of delivery. Semi-automated integration of the devices includes integrations wherein an operable connection between the integrated components aids the user (for example, patient or doctor) in selecting, inputting, calculating, or validating the amount, type, or time of medicament delivery of glucose values, for example, by transmitting data to another component and thereby reducing the amount of user input required. Automated integration between the devices includes integrations wherein an operable connection between the integrated components provides for full control of the system without required user interaction.07-26-2012
20120190954Method and Apparatus for Providing Dynamic Multi-Stage Amplification in a Medical Device - Methods and apparatus for providing multi-stage signal amplification in a medical telemetry system are provided.07-26-2012
20120259191SYSTEMS AND METHODS FOR PROCESSING SENSOR DATA - Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.10-11-2012
20120259192MEASURING APPARATUS AND SENSOR PLACEMENT METHOD - Provided are a measurement device, a sensor unit, and a sensor placement method, which enable the suppression of the occurrence of a situation where a measurement carried out with a sensor implanted under the skin, the implanted sensor becomes faulty. A sensor unit is used for measuring numerical information relating to a substance contained in a body fluid in a body. The sensor unit is provided with a sensor a part of which is placed under the skin and generates a signal according to the state of the substance, a base which is disposed on the skin and holds the sensor, a variable mechanism which is attached to the base and enables the position and/or the direction of the sensor with reference to the base to be varied, and an external terminal which is provided in the base and leads the signal generated by the sensor to the outside.10-11-2012
20090018426DEVICE AND METHODS FOR CALIBRATING ANALYTE SENSORS - The present invention relates to methods and systems for multipoint calibration of an analyte sensor. More specifically, the methods can be used to calibrate glucose sensors.01-15-2009
20120232367SYSTEMS, METHODS AND ANALYZERS FOR ESTABLISHING A SECURE WIRELESS NETWORK IN POINT OF CARE TESTING - A system and method for initiating and maintaining a secure wireless communication between a wireless analyzer and a target network (e.g., a hospital network connected to a LIS and/or HIS). The present disclosure provides novel processes and systems for securely networking a wireless analyzer with a Wi-Fi network without the need for an operator or user to engage in manual initiation steps on, or through, the wireless analyzer.09-13-2012
20080300476INSERTION DEVICES AND METHODS - Devices and methods relating to analyte sensor insertion devices and methods are provided.12-04-2008
20110004086METHOD OF ANALYZING BIOLOGICAL COMPONENT, BIOLOGICAL COMPONENT ANALYZER, REACTION CARTRIDGE OF BIOLOGICAL COMPONENT ANALYZER AND EXTRACTION CARTRIDGE OF BIOLOGICAL COMPONENT ANALYZER - This method of analyzing a biological component includes steps of arranging an extraction medium holding device on the skin of a subject, extracting an extract from the subject, attaching a reaction cartridge configured to be detachable on an extraction medium holding part of the extraction medium holding device and to be capable of transferring an extraction medium to a reaction part to the extraction medium holding part of the extraction medium holding device arranged on the skin, and transferring the extraction medium held in the extraction medium holding part to the reaction part.01-06-2011
20080287763Method and apparatus for providing data processing and control in a medical communication system - Methods and apparatus for providing data processing and control for use in a medical communication system are provided.11-20-2008
20110046468Method and Device for Utilizing Analyte Levels to Assist in the Treatment of Diabetes - A health-monitoring device assesses the health of a user based on levels of two analytes in a biological fluid. A first analyte that is utilized to assess a user's health is a fat metabolism analyte, such as ketones, free fatty acids and glycerol, which is indicative of fat metabolism. A second analyte that is utilized is a glucose metabolism analyte, such as glucose. The levels of the two analytes may be used to assess insulin sensitivity, to detect both recent hypoglycemia and the cause of high glucose levels, and/or to guide therapeutic intervention. The dual analyte model may calculate a discrepancy between an actual insulin activity level and a theoretical insulin activity level. The dual analyte model of the present invention may be used to identify individuals at risk for metabolic syndrome, insulin resistance and non-insulin dependent diabetes, and allows monitoring of the progression of those disease states, as well as progress made by therapeutic interventions.02-24-2011
20120271133Device for Non-Invasively Measuring Glucose - In order to increase the accuracy of non-invasive glucose measurement, the device uses a combination of three non-invasive methods: ultrasonic, electromagnetic and thermal. The non-invasive glucose monitor comprises a Main Unit, which drives three different sensor channels (one per technology), located on an external unit configured as an ear clip attached to the subject's ear lobe. To effect the ultrasonic channel, ultrasonic piezo elements are positioned on opposing portions of the ear clip and thus opposite sides of the ear lobe. For implementation of the electromagnetic channel, capacitor plates are positioned on opposing portions of the ear clip and the ear lobe serves as the dielectric. The thermal channel includes a heater and a sensor positioned on the ear clip in close juxtaposition to the ear lobe.10-25-2012
20120323100SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as interfering species, ischemia, pH changes, temperatures changes, known or unknown sources of mechanical, electrical and/or biochemical noise, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system processes some or the entire data stream continually or intermittently based at least in part on whether the signal artifact event has occurred.12-20-2012
20120323101BODILY FLUID COMPONENT MEASUREMENT SYSTEM - The waterproof property of a bodily fluid component measurement system is improved. A bodily fluid component measurement system according to this invention includes a sensor unit which is indwelled in the skin of a subject and connected to a bodily fluid in the subject to measure a predetermined bodily fluid component, and a transmission unit which is detachably attached to the sensor unit and transmits, to a display unit, a measurement signal obtained by the sensor unit or a calculation result calculated as a concentration of the bodily fluid component in a bodily fluid of the same type as or different type from the bodily fluid based on the measurement signal. The sensor unit measures the bodily fluid component and transmits the measurement signal to the transmission unit by being activated by electromagnetic induction caused by an electromagnetic field generated by the transmission unit.12-20-2012
20120095312POWER MANAGEMENT FOR A HANDHELD MEDICAL DEVICE - A system for managing power consumption of a handheld diabetes management device and limiting effects of temperature on operations performed by the handheld diabetes management device comprises a blood glucose measuring module, a temperature sensing module, and a power management module. The blood glucose measuring module selectively measures blood glucose in a blood sample and generates a status signal indicating a status of operation of the blood glucose measuring module. The temperature sensing module senses an internal temperature of the handheld diabetes management device and estimates an ambient temperature external to the handheld diabetes management device. The power management module deactivates one or more components of the handheld diabetes management device based on the status of operation of the blood glucose measuring module when the internal temperature of the handheld diabetes management device exceeds a threshold temperature. The power management module deactivates the blood glucose measuring module when the ambient temperature is greater than a first predetermined threshold or less than a second predetermined threshold.04-19-2012
20100228111BLOOD GLUCOSE METER CAPABLE OF WIRELESS COMMUNICATION - The present invention relates to a blood glucose meter (09-09-2010
20110237919DIAGNOSIS SUPPORT METHOD, DIAGNOSIS SUPPORT SYSTEM, AND DIAGNOSIS SUPPORT APPARATUS - A diagnosis support method comprising: obtaining first blood glucose level information at a first time point and/or second blood glucose level information at a second time point which is later, by a predetermined period, than the first time point; placing a collection member, which is configured to collect a tissue fluid, on the skin of the subject for the predetermined period from the first time point to the second time point; obtaining glucose information about an amount of glucose contained in the tissue fluid collected by the collection member; and generating diagnosis support information for supporting a diagnosis of presence or absence of hypoglycemia in the subject, based on the first blood glucose level information and/or the second blood glucose level information and the glucose information. A diagnosis support system and a diagnosis support apparatus are also disclosed.09-29-2011
20110237918METHODS AND SYSTEMS FOR PROVIDING THERAPEUTIC GUIDELINES TO A PERSON HAVING DIABETES - A method is disclosed for providing therapeutic guidelines to a person having diabetes. The method comprises measuring a blood glucose (bG) level of the person for two or more days, wherein at least one bG measurement is taken per day, and the at least one daily bG measurement corresponds to one or more daily events for the person; recording the measured bG levels in a computing device; determining, by the computing device, whether the recorded bG levels are below, within, or above one or more predetermined bG ranges; an automatically providing, by the computing device, therapeutic guidelines to the person, based on whether the recorded bG levels are below, within, or above the one or more predetermined bG ranges.09-29-2011
20110237917CALIBRATION OF GLUCOSE MONITORING SENSOR AND/OR INSULIN DELIVERY SYSTEM - Disclosed are methods, apparatuses, etc. for calibrating glucose monitoring sensors and/or insulin delivery systems. In certain example embodiments, blood glucose reference samples may be correlated with sensor measurements with regard to a delay associated with the sensor measurements. In certain other example embodiments, one or more parameters of a probability model may be estimated based on blood glucose reference sample-sensor measurement pairs. Based on such information, function(s) for estimating a blood-glucose concentration in a patient may be determined.09-29-2011
20100234710Analyte Sensor Calibration Management - Methods, devices, and systems for calibrating an analyte sensor are provided. Embodiments include determining a sensitivity value associated with an analyte sensor, retrieving a prior sensitivity value associated with the analyte sensor, determining whether a variance between the determined sensitivity value and the retrieved prior sensitivity value is within a predetermined sensitivity range, determining a composite sensitivity value based on the determined sensitivity value and the retrieved prior sensitivity value, and assigning a successful calibration sensitivity value based on the retrieved prior sensitivity value when the variance is within the predetermined sensitivity range.09-16-2010
20100234712DEVICE AND METHOD FOR ACCURATELY MEASURING CONCENTRATION OF BLOOD COMPONENT - A measurement computation device arranged in a measurement device detects a first component and a second component from perspiration in a first component detection unit and a second component detection unit, and the respective concentration in the perspiration is calculated in a concentration calculation unit. In a conversion computation unit, the concentration of the first component in the perspiration is corrected using the concentration of the second component, and then converted to the concentration of the first component in the blood.09-16-2010
20100234709Analyte Monitoring Device and Methods of Use - An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte. The analyte monitor may also be part of a drug delivery system to alter the level of the analyte based on the data obtained using the sensor.09-16-2010
20100234708WIRELESSLY CONFIGURABLE MEDICAL DEVICE FOR A BROADCAST NETWORK SYSTEM - A system for configuring one or more medical devices used for patient self-monitoring of medical parameters includes a broadcast provider and one or more medical devices in a network area of the broadcast provider. The one or more medical devices each include a receiver operable to receive data signals transmitted over the network area from the broadcast provider. The signals transmit medical device data to the one or more medical devices to facilitate the use of the medical device by the user while reducing the potential for errors that may be made by the user when using the medical device.09-16-2010
20120277564Optimizing Analyte Sensor Calibration - Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.11-01-2012
20120277563GLUCOSE MONITORING METHOD AND DEVICE FOR TREATING HUMANS - This invention relates to a monitoring and/or stabilizing glucose level in the blood stream in a human body signaling the person in the event glucose is at a dangerous level, said method comprising the following steps: 11-01-2012
20120277566SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA FOR SENSOR CALIBRATION - Systems and methods for processing sensor analyte data are disclosed, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. The sensor can be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. Reference data resulting from benchtop testing an analyte sensor prior to its insertion can be used to provide initial calibration of the sensor data. Reference data from a short term continuous analyte sensor implanted in a user can be used to initially calibrate or update sensor data from a long term continuous analyte sensor.11-01-2012
20120277565Method and System for Providing Analyte Monitoring - Methods and apparatuses for determining an analyte value are disclosed.11-01-2012
20110282175WIRELESS MOLECULAR SENSOR SYSTEM AND PROCESS - Wireless molecular sensor methods and systems integrate radio frequency (RF) technology to interrogate, power, operate and/or readout signals corresponding to levels of molecules of interest from microelectromechanical systems (MEMS) implanted within the body. Various alternative embodiments are disclosed.11-17-2011
20110319739CALIBRATION TECHNIQUES FOR A CONTINUOUS ANALYTE SENSOR - Disclosed herein are systems and methods for calibrating a continuous analyte sensor, such as a continuous glucose sensor. One such system utilizes one or more electrodes to measure an additional analyte. Such measurements may provide a baseline or sensitivity measurement for use in calibrating the sensor. Furthermore, baseline and/or sensitivity measurements may be used to trigger events such as digital filtering of data or suspending display of data.12-29-2011
20110319738Medical Devices and Insertion Systems and Methods - Implantable medical devices, systems, methods and kits for transcutaneous insertion of the implantable medical devices are provided.12-29-2011
20110319737METHOD AND SYSTEM FOR NON-INVASIVE DETERMINATION OF GLYCOGEN STORES - Provided is a non-transitory machine readable medium on which is stored a computer program for non-invasive determination of glycogen stores including, the computer program including instructions which when executed by a computer system perform the steps of: receiving an ultrasound scan of a target muscle; and evaluating at least a portion of the ultrasound scan to determine glycogen store within the target muscle.12-29-2011
20110319736SYSTEM FOR NON-INVASIVE DETERMINATION OF GLYCOGEN STORES - Provided is a system for non-invasive determination of glycogen stores including: a glycogen evaluator structured and arranged to evaluate at least one selected portion of a scan of a selected target muscle to determine a glycogen store within the target muscle.12-29-2011
20110319735METHOD FOR NON-INVASIVE DETERMINATION OF GLYCOGEN STORES - Provided is a non-invasive method of determining glycogen stores including: receiving an ultrasound scan of at least a portion of a target muscle; and evaluating at least a portion of the ultrasound scan to determine glycogen store within the target muscle.12-29-2011
20120101353Method and System for Providing Data Management in Data Monitoring System - Method and system for providing a fault tolerant data receiver unit configured with a partitioned or separate processing units, each configured to perform a predetermined and/or specific processing associated with the one or more substantially non-overlapping functions of the data monitoring and management system is provided04-26-2012
20120289805Analyte Monitoring System and Methods - Methods and systems for providing data communication in medical systems are disclosed.11-15-2012
20100204557Multi-Function Analyte Test Device and Methods Therefor - Methods, device and systems including receiving a request for a therapy profile for treating a medical condition, determining using a processor a plurality of therapy profile parameters, assigning a weighted value to each therapy profile parameter based on a hierarchy determined by the medical condition, querying a database to identify a stored therapy profile with therapy profile parameters that most closely correspond to the determined plurality of therapy profile parameters based on the hierarchy, generating an output data corresponding to the identified stored therapy profile, the output data a medication dosage information are provided. Also provided are systems and kits.08-12-2010
20100179409SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for detecting noise episodes and processing analyte sensor data responsive thereto. In some embodiments, processing analyte sensor data includes filtering the sensor data to reduce or eliminate the effects of the noise episode on the signal.07-15-2010
20100179408SYSTEMS AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for processing sensor data, including calculating a rate of change of sensor data and/or determining an acceptability of sensor or reference data.07-15-2010
20100179407SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM - Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as ischemia, pH changes, temperatures changes, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system replaces some or the entire data stream continually or intermittently including signal estimation methods that particularly address transient signal artifacts. The system is also capable of detecting the severity of the signal artifacts and selectively applying one or more signal estimation algorithm factors responsive to the severity of the signal artifacts, which includes selectively applying distinct sets of parameters to a signal estimation algorithm or selectively applying distinct signal estimation algorithms.07-15-2010
20100179406SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-15-2010
20100179405SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-15-2010
20100198032PORTABLE HANDHELD MEDICAL DIAGNOSTIC DEVICE HAVING A MEZZANINE CIRCUIT BOARD WITH A UNIVERSAL CONNECTION INTERFACE - A portable handheld medical diagnostic device capable of communicating with an external device and a method thereof are disclosed. The device has a protective enclosure, a main circuit board provided in the protective enclosure and having a wireless connectivity component and a controller facilitating a physiologic measurement and communications of results of the physiological measurement to the external device. Also provided in the protective enclosure is a mezzanine circuit board having at least one of a plurality of additional feature modules and a universal connection interface programmed to both facilitate operation of the additional feature module and operate under the control of the controller as a control interface between the controller and the additional feature module.08-05-2010
20100174168SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.07-08-2010
20130012798TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.01-10-2013
20130012796Smart device audio power harvesting glucose meter - A smart device audio power harvesting glucose meter and a system and method for blood glucose measurement and monitoring. The glucose meter operates by harvesting the micro amp power from the audio port of a smart phone or other handheld smart device and does not need batteries or other power sources for its operation. A smart glucose monitoring application downloaded and embedded in the smart phone or other hand held smart device stores results of the glucose measurements in a personalized cloud database to be accessed by the user and shared with physicians, emergency personnel, friends, or family members if needed through automated phone calls, SMS/text, or emails. The smart glucose monitoring application is self learning and has an option for self ordering test strips based on the needs of the user.01-10-2013
20130012797METHOD FOR MANAGING TREATMENT OF A PARTICULAR HEALTH CONDITION VIA A MOBILE PHONE DEVICE - A method for managing treatment of a particular health condition afflicting a patient through the use of a mobile phone device which includes a health management program stored in the mobile phone device that prompts a user for entry of health condition data, including patient physiological data, subjective patient health condition data, and medication delivery data, compiles the health condition data into an accumulated data summary, and transmits the data summary from the mobile phone device to a second processing unit through a communication port. A drop-down list related to subjective symptoms is provided, which includes stress and depression. A touch screen is provided for a graphical user interface. The health management program also provides prompts for the entry of diet data, and further displays drop-down lists related to daily activities and alerts for medication delivery.01-10-2013
20120150007MODULAR EXTERNAL INFUSION DEVICE - A modular external infusion device that controls the rate a fluid is infused into an individual's body, which includes a first module and a second module. More particularly, the first module may be a pumping module that delivers a fluid, such as a medication, to a patient while the second module may be a programming module that allows a user to select pump flow commands. The second module is removably attachable to the first module.06-14-2012
20130018244Budget Your Weight SystemAANM Kazemzadeh; MassoudAACI Clara CityAAST MNAACO USAAGP Kazemzadeh; Massoud Clara City MN USAANM Kazemzadeh; RoshanAACI Clara CityAAST MNAACO USAAGP Kazemzadeh; Roshan Clara City MN US - A system and method of monitoring a person's health information is disclosed. The method comprises the steps of providing a computer program algorithm accessible by a computer processing device and providing at least one monitor in electronic communication with the computer processing device wherein the monitor is configured to transmit the person's physical data to the computer processing device, and the algorithm is configured to store the physical data, average the physical data over one or more predetermined periods of time, and report the physical data in one or more predetermined formats. The computer processing device may be a cellular telephone, tablet computer, laptop computer, desktop computer, server, or networked computing device. The monitor may be any one of a pedometer, a heart rate monitor, a body temperature monitor, a blood glucose monitor, a blood pressure monitor, or a monitor configured to collect physical data from one or more of a person's body fluids. In some embodiments, the method is used to monitor a person's caloric balance, which may be computed or estimated.01-17-2013
20110160555Universal Models for Predicting Glucose Concentration in Humans - An embodiment of the invention provides a system for predicting future glucose levels in an individual including a glucose measuring device for generating glucose signals representing glucose levels obtained from the individual at fixed time intervals and an analyzer. The analyzer uses a glucose prediction function that is portable between individuals irrespective of health of the individuals. The glucose prediction function includes model coefficients that are invariant between the individuals. The glucose prediction function outputs the future glucose levels by weighing the previous glucose signals obtained from the individual by the model coefficients.06-30-2011
20110160554DEVICE AND METHOD FOR DETERMINING AT LEAST ONE CHARACTERIZING PARAMETER OF MULTILAYER BODY TISSUE - A device for the non-invasive measurement of a glucose level, body hydration or another characterizing parameter of body tissue comprises at least two coplanar waveguides arranged on a common support. An AC signal is applied to the first ends of the coplanar waveguides, and the signal arriving at the second end is measured. The coplanar waveguides have differing gap widths, such that their electric fields have different reach into the body tissue. This allows obtain depth resolved information about the permittivities of individual tissue layers and to obtain more accurate results.06-30-2011
20110160553Sensor and monitor system - A monitor system to monitor a characteristic of a user is disclosed. The monitor system includes a sensor to produce a signal indicative of a glucose characteristic measured in the user, the sensor further having a sensor port. The monitor system further includes a recorder within a recording housing, the recorder hosing also encompassing a batter. The recorder further includes a recorder port that interfaces with the sensor port in order to receive the produced signals from the sensor port. A recorder clock that assigns a time to the signals from the sensor is also defined within the recorder housing, as is a recorder processor that includes a recorder memory that is coupled to the recorder port to store the produced signals from the sensor. The recorder further includes a data port defined to interface with a dock receiver. A dock that is remotely located from the sensor and the recorder is also included with the monitor system. The dock includes the dock receiver that physically couples the recorder to the dock via the data port and a dock processor that is coupled to the dock receiver. The monitor system further includes a data processor defined to analyze the signals from the sensor that were stored in the recorder. The data processor includes: a data processor memory to store data from the recorder and a data processor clock. Further included with the data processor is a program to assign the time and date of the signals from the sensor by comparing the time and date on the data processor clock with the time assigned to the signals from the sensor by the recorder clock.06-30-2011
20080249387Enhanced monitor compliance - A monitoring system that enables enhanced compliance with a bio-sign monitor includes a method of transferring data to a consumer device, such as a cell phone or MP3 player and incorporating information related to the bio-sign data into the normal communication channel used by the consumer device. The combination of monitor and consumer device enables bio-sign related information to be made available in convenient and discreet manner that enhances the likelihood of compliance with the counter measures indicated by the bio-sign monitor.10-09-2008
20080242963SYSTEM, TOOLS, DEVICES AND A PROGRAM FOR DIABETES CARE - A method for diabetes care, the method (which also may be referred to as, involve or incorporate at least one of a tool, device or program) allowing for the characterization of the relevance of errors of parameters affecting glucose concentration on a postprandial glucose concentration outcome for a person with diabetes mellitusm, wherein the method involves at least one of sensing, determining, calculating, predicting, describing and communicating the effects of potential errors of parameters affecting glucose concentration on postprandial glucose concentration values within a clinically relevant glucose range.10-02-2008
20080234562Continuous analyte monitor with multi-point self-calibration - Analyte monitors and their methods of use. The analyte monitors include multiple calibration fluids which may have different known concentrations of an analyte, such as glucose. The analyte monitors may also include sensing or washing fluids. The analyte monitors are configured to be calibrated with the multiple calibration fluids to potentially provide a more accurate determination of analyte concentrations. The analyte monitors can be adapted to be self-calibrating with the multiple calibration fluids.09-25-2008
20080228057Method and system for controlling data information between two portable apparatuses - Disclosed is a method and system of controlling data information between two portable handheld apparatuses where the portable apparatuses include a first apparatus for performing a first operation and a second operation, and a second apparatus including a drug administration device. Each apparatus is capable one or more of the following: storing, transmitting, receiving, processing and displaying data information, and where the two apparatuses have a number of interrelated positions during normal use, where the method includes: automatically storing at least first data information relevant to said first operation in said first apparatus, automatically storing at least second data information relevant to said second operation in said second apparatus, and automatically transmitting, via short-range communications means, data information relevant to at least one of said first and second operations between said first and second apparatuses when said apparatuses are mutually positioned in one of said number of interrelated positions.09-18-2008
20080228056BASAL RATE TESTING USING FREQUENT BLOOD GLUCOSE INPUT - An apparatus comprising a user interface configured to generate an electrical signal to start a basal insulin rate test when prompted by a user, an input configured to receive sampled blood glucose data of a patient that is obtained during a specified time duration, including a time duration during delivery of insulin according to a specified basal insulin rate pattern, and a controller communicatively coupled to the input and the user interface. The controller includes an insulin calculation module configured for determining at least one of an amount of basal insulin over-delivered and an amount of basal insulin under-delivered during the basal insulin rate test in trying to meet a target blood glucose baseline. Other devices and methods are disclosed.09-18-2008
20080228055Fluctuating Blood Glucose Notification Threshold Profiles and Methods of Use - Embodiments of the present invention provide a new system and methods for monitoring blood glucose concentration. A user of a continuous glucose monitor may program upper and lower blood glucose notification thresholds to fluctuate over time in order to facilitate management of the short-term effects of food consumption, insulin delivery aberrations, physical activity, emotions, and unforeseen circumstances.09-18-2008
20130172710Handheld Diabetes Manager With A Personal Data Module - A handheld diabetes manager communicates with an external insulin pump and includes a port for blood glucose measurement, a blood glucose measurement module, a communications module that selectively communicates wirelessly with the insulin pump, and a user interface module. The user interface module communicates with the blood glucose measurement module and the communications module and operates to provide a graphical user interface on a display of the diabetes manager. The graphical user interface includes a personal data menu screen from which a logbook option can be selected to display a logbook screen, and a trend graph option that can be selected to display a trend graph screen. The logbook screen displays a plurality of time data records. Each time data record includes blood glucose data, bolus insulin data, and carbohydrate data for a corresponding time, and a plurality of data icons indicating corresponding events.07-04-2013
20130172706USER INTERFACE FEATURES FOR A DIABETES MANAGEMENT APPLICATION - A method is provided for contextualizing manual entries of blood glucose measures for a patient into a patient log of a portable computing device. The method includes: administering a structured collection procedure, where the structured collection procedure specifies two or more collection actions for obtaining blood glucose measures from a patient; generating a reminder notification for a given collection action of the structured collection procedure, where the given collection action is associated with a given event of patient; and displaying a data entry interface upon receipt of an acceptance input from a user in response to the reminder notification, where the data entry interface includes a first input for a blood glucose measure and a second input for an event associated with the blood glucose measure, such that value for the second input is defaulted to the given event from the reminder notification.07-04-2013
20130172707GRAPHICAL USER INTERFACE PERTAINING TO A BOLUS CALCULATOR RESIDING ON A HANDHELD DIABETES MANAGEMENT DEVICE - A handheld diabetes manager is presented with an improved graphical user interface for a bolus calculator. The bolus calculator is configured to receive blood glucose measurements from a blood glucose measurement module and operates, in response to an input, to compute an insulin recommendation for a patient based in part on the blood glucose measurements. The graphical user interface for the bolus calculator includes a health adjustment screen that enables a user to input a value for health events associated with the insulin recommendation, where the input value represents a cumulative effect of the health events on insulin of the patient and the health adjustment screen presents a different icon for each of the health events associated with the insulin recommendation.07-04-2013
20130172708Handheld Diabetes Manager With A User Interface For Displaying A Status Of An External Medical Device - A handheld diabetes manager has a graphical user interface for displaying status of an external medical device and includes a port configured to receive a test strip and a blood glucose measurement module. The diabetes manager includes a communications module that selectively communicates via a wireless data link with an external medical device to receive status data pertaining to the operation of the external medical device, and a user interface module in data communication with the blood glucose measurement module and the communications module. The graphical user interface includes a status screen that presents data pertaining to a glucose measure determined by the blood glucose measurement module concurrently with the status data received from the external medical device, such that the status data of the external medical device is presented on the status screen only when the communication module is in data communication with the external medical device.07-04-2013
20110263959METHOD OF INPUTTING DATA INTO AN ANALYTE TESTING DEVICE - A meter is provided that includes an improved user interface that enables the user to take a specific action, leading them directly to data input options. Such a user interface could be used to input first selected information, such as whether a test was premeal or postmeal, immediately after receiving a result. Optionally, the user interface may include the ability to add an additional comment after inputting the first selected information. Provision of such a user interface would facilitate simpler capture of the first selected information each time the user performs a test, leading to an enhanced understanding of a patient's level of glycemic control. Designing a user interface to enable first selected information to be entered by a user directly after receiving a result is more likely to engage a patient by making it easy and simple to enter important information. This may enable capture of the information thought to be most pertinent e.g. premeal and postmeal information, enhancing the understanding by patients and their carers of the patient's control.10-27-2011
20130178727ANALYTE SENSOR WITH LAG COMPENSATION - In particular embodiments, methods, devices and systems including calibrating analyte data associated with a monitored analyte level received from an analyte sensor based on a reference measurement, determining a lag time constant associated with the calibrated analyte data, and performing lag correction of the calibrated analyte data based on the determined time lag constant are disclosed.07-11-2013
20130172711DEVICE AND SYSTEM FOR BLOOD SAMPLING - A medical device is presented for reduced-pain blood sampling and testing. The device comprises a housing defining a finger site for supporting a user's finger or a portion thereof within said finger site during the device operation; piercing, sampling and testing assemblies sequentially actuatable to successively initiate piercing, sampling and testing operational modes of the device; a carriage at least partially accommodated within said housing and being adapted for movement with respect to said finger site between its first position corresponding to the piercing mode of the device and a second position corresponding to the sampling and testing modes of the device, the device being thereby capable of operating in the piercing, sampling and testing modes while at a static position of the user's finger.07-04-2013
20130172709Handheld Diabetes Manager With A Flight Mode - A handheld diabetes manager has a flight mode that cooperatively interacts with an external medical device and includes a port configured to receive a test strip for blood glucose measurement, a blood glucose measurement module operable with the test strip, a communications module and a user interface module. The communications module selectively communicates wirelessly with an external medical device. The user interface module communicates with the blood glucose measurement module and the communications module and operates to provide a graphical user interface on a display of the diabetes manager. The graphical user interface includes a screen with a flight mode option. When the flight mode option is enabled and the external medical device is paired and currently communicating with the diabetes manager, the user interface module interacts with the communication module to send a command to the external medical device to turn off wireless communication of the external medical device.07-04-2013
20130102867GLYCEMIC HEALTH METRIC DETERMINATION AND APPLICATION - Disclosed are methods, apparatuses, etc. for determination and application of a metric for assessing a patient's glycemic health. In one particular implementation, a computed metric may be used to balance short-term and long-term risks associated with a particular therapy.04-25-2013
20130102866METHOD AND/OR SYSTEM FOR MULTICOMPARTMENT ANALYTE MONITORING - Subject matter disclosed herein relates to monitoring and/or controlling levels of an analyte in bodily fluid. In particular, estimation of a concentration of the analyte in a first physiological compartment based upon observations of a concentration of the analyte in a second physiological compartment may account for a latency in transporting the analyte between the first and second physiological compartments.04-25-2013
20080200791ANALYTE SENSOR - Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.08-21-2008
20080200790Apparatus For Measuring Blood Sugar and Apparatus For Monitoring Blood Sugar Comprising the Same - There is provided an apparatus for measuring a blood sugar by using a microwave without withdrawing any blood while enhancing the reliability of measurement. The apparatus for measuring the blood sugar according to the present invention has a main body having a measurement surface configured to contact a measurement portion of a user, a probe part having a contact member exposed on the measurement surface so as to be in contact with the measurement portion, the probe part further having a probe disposed under the contact member for irradiating and receiving a microwave, a blood sugar measuring unit for supplying the microwave to the probe and measuring a blood sugar value from the received microwave, and a securing unit mounted on the main body for securing the measurement portion to the measurement surface.08-21-2008
20110224525Method and Apparatus for Providing Data Communication in Data Monitoring and Management Systems - Method and apparatus for communicating with a sealed electronic device via the electronic device's existing data ports for programming, testing configuration or diagnosis of the electronic device such as a transmitter unit for use in a data monitoring and management system such as analyte monitoring and management system is provided.09-15-2011
20110275920Smart Messages and Alerts for an Infusion Delivery and Management System - Method and system for providing diabetes management is provided.11-10-2011
20110237916AMBIENT TEMPERATURE SENSOR SYSTEMS AND METHODS - A first sensor may be configured to measure a sensed amount of a physiological parameter and to generate a first signal based on the sensed amount of the physiological parameter measured by the first sensor. A second sensor may be configured to measure a temperature and to generate a second signal based on the temperate measured by the second sensor. A housing may have heat-generating electronics including a processor that may be configured to determine an overall amount of the physiological parameter based on the first signal generated from the first sensor and the second signal generated from the second sensor. The second sensor may be thermally insulated from the heat-generating electronics.09-29-2011
20100305421GLUCOSE MONITORING SYSTEM WITH WIRELESS COMMUNICATIONS - A glucose monitor having only a test strip reader and wireless transmission to a remote hand held calculation processor. All glucose data processing occurs in a remote hand held calculator processor with the glucose monitor providing only sensing and wireless transfer of data. In an embodiment, the glucose monitor includes a button for use in wirelessly pairing the monitor to a smart phone for data communication with a non-proprietary communication protocol, and a light source to communicate the progress of the pairing. In a further embodiment, the glucose monitor includes a switch coupled to the strip reader such that power is applied to the monitor when a test strip is inserted and power is removed with the withdrawal of the test strip. In another embodiment, inserting the test strip and activating the switch also places the glucose monitor into the pairing search mode to communication with a host remote processor.12-02-2010
20100317953Medical Devices and Methods of Using the Same - Medical devices having restrictive access, and methods thereof are provided.12-16-2010
20100317952METHODS FOR REDUCING FALSE HYPOGLYCEMIA ALARM OCCURRENCE - A system and method for reducing the number of hypoglycemic alarms presented to a user is presented. The system and methods include use of model based state estimation and variable-delayed threshold values to balance the risk of not presenting an alarm caused by an actual hypoglycemic state with the presentation of alarms caused by artifacts in the signals produced by a continuous glucose monitor.12-16-2010
20100317951PORTABLE HANDHELD MEDICAL DIAGNOSTIC DEVICES WITH COLOR-CHANGING INDICATOR - A portable handheld medical diagnostic device includes a housing forming a protective enclosure. A main circuit board is located in the protective enclosure. The main circuit board includes a controller facilitating a physiologic measurement. A display device is connected to the main circuit board that displays information related to the physiologic measurement. An electronic skin is on the housing. The electronic skin comprises a liquid crystal material and is configured to display a color.12-16-2010
20100317950DEVICE, METHOD, AND GRAPHICAL USER INTERFACE FOR SEARCHING, FILTERING AND DISPLAYING EVENT-ALIGNED INFORMATION SETS RELATED TO DIABETES - A device, method, and graphical user interface for displaying diabetes related information sets aligned by the occurrence of a particular event are disclosed. After receiving a request for an event-aligned display of diabetes related information based on an event, a search for a plurality of tagged occurrences of the event and retrieval of an information set for each of the plurality of tagged occurrences is provided. Each information set may include diabetes related information chronologically related to the tagged occurrence. The retrieved information sets is displayed on a display, wherein the retrieved information sets are shown on the display aligned by their tagged occurrences such that all diabetes related information is positioned relative the event based on its chronological relationship with the event.12-16-2010
20120283543TRANSCUTANEOUS ANALYTE SENSOR - The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.11-08-2012
20120283542Correlation of Alternative Site Blood and Interstitial Fluid Glucose Concentrations to Venous Glucose Concentration - The invention relates to a method for calibrating an analyte-measurement device that is used to evaluate a concentration of analyte in bodily fluid at or from a measurement site in a body. The method involves measuring a concentration, or calibration concentration, of an analyte in blood from an “off-finger” calibration site, and calibrating the analyte-measurement device based on that calibration concentration. The invention also relates to a device, system, or kit for measuring a concentration of an analyte in a body, which employs a calibration device for adjusting analyte concentration measured in bodily fluid based on an analyte concentration measured in blood from an “off-finger” calibration site.11-08-2012
20120283541SYSTEM AND METHODS FOR PROCESSING ANALYTE SENSOR DATA - Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor.11-08-2012
20120283540IMPLANTABLE SENSOR DEVICE AND MEDICAL DELIVERY DEVICE CONNECTABLE TO SUCH A SENSOR DEVICE - The invention relates to a sensor device for in vivo monitoring of glucose in diabetics, wherein the sensor device comprises a micro-array with multiple sensors to be implanted subcutaneously in a patient wherein each sensor may be activated separately for monitoring purposes. Preferably, the sensors in said micro-array are comprised in a mold that is covered by a metal membrane, and even more preferably, the membrane is electrically openable to expose each specific activated sensor in the micro-array separately for monitoring purposes. A transceiver may be provided for monitoring signals obtained by each specific activated sensor to an external receiver and the receiver may be connected to a display means for displaying data representative of the signals obtained by the specific activated sensor.11-08-2012
20120283539Tissue penetration device - A body fluid testing device has at least one penetrating member and a penetrating member driver configured to be coupled to the at least one penetrating member. A plurality of analyte sensors are coupled to a spoked disk substrate. Each of a penetrating member can pass between spokes of the disk substrate to provide that a used penetrating member can be removed and a new penetrating inserted without removing the disk. A disposable houses the at least one penetrating member and the plurality of analyte sensors.11-08-2012
20130184548BIOLOGICAL SAMPLE MEASURING DEVICE FOR MEDICAL INSTITUTIONS - This biological sample measuring device has the display screen of a display section (07-18-2013
20130184547Method and Apparatus for Determining Medication Dose Information - Methods, devices, and kits are provided for determining a recommended insulin dose to be administered to user based upon analyte data determined by an analyte sensor.07-18-2013
20110313267BLOOD GLUCOSE MONITORING SYSTEM, STRIP ACCOMMODATION DEVICE, STRIP STORAGE DEVICE, AND AUTOMATED BLOOD COLLECTION DEVICE - The present invention relates to a blood glucose monitoring system, a strip accommodation device, a strip storage device, and an automated blood collection device, wherein the blood glucose monitoring system has the strip accommodation device formed integrally therewith, the strip accommodation device being configured to convert a rotary motion of a cover of an operating member into an upward linear motion and to eject one of a plurality of strips through an ejection hole, thereby easily storing the strips therein, preventing the contamination of the strips from the foreign matters like outside moisture, and accurately and easily measuring the concentration of the glucose in the blood.12-22-2011
20130190583METHOD AND/OR SYSTEM FOR ASSESSING A PATIENT'S GLYCEMIC RESPONSE - Subject matter disclosed herein relates to a method and/or system for tailoring insulin therapies to physiological characteristics of a patient. In particular, observations of a blood glucose concentration of a patient responsive to a meal profile and an insulin profile may be used for estimating one or more physiological parameters.07-25-2013
20120029333MODULAR INFUSION SET WITH AN INTEGRATED ELECTRICALLY POWERED FUNCTIONAL COMPONENT - An infusion set for administering a medicament delivered by an infusion pump which can be carried separately from the infusion set as well as an infusion system including the infusion set are disclosed. The infusion set can comprise a disposable part, a reusable part, and an electrically powered functional component. The disposable part can comprise a single lumen infusion cannula that projects from the underside and is the only skin piercing or penetrating element of the infusion set. The reusable part when in the interconnected state is fluidically isolated from the disposable part. The disposable part can comprise a feeding line which fluidically connects an upstream end of the first connector with a downstream end of a cannula to feed and deliver the medicament via the disposable part and bypass the reusable part.02-02-2012
20130197335DEVICE AND METHOD FOR POSITIONING A BODY PART FOR FLUID ANALYSIS - A device and a method are disclosed for positioning a body part (08-01-2013
20120095318HANDHELD DIABETES MANAGEMENT DEVICE WITH BOLUS CALCULATOR - A method for monitoring blood glucose (bG) levels of a diabetic user. The method may be implemented on a non-transitory computer readable medium adapted to run on a processing subsystem, the processing subsystem forming a portion of a handheld diabetes management device for monitoring the bG levels of a diabetic user and determining a correction bolus to be provided to the user. The method may comprise using a memory to store information in a plurality of different time blocks. The information may include a plurality of differing user defined health events that each include a predetermined associated percentage value set by the user by which a correction bolus calculation will be modified to account for one of an increase or a decrease in insulin associated with each one of the defined health events. The processing subsystem may be used to communicate with the memory and to obtain the information and to calculate therefrom the correction bolus.04-19-2012
20120095317COMMUNICATION PROTOCOL THAT SUPPORTS STRUCTURED COLLECTION PROCEDURES USED IN DIABETES CARE - A computer-implemented diabetes management system is provided for configuring a structured collection procedure implemented on a collection device having a meter that measures the concentration of glucose in blood. The system includes: a collection application that executes a structured collection procedure for obtaining measurement data from the meter and provides access to the measurement data via a communication protocol defined in accordance with IEEE standard 11073-20601; a configuration application that accesses and manipulates the parameters of the structured collection procedure using a set of action commands, where the set of action commands are defined in compliance with the communication protocol; and a collection interface that receives an action command from the configuration application, executes the received action command and issues a response command in response thereto, where the response command is defined in compliance with the communication protocol.04-19-2012
20120095316HANDHELD DIABETES MANAGING DEVICE WITH LIGHT PIPE FOR ENHANCED ILLUMINATION - A handheld diabetes management device for providing enhanced illumination includes a housing with an access port and a light aperture. The housing further includes a coupling member on an inner surface thereof. Furthermore, the device includes a measurement engine housed within the housing and communicating with the access port for analyzing body fluid disposed on a dosing area of a diabetes test element. Also, the device includes a circuit board communicating with the measurement engine. The device further includes a light source mounted to the circuit board and a light pipe coupled to the housing via the coupling member. The light pipe is disposed adjacent the light source to receive light from the light source travelling in a first direction. The light pipe redirects the light along a second direction to be emitted out of the housing through the light aperture toward the dosing area of the diabetes test element.04-19-2012
20120095315CONFIGURATION OF BLOOD GLUCOSE METER INTERFACES - A handheld diabetes management device includes a blood glucose measurement engine that measures a blood glucose level of a patient. The device includes a physical port that is exposed at an exterior of the device. The device includes a processing module that includes first, second, and third physical interfaces that are internal to the device. The device includes a multiplexing module that alternatively connects the physical port to one of the first, second, and third physical interfaces of the processing module. The processing module selectively operates the first physical interface using first and second modes. When an external host is connected to the physical port, the processing module selectively transfers information based on the blood glucose level to the external host using the first mode. When the external host is connected to the physical port, the processing module selectively provides file access to the external host using the second mode.04-19-2012
20120095314HANDHELD DIABETES MANAGEMENT DEVICE HAVING A DATABASE MANAGEMENT SYSTEM - A handheld diabetes management device having a database management system is disclosed. The device comprises a plurality of input modules, including a blood glucose reader, a user interface, a communications interface, and a continuous blood glucose input module. The input modules output data used to generate data records of different record types. The device further comprises N databases, each database having a different frequency range associated thereto, wherein the new record is stored in a particular database of the N databases based on the frequency range of the particular database and the frequency of the particular record type, and N is an integer greater than 1. The device further includes a database operation module that performs database operations on the N databases. The database management system provides increased reliability in the keeping of records on which medically important decisions are made.04-19-2012
20120095313MEDICAL DEVICES THAT SUPPORT ENHANCED SYSTEM EXTENSIBILITY FOR DIABETES CARE - A medical device or medical software is provided that supports system extensibility for diabetes care. The medical device or software is comprised of an application and particular data structures that support diabetes care. The data structures include: a patient class that has attributes and methods associated with a person receiving medical treatment for diabetes; a patient log class that has a composition relationship with the patient class and attributes and methods that log actions taken by the patient; a treatment plan class that has a composition relationship with the patient class and attributes and methods that define a series of planned actions related to medical treatment of the patient; and an adherence class that has a composition relationship with the patient log class and attributes and methods define relationships between actions planned for the patient and actions taken by the patient. The application instantiates an object from at least one of the patient log class, the adherence class and the treatment plan class, having only external-to-the-composition knowledge of which objects are instantiated, and performs a function using the instantiated object.04-19-2012
20120095311COEXISTENCE OF MULTIPLE RADIOS IN A MEDICAL DEVICE - A handheld diabetes management device having a plurality of communication modules for communicating with a plurality of medical devices via a shared antenna or multiple antennas, where the handheld diabetes management device includes a first communication module, a second communication module, and an arbitration module. The first communication module selectively communicates in a first frequency band with an insulin infusion pump external to the handheld diabetes management device via a first antenna using a first wireless communication protocol. The second communication module selectively communicates in the first frequency band with a continuous glucose monitor external to the handheld diabetes management device via a second antenna or the first antenna using a second wireless communication protocol. The arbitration module grants permission to communicate to the first communication module and denies permission to communicate to the second communication module when the first and second communication modules request permission to communicate concurrently.04-19-2012
20120095310TIME BLOCK MANIPULATION FOR INSULIN INFUSION DELIVERY - The present teachings provide a system for modifying insulin therapy support parameters such as warning limit data and time block data on a hand-held diabetes management device. The system can include a graphical user interface module that creates a graphical user interface having a plurality of bar structures positionable on or between a first line that indicates an upper limit and a second line that illustrates a lower limit. Each of the bar structures can have a first side that indicates a start time of a time window opposite a second side that indicates an end time of the time window and a third side that indicates a lower target value for a blood glucose level opposite a fourth side that indicates an upper target value for the blood glucose level. The bar structures, the first line and the second line can be adjustable by a user input.04-19-2012
20120095309UPDATABILITY OF STRUCTURED BLOOD GLUCOSE TESTS PERFORMED ON HANDHELD DIABETES MANAGEMENT DEVICES - A method of improving updatability of entry, adherence, and exit criteria stored in memory of a handheld diabetes management device, the method includes: providing the handheld diabetes management device with a blood glucose (bG) measurement engine that measures a bG level in a sample of blood of a user and that generates sample data indicative of the bG level; providing the handheld diabetes management device with the memory and a touchscreen display; providing the handheld diabetes management device with a processor module that is in communication with the bG measurement engine, the touchscreen display, and the memory; storing firmware that is executable by the processor module for performing operations to carry out a structured bG test in a non-modifiable portion of the memory; and storing the entry, adherence, and exit criteria in a modifiable portion of the memory.04-19-2012
20130211220ESTIMATION OF INSULIN SENSITIVITY FROM CGM AND SUBCUTANEOUS INSULIN DELIVERY IN TYPE 1 DIABETES - In a method of determining insulin sensitivity in a patient, glucose level is sensed continuously. A first area under the curve representing the glucose level over time is calculated. An amount of insulin that has been administered to the patient is sensed. An estimation of insulin on board the patient is calculated based on the glucose level and the amount of insulin administered to the patient. A second area under the curve representing the insulin on board over time is calculated. Patient data indicative of at least one patient physical parameter is received. Information indicative of amount of glucose ingested by the patient during a meal is received. An insulin sensitivity output indicative of ability of insulin to stimulate glucose utilization and inhibit glucose production in the patient based on the first and second area under the curve, the patient data and the meal information is generated.08-15-2013

Patent applications in class Glucose measurement